Document:

EX-10.1

 Exhibit 10.1 

Execution 
  

 
  

INVESTMENT AGREEMENT 
 by and
among 
 BOX, INC., 
 POWELL
INVESTORS III L.P., 
 KKR-MILTON CREDIT HOLDINGS L.P., 

KKR-NYC CREDIT C L.P. 

TAILORED OPPORTUNISTIC CREDIT FUND 

and 
 CPS HOLDINGS (US) L.P. 

Dated as of April 7, 2021 
  

 
  

 TABLE OF CONTENTS 
  

							
	 	 	 	  	PAGE	 
	 ARTICLE I DEFINITIONS
	  	 	1	 
			
	 Section 1.01
	 	Definitions	  	 	1	 
		
	 ARTICLE II PURCHASE AND SALE
	  	 	11	 
			
	 Section 2.01
	 	Purchase and Sale	  	 	11	 
	 Section 2.02
	 	Closing	  	 	11	 
		
	 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	  	 	12	 
			
	 Section 3.01
	 	Organization; Standing	  	 	12	 
	 Section 3.02
	 	Capitalization	  	 	13	 
	 Section 3.03
	 	Authority; Noncontravention	  	 	14	 
	 Section 3.04
	 	Governmental Approvals	  	 	15	 
	 Section 3.05
	 	Company SEC Documents; Undisclosed Liabilities	  	 	15	 
	 Section 3.06
	 	Absence of Certain Changes	  	 	17	 
	 Section 3.07
	 	Legal Proceedings	  	 	17	 
	 Section 3.08
	 	Compliance with Laws; Permits	  	 	17	 
	 Section 3.09
	 	Tax Matters	  	 	19	 
	 Section 3.10
	 	No Rights Agreement; Anti-Takeover Provisions	  	 	19	 
	 Section 3.11
	 	Brokers and Other Advisors	  	 	19	 
	 Section 3.12
	 	Sale of Securities	  	 	19	 
	 Section 3.13
	 	Listing and Maintenance Requirements	  	 	20	 
	 Section 3.14
	 	Status of Securities	  	 	20	 
	 Section 3.15
	 	Certain Material Indebtedness	  	 	20	 
	 Section 3.16
	 	Investment Company Status	  	 	20	 
	 Section 3.17
	 	Ability to Pay Dividends	  	 	20	 
	 Section 3.18
	 	IP; Security	  	 	21	 
	 Section 3.19
	 	No Other Company Representations or Warranties	  	 	21	 
	 Section 3.20
	 	No Other Investor Representations or Warranties	  	 	21	 
		
	 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE INVESTOR
	  	 	22	 
			
	 Section 4.01
	 	Organization; Standing	  	 	22	 
	 Section 4.02
	 	Authority; Noncontravention	  	 	22	 
	 Section 4.03
	 	Governmental Approvals	  	 	23	 
	 Section 4.04
	 	Financing	  	 	23	 
	 Section 4.05
	 	Brokers and Other Advisors	  	 	23	 
	 Section 4.06
	 	Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans	  	 	23	 
	 Section 4.07
	 	Purchase for Investment	  	 	24	 
	 Section 4.08
	 	No Other Investor Representations or Warranties	  	 	24	 

  
 i 

							
	 Section 4.09
	 	No Other Company Representations or Warranties	  	 	25	 
		
	 ARTICLE V ADDITIONAL AGREEMENTS
	  	 	25	 
			
	 Section 5.01
	 	Negative Covenants	  	 	25	 
	 Section 5.02
	 	Reasonable Best Efforts; Filings	  	 	26	 
	 Section 5.03
	 	Corporate Actions	  	 	28	 
	 Section 5.04
	 	Public Disclosure	  	 	29	 
	 Section 5.05
	 	Confidentiality	  	 	29	 
	 Section 5.06
	 	NYSE Listing of Shares	  	 	30	 
	 Section 5.07
	 	Standstill	  	 	31	 
	 Section 5.08
	 	Transfer Restrictions	  	 	33	 
	 Section 5.09
	 	Legend	  	 	35	 
	 Section 5.10
	 	Election of Directors	  	 	36	 
	 Section 5.11
	 	Voting	  	 	38	 
	 Section 5.12
	 	Tax Matters	  	 	39	 
	 Section 5.13
	 	Use of Proceeds	  	 	40	 
	 Section 5.14
	 	KKR Sponsor	  	 	40	 
	 Section 5.15
	 	Financing Cooperation	  	 	41	 
	 Section 5.16
	 	Exclusivity	  	 	42	 
	 Section 5.17
	 	Preemptive Rights	  	 	43	 
	 Section 5.18
	 	Available Registration Statement	  	 	45	 
	 Section 5.19
	 	Section 16 Matters	  	 	45	 
	 Section 5.20
	 	CUSIP	  	 	46	 
		
	 ARTICLE VI CONDITIONS TO CLOSING
	  	 	46	 
			
	 Section 6.01
	 	Conditions to the Obligations of the Company and the Investors	  	 	46	 
	 Section 6.02
	 	Conditions to the Obligations of the Company	  	 	46	 
	 Section 6.03
	 	Conditions to the Obligations of the Investor	  	 	47	 
		
	 ARTICLE VII TERMINATION; SURVIVAL
	  	 	48	 
			
	 Section 7.01
	 	Termination	  	 	48	 
	 Section 7.02
	 	Effect of Termination	  	 	49	 
	 Section 7.03
	 	Survival	  	 	49	 
		
	 ARTICLE VIII MISCELLANEOUS
	  	 	50	 
			
	 Section 8.01
	 	Amendments; Waivers	  	 	50	 
	 Section 8.02
	 	Extension of Time, Waiver, Etc.	  	 	50	 
	 Section 8.03
	 	Assignment	  	 	50	 
	 Section 8.04
	 	Counterparts	  	 	51	 
	 Section 8.05
	 	Entire Agreement; No Third Party Beneficiaries; No Recourse	  	 	51	 
	 Section 8.06
	 	Governing Law; Jurisdiction	  	 	52	 
	 Section 8.07
	 	Specific Enforcement	  	 	52	 
	 Section 8.08
	 	WAIVER OF JURY TRIAL	  	 	53	 
	 Section 8.09
	 	Notices	  	 	53	 

  
 ii 

							
	 Section 8.10
	 	Severability	  	 	55	 
	 Section 8.11
	 	Expenses	  	 	55	 
	 Section 8.12
	 	Interpretation	  	 	55	 
	 Section 8.13
	 	Investor Representative	  	 	56	 
	 Section 8.14
	 	Not a Group; Independent Nature of Holders’ Obligations and Rights	  	 	56	 

 EXHIBITS 

EXHIBIT A – Form of Series A Certificate of Designations 

EXHIBIT B – Form of Registration Rights Agreement 
 EXHIBIT C
– Form of Permitted Investor Transferee Joinder 
 EXHIBIT D – Form of Permitted Transferee Joinder 

  
 iii 

 This INVESTMENT AGREEMENT dated as of April 7, 2021 (this
“Agreement”), is made and entered into by and among Box, Inc., a Delaware corporation (the “Company”), Powell Investors III L.P., a Cayman Islands exempted limited partnership,
KKR-Milton Credit Holdings L.P., a Cayman Islands exempted limited partnership, KKR-NYC Credit C L.P., a Delaware limited partnership and Tailored Opportunistic Credit
Fund, an Australian trust and CPS Holdings (US) L.P., a Delaware limited partnership, each of which are managed or advised by KKR Credit Advisors (US) LLC or Affiliates thereof (collectively, the “Investor”). 

RECITALS 
 WHEREAS, the Company
desires to issue, sell and deliver to the Investor, and the Investor desires to purchase and acquire from the Company, pursuant to the terms and conditions set forth in this Agreement, an aggregate of 500,000 shares of the Company’s Series A
Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), having the powers, designations, preferences and relative, participating, optional or other special rights, and the qualifications,
limitations and restrictions thereof specified in the form of Certificate of Designations attached hereto as Exhibit A (the “Certificate of Designations”); 

NOW, THEREFORE, in consideration of the mutual covenants, representations, warranties and agreements contained in this Agreement, the receipt
and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: 
 ARTICLE I 

Definitions 

Section 1.01 Definitions. (a) As used in this Agreement (including the recitals hereto), the following terms shall
have the following meanings: 
 “50% Beneficial Ownership Requirement” means that the Investor, together with the other
Permitted Transferees of the Investor, continues to beneficially own at all times Acquired Shares and/or shares of Common Stock issued or issuable upon conversion of such Acquired Shares, that represent in the aggregate and on an as converted basis,
at least 50% of the number of Acquired Shares beneficially owned by the Investor, on an as converted basis, as of immediately following the Closing. For the avoidance of doubt, any Acquired Shares, and/or Common Stock issued or issuable upon
conversion of such Acquired Shares, purchased by any Permitted Investor Transferees at the Closing shall not be considered owned by the Investor as of or immediately following the Closing. 

“Activist Shareholder” means, as of any date of determination, a Person (other than the Investor Parties and their respective
Affiliates) that has, directly or indirectly through its Affiliates, whether individually or as a member of a “group” (as defined in Section 13(d)(3) of the Exchange Act), within the three-year period immediately preceding such date
of determination (i) called or publicly sought to call a meeting of the stockholders or other equityholders of any Person not publicly approved (at the time of the first such action) by the board of directors or similar governing body of such
Person, (ii) publicly initiated any proposal for action by stockholders or other equityholders of any Person initially publicly opposed by the 

 board of directors or similar governing body of such Person, (iii) publicly sought election to, or to
place a director or representative on, the board of directors or similar governing body of a Person, or publicly sought the removal of a director or other representative from such board of directors or similar governing body, in each case which
election or removal was not recommended or approved publicly (at the time such election or removal is first sought) by the board of directors or similar governing body of such Person (iv) made, engaged in or been a participant in any
“solicitation” of “proxies”, as such terms are used in the proxy rules of the SEC promulgated under Section 14 of the Exchange Act, with respect to the matters set forth in clauses (i) through (iii), or
(v) publicly disclosed any intention, plan or arrangement to do any of the foregoing. For the avoidance of doubt, neither the Investor nor any Permitted Investor Transferees (or their respective Affiliates) are Activist Shareholders. 

“Affiliate” means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is
under common control with, such Person; provided, however, (i) that the Company and its Subsidiaries, on the one hand, and any Investor Party or any of its Affiliates, on the other hand, shall not be deemed to be Affiliates, (ii)
“portfolio companies” (as such term is customarily used among institutional investors) in which any Investor Party or any of its Affiliates has an investment (whether as debt or equity) shall not be deemed an Affiliate of such Investor
Party, (iii) the Excluded Sponsor Parties shall not be deemed to be Affiliates of any Investor Party, the Company or any of the Company’s Subsidiaries, (iv) any fund or account managed or advised by KKR Credit Advisors (US) LLC and
any of its affiliates other than the Investor shall be deemed an Affiliate of the KKR Investor Group, and (v) none of the Permitted Investor Transferees or any of their respective Permitted Transferees or Affiliates shall be deemed an Affiliate
of the Investor. For this purpose, “control” (including its correlative meanings, “controlling”, “controlled by” and “under common control with”), with respect to the relationship
between or among two or more Persons, means the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management of a Person, whether through the ownership of voting securities, as trustee or executor,
by Contract or otherwise. 
 “Anti-Money Laundering Laws” means anti-money laundering-related laws, regulations, and codes
of practice applicable to the Company and its Subsidiaries and their operations from time to time, including without limitation the EU Anti-Money Laundering Directives and any laws, decrees, administrative orders, circulars, or instructions
implementing or interpreting the same. 
 “as converted basis” means, with respect to a Person or Persons, all outstanding
shares of Common Stock beneficially owned by such Person or Persons, calculated on a basis in which all shares of Common Stock issuable upon conversion of the outstanding shares of Series A Preferred Stock (at the Conversion Rate in effect on such
date as set forth in the Certificate of Designations) are assumed to be outstanding as of such date. 
 “Available Registration
Statement” shall mean, with respect to a Registration Statement as of a date, that (i) as of such date such Registration Statement is effective for an offering to be made on a delayed or continuous basis, there is no stop order with
respect thereto and the Company reasonably believes that such Registration Statement will be continuously available for the resale of Registrable Securities for the next ten (10) Business Days and (ii) as of such date and continuously for
the next ten (10) Business Days, (a) there is not in effect a Postponement Period or Quarterly Blackout Period (as each such term is defined in the Registration Rights Agreement) and (b) the Investor Parties are not restricted by the
holdback provision of Section 9(a) of the Registration Rights Agreement or any related “lock-up” agreement. 

  
 2 

 Any Person shall be deemed to “beneficially own”, to have
“beneficial ownership” of, or to be “beneficially owning” any securities (which securities shall also be deemed “beneficially owned” by such Person) that such Person is deemed to “beneficially
own” within the meaning of Rules 13d-3 and 13d-5 under the Exchange Act; provided that any Person shall be deemed to beneficially own any securities that
such Person has the right to acquire, whether or not such right is exercisable immediately (including assuming conversion of all Series A Preferred Stock, if any, owned by such Person to Common Stock). For the avoidance of doubt, for purposes of
this Agreement, an Investor Party (or any other person) shall at all times be deemed to have beneficial ownership of the Series A Preferred Stock, including shares of Common Stock issuable upon conversion of the Series A Preferred Stock directly or
indirectly held by it, irrespective of any restrictions on transfer or voting contained in this Agreement or the Certificate of Designations. 

“Board” means the Board of Directors of the Company. 

“Business Day” means any day except a Saturday, a Sunday or other day on which the SEC or banks in the City of New York are
authorized or required by Law to be closed with respect to the provision of “essential services” (as defined by any applicable Governmental Authority from time to time). 

“Class B Common Stock” means the Class B Common Stock, par value $0.0001 per share, of the Company.

 “Code” means the United States Internal Revenue Code of 1986, as amended. 

“Common Stock” means the Class A Common Stock, par value $0.0001 per share, of the Company. 

“Company Charter Documents” means the Company’s certificate of incorporation and bylaws, each as amended to the date of
this Agreement, and shall include the Certificate of Designations, as filed with the Secretary of State of the State of Delaware. 

“Company Plan” means each plan, program, policy, agreement or other arrangement covering current or former employees,
directors or consultants, that is (i) an employee welfare plan within the meaning of Section 3(1) of ERISA, (ii) an employee pension benefit plan within the meaning of Section 3(2) of ERISA, other than any plan which is a
“multiemployer plan” (as defined in Section 4001(a)(3) of ERISA), (iii) a stock option, stock purchase, stock appreciation right or other stock-based agreement, program or plan, (iv) an individual employment, consulting,
severance, retention or other similar agreement or (v) a bonus, incentive, deferred compensation, profit-sharing, retirement, post-retirement, vacation, severance or termination pay, benefit or fringe-benefit plan, program, policy, agreement or
other arrangement, in each case that is sponsored, maintained or contributed to by the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries is obligated to contribute to or has or may have any liability, other than
any plan, program, policy, agreement or arrangement sponsored and administered by a Governmental Authority. 

  
 3 

 “Company PSU” means a restricted stock unit with respect to Common Stock
that was granted subject to performance-based vesting conditions. 
 “Company RSU” means a restricted stock unit with
respect to Common Stock, other than a Company PSU. 
 “Company Stock Option” means an option to purchase shares of Common
Stock. 
 “Company Stock Plans” means the 2015 Equity Incentive Plan and the 2015 Employee Stock Purchase Plan, 2011 Equity
Incentive Plan, and 2006 Stock Incentive Plan in each case as amended from time to time. 
 “Competing Securities Issuance”
means any proposal or offer from any Person relating to any direct or indirect issuance or sale by the Company or any of its Subsidiaries of any debt or equity securities of the Company or its Subsidiaries (or options, rights or warrants to
purchase, or securities convertible into or exchangeable for, such securities) (other than grants of Company Stock Options, Company PSUs and Company RSUs under the Company Stock Plans in the ordinary course of business to directors, employees,
officers, consultants or other service providers of the Company or any of its Subsidiaries or shares of Common Stock issuable upon settlement or exercise of Company Stock Options, Company PSUs and Company RSUs, pursuant to the Notes, or shares of
Common Stock required to be issued pursuant to any earn-out existing in any Contract existing as of the date hereof). For the avoidance of doubt, a “Competing Securities Issuance” does not include
any proposal or offer for a transaction constituting a Change of Control (as defined in the Certificate of Designations). 

“Competitor” means (i) any Person that is primarily engaged in any business that directly or indirectly competes with
the business of the Company and its Subsidiaries of providing software or services in the enterprise content management space or (ii) any Person that owns or controls any Person referenced in the foregoing clause (i). 

“Conversion Rate” has the meaning set forth in the Certificate of Designations. 

“COVID-19” shall mean
SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemic or disease
outbreaks, or any escalation or worsening of any of the foregoing (including any subsequent waves). 
 “COVID-19 Measures” shall mean any public health, quarantine, “shelter in place,” “stay at home,” social distancing, shut down, closure, sequester, safety or similar law, requirement,
directive or mandate promulgated by any Governmental Authority, in each case in connection with or in response to COVID-19. 

“DGCL” means the Delaware General Corporation Law, as amended, supplemented or restated from time to time. 

  
 4 

 “ERISA” means the Employee Retirement Income Security Act of 1974, as
amended. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder. 
 “Existing Credit Agreement” means the Credit Agreement, dated as of November 27, 2017, by and between
the Company and Wells Fargo Bank, as amended by that certain Amendment No. 1, dated as of July 12, 2019, as further amended by that certain letter agreement, dated as of September 27, 2019, as further amended by that certain letter
agreement, dated as of April 17, 2020, as further amended that certain letter agreement, dated as of February 2, 2021, and as further amended by that certain letter agreement, dated on or about of April 7, 2021. 

“Export Control Laws” means the EC Regulation 428/2009 and the implementing laws and regulations of the EU member states; the
U.S. Export Administration Act, U.S. Export Administration Regulations, U.S. Arms Export Control Act, U.S. International Traffic in Arms Regulations, and their respective implementing rules and regulations; the U.K. Export Control Act 2002 (as
amended and extended by the Export Control Order 2008) and its implementing rules and regulations; and other similar export control laws or restrictions applicable to the Company, its Subsidiaries and their respective operations from time to time.

 “Fall-Away of Investor Board Rights” means the first day on which the KKR Investor Group no longer meets the 50%
Beneficial Ownership Requirement. 
 “Fraud” means actual, not constructive, common law fraud (under the laws of the State
of Delaware), committed with scienter, in the making of the representations and warranties expressly given in this Agreement. 

“GAAP” means generally accepted accounting principles, as in effect in the United States from time to time. 

“Governmental Authority” means any government, court, regulatory or administrative agency, commission, arbitrator or
authority or other legislative, executive or judicial governmental official or entity (in each case including any self-regulatory organization), whether federal, state or local, domestic, foreign or multinational. 

“Hedge” means the making any swap, short sale of, derivative transaction, granting any option for the purchase of, or
entering into any hedging or similar transaction that transfers to any Person, directly or indirectly, in whole or in part, any of the economic consequences of ownership of any shares of Series A Preferred Stock or Common Stock, or otherwise
establishing or increasing, directly or indirectly, a put equivalent position, as defined in Rule 16a-1(h) under the Exchange Act, with respect to the any of the Series A Preferred Stock or Common Stock or any
other capital stock of the Company. 
 “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended, and the rules and regulations promulgated thereunder. 

  
 5 

 “Indenture” means the Indenture, dated January 14, 2021, between the
Company and U.S. Bank National Association. 
 “Intellectual Property” means all intellectual property rights, including
patents, trade secrets, know-how, inventions, methods, processes, copyrights, trademarks, service marks, domain names, social and mobile media identifiers, trade dress and other source indicators and all
associated goodwill. 
 “Investor” has the meaning set forth in the Preamble. Any reference to any action by the Investor
Parties in this Agreement that requires an instrument in writing signed by the Investor Parties shall require an instrument in writing signed by the Investor, so long as it is an Investor Party, or each of the Investor Parties. 

“Investor Designee” means an individual designated in writing by the KKR Investor Group to be appointed or nominated by the
Company for election to the Board pursuant to Section 5.10(a), Section 5.10(c) or Section 5.10(d), as applicable; provided, that, unless the Company otherwise
consents, any Investor Designee must be an employee of the KKR Sponsor with the title of managing director or member. 
 “Investor
Director” means a member of the Board who was appointed or elected to the Board as an Investor Designee. 
 “Investor
Material Adverse Effect” means any effect, change, event or occurrence that, individually or in the aggregate, would or would reasonably be expected to, prevent, materially delay, interfere with, hinder or impair (i) the consummation
by the Investor Party of any of the Transactions or (ii) the compliance by the Investor Parties of its obligations under this Agreement. 

“Investor Parties” means (a) the Investor and its Permitted Transferees and (b) any Permitted Investor Transferee
and its Permitted Transferees. The Investor and its Permitted Transferees shall not be considered part of the “Investor Parties” for any Permitted Investor Transferee and its Permitted Transferees, and such Permitted Investor Transferee
and respective Permitted Transferees shall be solely responsible for their own compliance with the terms of this Agreement. 
 “IT
Assets” means all hardware, software, code, systems, networks, websites, applications, databases and other information technology assets and equipment. 

“KKR Investor Group” means the Investor and each Permitted Transferee of such Investor. 

“KKR Sponsor” means KKR Credit Advisors (US) LLC. 

“Knowledge” means, with respect to the Company, the actual knowledge of the individuals listed on
Section 1.01 of the Company Disclosure Letter, after reasonable inquiry of their direct reports. 

  
 6 

 “Liens” means any mortgage, pledge, lien, charge, encumbrance, security
interest, adverse ownership interest or other restriction of any kind or nature, whether based on common law, statute or contract. 

“Lock-Up Period” means the period commencing on the date hereof and ending on the
first anniversary of the Closing Date. 
 “Material Adverse Effect” means any effect, change, event or circumstance (an
“Effect”) that, individually or in the aggregate, has had, or would reasonably be expected to have a material adverse effect on the business, assets, properties, financial condition or results of operation of the Company and its
Subsidiaries, taken as a whole; provided, however, that any changes or events resulting from the following items shall not be considered when determining whether a Material Adverse Effect has occurred: (a) changes in economic,
political, regulatory, financial or capital market conditions generally or in the industries in which the Company and its Subsidiaries operate, (b) any acts of war, sabotage, terrorist activities or changes imposed by a Governmental Authority
associated with national security, (c) epidemics, pandemics or disease outbreaks (including COVID-19), hurricanes, tsunamis, tornadoes, floods, mudslides, wild fires or other natural disasters or weather
or meteorological events, and other force majeure events in the United States or any other country or region in the world (or escalation or worsening of any of the foregoing, including, as applicable, second or subsequent wave(s)), (d) any
change of Law (including COVID-19 Measures), accounting standards, regulatory policy or industry standards after the date of this Agreement, (e) the announcement, execution or delivery of this Agreement
or the consummation of the Transactions, including the impact thereof on the relationships, contractual or otherwise, of the Company and its Subsidiaries with employees, suppliers, customers, partners, vendors or any other third Person (it being
understood that this clause (e) shall not apply to a breach of any representation or warranty set forth in Section 3.01, Section 3.03 or Section 3.04), (f) any
actions taken by, or at the written request of, Investor or the Investor Parties (g) any failure by the Company to meet projections or forecasts or revenue or earnings predictions for any period (but, for the purposes of clarity, not the
underlying cause of such failure), (h) any Actions arising from allegations of breach of fiduciary duty or otherwise relating to this Agreement or the transactions contemplated hereby or thereby or by an Activist Shareholder (provided that with
respect to any Action by an Activist Shareholder the underlying causes or Effects of any such Actions may, to the extent not otherwise excluded by another clause of this definition, be considered in determining whether there is or has been a
Material Adverse Effect), (i) changes in the price or trading volume of the Common Stock, in and of or any change in the credit ratings or ratings outlook of the Company (provided, that the underlying causes of such changes may, to the extent not
otherwise excluded by another clause of this definition, be considered in determining whether there is or has been a Material Adverse Effect), (j) any COVID-19 Measures, including any Effect with respect to COVID-19 Measures except, solely with respect to clauses (a), (b), (c), (d) and (j), to the extent the Company and its Subsidiaries, taken as a whole, are materially and disproportionately affected thereby relative
to other participants in the industry or industries in which the Company and its Subsidiaries operate (in which case only the incremental material and disproportionate effect or effects may be taken into account in determining whether there has been
a Material Adverse Effect). 
 “Notes” means the 0% Convertible Senior Notes of the Company due 2026. 

  
 7 

 “NYSE” means the New York Stock Exchange. 

“Permitted Transferee” means, with respect to any Investor Party (i) an Affiliate of such Investor Party that executes
and delivers to the Company a Joinder becoming an Investor Party to this Agreement, (ii) any successor entity, (iii) any customary co-investor so long as such transferor or its Affiliates continue to
retain sole control of the voting and disposition of the Series A Preferred Stock or Common Stock so transferred or (iv) any investment fund, vehicle, holding company or similar entity for separately managed accounts with respect to which the
Investor or any Affiliate thereof serves as a general partner, managing member, manager or fund advisor, or any successor entity of the Persons described in this clause (iii) that executes and delivers to the Company a Joinder to this
Agreement; provided, however, that in no event shall (x) the Company or any of its Subsidiaries, (y) any “portfolio company” (as such term is customarily used among institutional investors) of any Person or any entity controlled
by any portfolio company of any Person or (z) any Competitor or Activist Shareholder (whether or not an Affiliate of such Person) constitute a “Permitted Transferee”. 

“Person” means any individual, corporation, limited liability company, limited or general partnership, joint venture,
association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof, any other form of entity or any group comprised of two or more of the foregoing. 

“Preferred Stock” means the Series A Preferred Stock. 

“Pro Rata Share” means, with respect to an Investor Party, means the percentage set forth opposite its name under the heading
“Pro Rata Share” on Section 8.3 of the Company Disclosure Letter, as may be amended from time to time pursuant to any Joinder. 

“Registrable Securities” has the meaning set forth in the Registration Rights Agreement. 

“Registration Rights Agreement” means that certain Registration Rights Agreement to be entered into by the Company and the
Investor on the Closing Date, the form of which is set forth as Exhibit B hereto, as it may be amended, supplemented or otherwise modified. 

“Registration Statement” has the meaning set forth in the Registration Rights Agreement. 

“Representatives” means, with respect to any Person, its officers, directors, principals, partners, managers, members,
employees, consultants, agents, financial advisors, investment bankers, attorneys, accountants, other advisors and other representatives. 

“SEC” means the Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. 

  
 8 

 “Subsidiary” means with respect to any entity, (i) any corporation of
which a majority of the securities entitled to vote generally in the election of directors thereof, at the time as of which any determination is being made, are owned by such entity, either directly or indirectly, and (ii) any joint venture,
general or limited partnership, limited liability company or other legal entity in which such entity is the record or beneficial owner, directly or indirectly, of a majority of the voting interests or the general partner. 

“Tax” or “Taxes” mean all taxes, imposts, levies, duties, deductions, withholdings (including backup
withholding), assessments, fees or other like assessments or charges, in each case in the nature of a tax, imposed by a Governmental Authority, together with all interest, penalties and additions imposed with respect to such amounts. 

“Tax Return” means any report, return, information return, filing, claim for refund or other information filed or required to
be filed with a Governmental Authority in connection with Taxes, including any schedules or attachments thereto, and any amendments to any of the foregoing. 

“Transaction Documents” means this Agreement, the Certificate of Designations, the Registration Rights Agreement and all
other documents, certificates or agreements executed in connection with the transactions contemplated by this Agreement, the Certificate of Designations and the Registration Rights Agreement. 

“Transactions” means the Purchase and the other transactions expressly contemplated by this Agreement and the other
Transaction Documents, including the exercise by any Investor Party of the right to convert Acquired Shares into shares of Common Stock. 

“Transfer” means, directly or indirectly, to sell, transfer, assign, pledge, encumber, mortgage, gift, hypothecate or dispose
of, either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, pledge, encumbrance, mortgage, gift, hypothecation or disposition of, any shares of
equity securities beneficially owned by a Person or any interest in any shares of equity securities beneficially owned by a Person; provided, however, that, notwithstanding anything to the contrary in this Agreement, a Transfer shall
not include (i) the conversion of one or more shares of Series A Preferred Stock into shares of Common Stock pursuant to the Certificate of Designations, (ii) the redemption or other acquisition of Common Stock or Series A Preferred Stock
by the Company or (iii) the direct or indirect transfer of any limited partnership interests or other equity interests in any Investor Party (or any direct or indirect parent entity of such Investor Party) (provided that if any
transferor or transferee referred to in this clause (iii) ceases to be controlled (directly or indirectly) by the Person (directly or indirectly) controlling such Person immediately prior to such transfer, such event shall be deemed to
constitute a “Transfer”) In the event that any Person that is a corporation, partnership, limited liability company or other legal entity (other than an individual, trust or estate) ceases to be controlled by the Person controlling
such Person or a Permitted Transferee thereof, such event shall be deemed to constitute a “Transfer” subject to the restrictions on Transfer contained or referenced herein. 

  
 9 

 “Willful Breach” means, with respect to any Person, a material breach or
failure to perform that is the consequence of an act or omission of such party with the knowledge that such act or omission would, or would be reasonably expected to, cause a material breach of this Agreement. 

(b) In addition to the terms defined in Section 1.01(a), the following terms have the meanings assigned thereto in
the Sections set forth below: 
  

			
	 Term
	  	 Section

	 Acquired Shares
	  	2.01
	 Action
	  	3.07
	 Agreement
	  	Preamble
	 Anti-Corruption Laws
	  	3.08(b)
	 Balance Sheet Date
	  	3.05(c)
	 Bankruptcy and Equity Exception
	  	3.03(a)
	 Capitalization Date
	  	3.02(a)
	 Certificate of Designations
	  	Recitals
	 Closing
	  	2.02(a)
	 Closing Date
	  	2.02(a)
	 Company
	  	Preamble
	 Company Disclosure Letter
	  	Article III
	 Company SEC Documents
	  	3.05(a)
	 Company Securities
	  	3.02(b)
	 Confidential Information
	  	5.05
	 Confidentiality Agreement
	  	5.05
	 Contract
	  	3.03(b)
	 DOJ
	  	5.02(c)
	 Excluded Sponsor Parties
	  	5.14(a)
	 Filed SEC Documents
	  	Article III
	 FTC
	  	5.02(c)
	 HSR Form
	  	5.02(b)
	 Initial Investor Director Designee
	  	5.10(a)
	 Investor Representative
	  	8.13
	 IRS
	  	5.12(a)
	 Issuer Agreement
	  	5.16
	 Judgments
	  	3.07
	 KKR
	  	5.02(b)
	 Laws
	  	3.08(a)
	 New Security
	  	5.18(a)
	 Non-Recourse Party
	  	8.05(b)
	 OFAC
	  	3.08(d)
	 Permits
	  	3.08(a)
	 Permitted Investor Transferee
	  	5.08(a)
	 Permitted Loan
	  	5.08(b)(vi)
	 Preemptive Rights Portion
	  	5.18(b)
	 Preemptive Securities
	  	5.18(a)
	 Purchase
	  	2.01

  
 10 

			
	 Purchase Price
	  	2.01
	 Restraints
	  	6.01(a)
	 Restricted Country
	  	3.08(e)
	 Sanctions
	  	3.08(d)
	 Series A Preferred Stock
	  	Recitals
	 Standstill Expiration Date
	  	5.07
	 Termination Date
	  	7.01(b)

 ARTICLE II 

Purchase and Sale 

Section 2.01 Purchase and Sale. On the terms of this Agreement and subject to the satisfaction (or, to the extent permitted by
applicable Law, waiver by the party entitled to the benefit thereof) of the conditions set forth in Article VI, at the Closing, the Investor and the Permitted Investor Transferees, if any, shall purchase and acquire from the Company, and the
Company shall issue, sell and deliver to the Investor and any Permitted Investor Transferees, if any, an aggregate of 500,000 shares of Series A Preferred Stock (the “Acquired Shares”) for a purchase price per Acquired Share equal
to $1,000.00 representing an aggregate purchase price of $500,000,000 (such aggregate purchase price, the “Purchase Price”), in each case, in accordance with the Pro Rata Shares of Investor and the Permitted Investor Transferees.
The purchase and sale of the Acquired Shares pursuant to this Section 2.01 is referred to as the “Purchase”. 

Section 2.02 Closing. (a) On the terms of this Agreement, the closing of the Purchase (the “Closing”)
shall occur as promptly as practicable, and in any event, no later than 8:00 a.m. (New York City time) on the second (2nd) Business Day following such date on which the conditions to the
Closing set forth in Article VI of this Agreement have been satisfied or, to the extent permitted by applicable Law, waived by the party entitled to the benefit thereof (other than those conditions that by their nature are
to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at such time), and shall be conducted remotely via the electronic exchange of documents and signatures, or at such other place, time and date as shall be
agreed between the Company and the Investor; provided that notwithstanding anything to the contrary herein, the parties shall not be required to effect the Closing prior to April 23, 2021; provided further, that, the Closing shall not
occur prior to May 12, 2021 (with the Company to provide at least five Business Days’ prior notice of any anticipated Closing Date prior to May 12, 2021) without the Company’s prior written consent, in its sole discretion (the
date on which the Closing occurs, the “Closing Date”). 
 (b) At the Closing: 

(i) the Company shall deliver to the Investor and any Permitted Investor Transferees (A) its Pro Rata Share of the
Acquired Shares, free and clear of all Liens, except restrictions imposed by the Certificate of Designations, the Securities Act, Section 5.08 and any applicable securities Laws and evidence of the issuance of the Acquired
Shares to the Investor, credited to book-entry accounts maintained by the transfer agent of the Company, (B) the Registration Rights Agreement, duly executed by the Company and (C) the Joinder with respect to such Permitted Investor
Transferee, duly executed by the Company; and 

  
 11 

 (ii) each of the Investor and any Permitted Investor Transferees shall
(A) pay an aggregate amount equal to its Pro Rata Share of the Purchase Price to the Company, by wire transfer of immediately available U.S. federal funds, to the account designated by the Company in writing at least two (2) Business Days
prior to the Closing Date, (B) deliver to the Company the Registration Rights Agreement, duly executed by the Investor or such Permitted Investor Transferee, as applicable, and (C) deliver to the Company the Joinder with respect to such
Permitted Investor Transferee, duly executed by the Investor and such Permitted Investor Transferee. 
 ARTICLE III 

Representations and Warranties of the Company 

The Company represents and warrants to the Investor as of the date of this Agreement and as of the Closing (except to the extent made only as
of a specified date, in which case such representation and warranty is made as of such date) that, except as (A) set forth in the confidential disclosure letter delivered by the Company to the Investor prior to the execution of this Agreement
(the “Company Disclosure Letter”) (it being understood that any information, item or matter set forth on one section or subsection of the Company Disclosure Letter shall only be deemed disclosure with respect to, and shall only be
deemed to apply to and qualify, the section or subsection of this Agreement to which it corresponds in number and each other section or subsection of this Agreement to the extent that it is reasonably apparent on its face that such information, item
or matter is relevant to such other section or subsection) or (B) disclosed in any report, schedule, form, statement or other document (including exhibits) filed with, or furnished to, the SEC (and publicly available) after February 1,
2019 and prior to the date of this Agreement (the “Filed SEC Documents”), other than any risk factor disclosures in any such Filed SEC Document contained in the “Risk Factors” section or any forward-looking statements
within the meaning of the Securities Act or the Exchange Act thereof (it being acknowledged that nothing disclosed in the Filed SEC Documents shall be deemed to qualify or modify the representations and warranties set forth in Sections 3.01(a),
3.02, 3.03, 3.10 and 3.11): 
 Section 3.01 Organization; Standing. (a) The Company is a corporation duly
organized and validly existing under the Laws of the State of Delaware, is in good standing and has all requisite corporate power and corporate authority necessary to carry on its business as it is now being conducted, except (other than with
respect to the Company’s due organization and valid existence) as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is duly licensed or qualified to do business and is in good
standing (where such concept is recognized under applicable Law) in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or
qualification necessary, except where the failure to be so licensed, qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. True and complete copies of the Company Charter
Documents are included in the Filed SEC Documents. 

  
 12 

 (b) Each of the Company’s Subsidiaries is duly organized, validly existing and in good
standing (where such concept is recognized under applicable Law) under the Laws of the jurisdiction of its organization, except where the failure to be so organized, existing and in good standing would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. Each of the Company’s Subsidiaries is duly licensed or qualified to do business and is in good standing (where such concept is recognized under applicable Law) in each jurisdiction in
which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified or in good
standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 
 Section 3.02
Capitalization. (a) The authorized capital stock of the Company consists of 1,000,000,000 shares of Common Stock, no shares of Class B Common Stock and 100,000,000 shares of undesignated Preferred Stock, par value $0.0001 per
share. At the close of business on April 2, 2021 (the “Capitalization Date”), (i) 162,670,782 shares of Common Stock were issued and outstanding, (ii) 27,555,362 shares of Common Stock were reserved and available for future
issuance pursuant to the Company Stock Plans, (iii) 5,356,820 shares of Common Stock were subject to outstanding Company Stock Options, (iv) 18,222,742 Company RSUs were outstanding, (v) no Company PSUs were outstanding and (vi) no shares
of Preferred Stock, par value $0.0001 per share, of the Company were issued or outstanding. 
 (b) Except as described in this
Section 3.02, there are (i) no outstanding shares of capital stock of, or other equity or voting interests of any character in, the Company as of the date hereof other than shares that have become outstanding after the
Capitalization Date which were reserved for issuance as of the Capitalization Date as set forth in Section 3.02(a), (ii) no outstanding securities of the Company convertible into or exercisable or exchangeable for
shares of capital stock of, or other equity or voting interests of any character in, the Company, (iii) no outstanding obligations, options, warrants, rights, pledges, calls, puts, phantom equity, premptive rights, or other rights, commitments,
agreements or arrangements of any character to acquire from the Company, or that obligate the Company to issue, any capital stock of, or other equity or voting interests (or voting debt) in, or any securities convertible into or exercisable or
exchangeable for shares of capital stock of, or other equity or voting interests (or voting debt) in, the Company other than obligations under the Company Plans in the ordinary course of business and the Notes, (iv) no obligations of the
Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security or other similar agreement or commitment relating to any capital stock of, or other equity or voting interests (or voting debt) in, the
Company (the items in clauses (i), (ii), (iii) and (iv) being referred to collectively as “Company Securities”) and (v) no other obligations by the Company or any of its Subsidiaries to make any payments based on the price
or value of any Company Securities. There are no outstanding agreements of any kind which obligate the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any Company Securities (other than pursuant to the cashless exercise
of Company Stock Options or settlement of Company RSUs and Company PSUs or the forfeiture or withholding of Taxes with respect to Company Stock Options, Company PSUs or Company RSUs), or obligate the Company to grant, extend or enter into any such
agreements relating to any Company Securities, including any agreements granting any preemptive rights, subscription rights, anti-dilutive rights, rights of first refusal or similar rights with respect to any Company Securities. Except as set forth
on Section 3.02(b) of the Company Disclosure Letter, 

  
 13 

 
none of the Company or any Subsidiary of the Company is a party to any stockholders’ agreement, voting trust agreement, registration rights agreement or other similar agreement or
understanding relating to any Company Securities or any other agreement relating to the disposition, voting or dividends with respect to any Company Securities. All outstanding shares of Common Stock have been duly authorized and validly issued and
are fully paid, nonassessable and were not issued in violation of any purchase option, call option, right of first refusal, subscription right, preemptive or similar rights of a third Person, the Company Charter Documents or any agreement to which
the Company is a party. All of the outstanding shares of capital stock or equity interests of the Company’s Subsidiaries have been duly authorized, validly issued, fully paid and non-assessable and none
of such capital stock or equity interests are subject to or were issued in violation of any applicable Laws and are not subject to and have not been issued in violation of any stockholders agreement, proxy, voting trust or similar agreement, or any
preemptive rights, rights of first refusal or similar rights of any Person, except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole. 

Section 3.03 Authority; Noncontravention. (a) The Company has all necessary corporate power and corporate
authority to execute and deliver this Agreement and the other Transaction Documents and to perform its obligations hereunder and thereunder and to consummate the Transactions. The execution, delivery and performance by the Company of this Agreement
and the other Transaction Documents, and the consummation by it of the Transactions, have been duly and unanimously authorized and approved by the Board and no other corporate action on the part of the Company is necessary to authorize the
execution, delivery and performance by the Company of this Agreement and the other Transaction Documents and the consummation by it of the Transactions. This Agreement has been and at the Closing, the other Transaction Documents will be, duly
executed and delivered by the Company and, assuming due authorization, execution and delivery hereof or thereof, as applicable, by the Investor and the other parties hereto or thereto, constitutes (or in the case of the other Transaction Documents,
at the Closing will constitute) a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except that such enforceability (i) may be limited by bankruptcy, insolvency, fraudulent
transfer, reorganization, moratorium and other similar Laws of general application affecting or relating to the enforcement of creditors’ rights generally and (ii) is subject to general principles of equity, whether considered in a
proceeding at law or in equity (the “Bankruptcy and Equity Exception”). 
 (b) Neither the execution and delivery of this
Agreement or the other Transaction Documents by the Company, nor the consummation by the Company of the Transactions, nor performance or compliance by the Company with any of the terms or provisions hereof or thereof, will (i) conflict with or
violate any provision of (A) the Company Charter Documents or (B) the similar organizational documents of any of the Company’s Subsidiaries or (ii) assuming that the authorizations, consents and approvals referred to in
Section 3.04 are obtained prior to the Closing Date and the filings referred to in Section 3.04 are made and any waiting periods thereunder have terminated or expired prior to the Closing Date,
(x) violate any Law, or Judgment applicable to the Company or any of its Subsidiaries or (y) violate or constitute a default (or constitute an event which, with notice or lapse of time or both, would violate or constitute a default) under,
result in the termination of or a right of termination or cancellation under, result in the loss of any benefit or require a payment or incur a penalty under, any of the terms or provisions of any loan or credit agreement, indenture,

  
 14 

 
debenture, note, bond, mortgage, deed of trust, lease, sublease, license, contract or other agreement (each, a “Contract”) to which the Company or any of its Subsidiaries is a
party or by which it is bound or accelerate the Company’s or, if applicable, any of its Subsidiaries’ obligations under any such Contract or violate the Privacy Policy, except, in the case of clause (ii), as would not, individually or
in the aggregate, have or reasonably be expected to have, a Material Adverse Effect or prevent or materially delay, interfere with, hinder or impair the consummation by the Company or its Subsidiaries of any of the Transactions on a timely basis.

 Section 3.04 Governmental Approvals. Except for (a) the filing of the Certificate of Designations with the
Secretary of State of the State of Delaware, (b) filings required under, and compliance with other applicable requirements of the HSR Act, if required, and (c) compliance with any applicable state securities or blue sky laws, no consent or
approval of, or filing, license, permit or authorization, declaration or registration with, any Governmental Authority is necessary for the execution and delivery of this Agreement and the other Transaction Documents by the Company, the performance
by the Company of its obligations hereunder and thereunder and the consummation by the Company of the Transactions, other than such other consents, approvals, filings, licenses, permits or authorizations, declarations or registrations that, if not
obtained, made or given, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect or prevent or materially delay, interfere with, hinder or impair the consummation by the Company or its Subsidiaries of
any of the Transactions on a timely basis. 
 Section 3.05 Company SEC Documents; Undisclosed Liabilities. (a) The
Company has filed with the SEC, on a timely basis, all required reports, schedules, forms, statements and other documents required to be filed by the Company with the SEC pursuant to the Exchange Act since February 1, 2019 (collectively, the
“Company SEC Documents”). As of their respective SEC filing dates, the Company SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and/or the Sarbanes-Oxley Act of 2002 (and
the regulations promulgated thereunder), as the case may be, applicable to such Company SEC Documents, and none of the Company SEC Documents as of such respective dates (or, if amended prior to the date of this Agreement, the date of the filing of
such amendment, with respect to the disclosures that are amended) contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. 
 (b) The consolidated financial statements of the Company and its
Subsidiaries (including all related notes or schedules) included or incorporated by reference in the Company SEC Documents complied as to form, as of their respective dates of filing with the SEC, in all material respects with the published rules
and regulations of the SEC with respect thereto, have been prepared in accordance with GAAP (except, in the case of unaudited quarterly statements, as permitted by Form 10-Q of the SEC or other rules and
regulations of the SEC) applied on a consistent basis during the periods involved (except (i) as may be indicated in the notes thereto or (ii) as permitted by Regulation S-X) and present fairly,
in all material respects, the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of their operations and cash flows for the periods shown (subject, in the case of
unaudited quarterly financial statements, to normal year-end adjustments. which are not reasonably expected to be materially adverse individually or in the aggregate to the Company and its Subsidiaries, taken
as a whole). 

  
 15 

 (c) Neither the Company nor any of its Subsidiaries has any liabilities of any nature
(whether accrued, absolute, contingent or otherwise) that would be required under GAAP, to be reflected on a consolidated balance sheet of the Company (including the notes thereto) except liabilities (i) reflected or reserved against in the
balance sheet (or the notes thereto) of the Company and its Subsidiaries as of January 31, 2021 (the “Balance Sheet Date”) included in the Filed SEC Documents, (ii) incurred after the Balance Sheet Date in the ordinary
course of business and that do not arise from any material breach of a Contract, (iii) as expressly contemplated by this Agreement or otherwise incurred in connection with the Transactions, (iv) that have been discharged or paid prior to
the date of this Agreement or (v) as would not, individually or in the aggregate, have had or reasonably be expected to have, a Material Adverse Effect. 

(d) The Company has established and maintains, and at all times since February 1, 2019 has maintained, disclosure controls and procedures
and a system of internal controls over financial reporting (as such terms are defined in paragraphs (e) and (f), respectively, of Rule 13a-15 under the Exchange Act) as required by Rule 13a-15 under the Exchange Act relating to the Company and its consolidated Subsidiaries sufficient to provide reasonable assurance that (a) transactions are executed in accordance with Company management’s
general or specific authorization, (b) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP, consistently applied, and to maintain accountability for assets, (c) access to assets is
permitted only in accordance with Company management’s general or specific authorization and (d) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect
to any differences. There are no “significant deficiencies” or “material weaknesses” (as defined by the Public Company Accounting Oversight Board) in the design or operation of the Company’s internal controls over, and
procedures relating to, financial reporting which would reasonably be expected to adversely affect in any material respect the Company’s ability to record, process, summarize and report financial data, in each case which has not been
subsequently remediated. Since February 1, 2019, there has not been any Fraud, whether or not material, that involves management or other employees of the Company or any of its Subsidiaries who have a significant role in the Company’s
internal controls over financial reporting. As of the date of this Agreement, to the Knowledge of the Company, there is no reason that its outside auditors and its chief executive officer and chief financial officer will not be able to give the
certifications and attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, without qualification, when next due. 

(e) There is no transaction, arrangement or other relationship between the Company and/or any of its Subsidiaries and an unconsolidated or
other off-balance sheet entity that is required by applicable Law to be disclosed by the Company in its Filed SEC Documents and is not so disclosed. 

  
 16 

 Section 3.06 Absence of Certain Changes. (a) Since the
Balance Sheet Date through the date of this Agreement, except for the execution and performance of this Agreement and any other agreements contemplated hereby and evaluations, processes, discussions, negotiations and transactions contemplated hereby
and other strategic transactions, the business of the Company and its Subsidiaries has been carried on and conducted in all material respects in the ordinary course of business, and (b) since the Balance Sheet Date, there has not been any
Material Adverse Effect or any event, change or occurrence that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

Section 3.07 Legal Proceedings. Except as would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect (or prevent or materially delay, interfere with, hinder or impair the consummation by the Company or its Subsidiaries of any of the Transactions on a timely basis), there is no (a) pending or, to the Knowledge of the
Company, threatened legal, regulatory or administrative proceeding, suit, proceeding, dispute, investigation (of which the Company has Knowledge), arbitration or action (an “Action”) against the Company or any of its Subsidiaries or
(b) outstanding order, judgment, injunction, ruling, writ or decree of any Governmental Authority (“Judgments”) imposed upon the Company or any of its Subsidiaries or any of their respective assets, in each case, by or before
any Governmental Authority. To the Knowledge of the Company, as of the date of this Agreement, there is no pending or threatened claim or dispute relating (and the Company has not received notice of any third party objection) to the transactions
contemplated by this Agreement. 
 Section 3.08 Compliance with Laws; Permits. 

(a) The Company and each of its Subsidiaries are and since February 1, 2019 have been, in compliance with all (i) state or federal
laws, common law, statutes, ordinances, codes, rules or regulations or other similar requirement enacted, adopted, promulgated, or applied by any Governmental Authority (“Laws”), (ii) Privacy Policies and (iii) Judgments, in
each case of clauses (i) through (iii), that are applicable to the Company or any of its Subsidiaries, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and each of its
Subsidiaries hold all licenses, franchises, permits, certificates, approvals and authorizations from Governmental Authorities (“Permits”) necessary for the lawful conduct of their respective businesses, except where the failure to
hold the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 
 (b) The Company, each
of its Subsidiaries, and each of their respective officers, directors, employees and, to the Company’s Knowledge, agents acting on their behalf is, and for the last five years has been, in compliance in all material respects with (i) the
Foreign Corrupt Practices Act of 1977 and any rules and regulations promulgated thereunder, (ii) the United Kingdom Bribery Act, (iii) anti-bribery legislation promulgated by the European Union and implemented by its member states,
(iv) legislation adopted in furtherance of the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions and (v) any other Laws applicable to the Company and its Subsidiaries that address the
prevention of corruption, bribery or terrorism (collectively, the “Anti-Corruption Laws”). None of the Company, any of its Subsidiaries or any director, officer, or, to the Company’s Knowledge, any agent, employee, or other
person associated with or acting on behalf of the 

  
 17 

 
Company or its Subsidiaries within the last five (5) years has offered, promised, provided, or authorized the provision of any money or other thing of value, directly or indirectly, to any
Person to improperly influence official action or secure an improper advantage, or to encourage the recipient to breach a duty of good faith or loyalty or the policies of his/her employer, nor has violated or is in violation of any provision of any
Anti-Corruption Laws. 
 (c) The Company, each of its Subsidiaries, and to the Company’s Knowledge, each of their respective officers,
directors, employees and, to the Company’s Knowledge, agents acting on their behalf is, and for the last five (5) years has been, in material compliance with Anti-Money Laundering Laws and Export Control Laws. 

(d) The Company, each of its Subsidiaries, and each of their officers, directors, employees and, to the Company’s Knowledge, agents acting
on their behalf is, and, for the last five (5) years has been, in compliance with all Laws or other financial restrictions administered by (i) the United States (including without limitation the Office of Foreign Assets Control of the
United States Treasury Department (“OFAC”), including OFAC’s Specially Designated Nationals and Blocked Persons List, and the U.S. Department of State), (ii) the European Union and enforced by its member states, (iii) the
United Nations, (iv) Her Majesty’s Treasury or (v) other similar governmental bodies with regulatory authority over the Company, its Subsidiaries and their respective operations from time to time (collectively,
“Sanctions”). None of the Company, any of its Subsidiaries, or any director, officer, or to the Company’s Knowledge, agent, or employee of the Company or any of its Subsidiaries is currently the subject or the target of any
Sanctions, nor is the Company or any of its Subsidiaries (x) located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Syria and Crimea, or
(y) majority-owned or controlled by a Person that is the subject of Sanctions. 
 (e) To the Company’s Knowledge, the Company and
its Subsidiaries have not engaged in, nor are now engaged in, any dealings or transactions with or for the benefit of any person located, organized, or ordinarily resident in Cuba, Iran, North Korea, Sudan, Syria, or Crimea (each a
“Restricted Country”), in each case directly or indirectly, including through agents or other persons acting on its behalf. 

(f) Neither the Company nor any of its Subsidiaries is party to any actual or threatened legal proceedings or outstanding enforcement action
relating to any breach or suspected breach of Anti-Corruption Laws, Anti-Money Laundering Laws, Sanctions or Export Control Laws. 
 (g) The
Company and its Subsidiaries will not use the proceeds from the Transactions (i) in furtherance of an offer, payment, promise to pay or authorization of the payment or giving of money or anything else of value, to any Person in violation of any
Anti-Corruption Laws, or (ii) directly, or Knowingly, indirectly fund or facilitate any activities of or business with any person, or in any country or territory, that, at the time of such funding, is the subject or the target of Sanctions.

  
 18 

 (h) The Company and its Subsidiaries have instituted and maintain policies and procedures
designed to ensure, and which are reasonably expected to continue to ensure, compliance with all applicable Anti-Corruption Laws and Sanctions. No action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any of its Subsidiaries with respect to Anti-Corruption Laws or Sanctions is pending or, to the Knowledge of the Company, threatened. 

Section 3.09 Tax Matters. Except as would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect: (a) the Company and each of its Subsidiaries has prepared (or caused to be prepared) and timely filed (taking into account valid extensions of time within which to file) all Tax Returns required to be filed by it, and all such
filed Tax Returns (taking into account all amendments thereto) are true, complete and accurate, (b) all Taxes owed by the Company and each of its Subsidiaries that are due (whether or not shown on any Tax Return) have been timely paid, except
for Taxes that are being contested in good faith by appropriate proceedings and that have been adequately reserved against in accordance with GAAP, (c) no examination or audit of any Tax Return relating to any Taxes of the Company or any of its
Subsidiaries or with respect to any Taxes due from the Company or any of its Subsidiaries by any Governmental Authority is currently in progress or threatened in writing, (d) none of the Company or any of its Subsidiaries has liability for the
Taxes of any other Person (other than the Company and its Subsidiaries) under Treasury Regulations Section 1.1502-6 (or any similar provision of state, local or foreign Law), as a transferee or successor,
or by contract and (e) none of the Company or any of its Subsidiaries has engaged in any “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4(b)(2). 

Section 3.10 No Rights Agreement; Anti-Takeover Provisions. (a) As of the date of this Agreement, neither the Company
nor any of its Subsidiaries is party to a stockholder rights agreement, “poison pill” or similar anti-takeover agreement or plan. 

(b) The Board has taken all necessary actions to ensure that no restrictions included in any “control share acquisition,” “fair
price,” “moratorium,” “business combination” or other state anti-takeover Law (including Section 203 of the DGCL) is, or as of the Closing will be, applicable to the Transactions, including the Company’s issuance
of shares of Common Stock upon conversion of the Series A Preferred Stock and any issuance pursuant to Section 5.18. 

Section 3.11 Brokers and Other Advisors. Other than fees payable in accordance with Section 8.11
and except as set forth on Section 3.11 of the Company Disclosure Letter, no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other
similar fee or commission, or the reimbursement of expenses as a result of such capacities, in connection with the Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries. 

Section 3.12 Sale of Securities. Assuming the accuracy of the representations and warranties set forth in
Section 4.08, the offer, sale and issuance of the shares of Series A Preferred Stock at the Closing pursuant to this Agreement is and will be exempt from the registration and prospectus delivery requirements of the
Securities Act and the rules and regulations thereunder. Without limiting the foregoing, neither the Company nor any other Person authorized by the Company to act on its behalf, has engaged in a general solicitation or

  
 19 

 
general advertising (within the meaning of Regulation D of the Securities Act) of investors with respect to offers or sales of Series A Preferred Stock, and neither the Company nor any Person
acting on its behalf has made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the offering or issuance of Series A Preferred Stock under this Agreement to be integrated with prior
offerings by the Company for purposes of the Securities Act that would result in none of Regulation D or any other applicable exemption from registration under the Securities Act to be available, nor will the Company take any action or steps that
would cause the offering or issuance of Series A Preferred Stock under this Agreement to be integrated with other offerings by the Company. 

Section 3.13 Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) of the
Exchange Act and listed on the NYSE, and the Company has taken no action designed to, or which to the Knowledge of the Company is reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or
delisting the Common Stock from the NYSE, nor has the Company received any notification that the SEC or the NYSE is contemplating terminating such registration or listing. The Company is in compliance in all material respects with the listing and
listing maintenance requirements of the NYSE applicable to it for the continued trading of its Common Stock on the NYSE. 

Section 3.14 Status of Securities. As of the Closing, all of the Acquired Shares, and the shares of Common Stock issuable
upon conversion of any of the Acquired Shares and any accrued and compounded dividends, will be, when issued, duly authorized by all necessary corporate action on the part of the Company, validly issued, fully paid and nonassessable and issued in
compliance with all applicable federal and state securities Laws and will not be subject to preemptive rights of any other stockholder of the Company, and will be free and clear of all Liens, except restrictions imposed by the Certificate of
Designations, the Securities Act, Section 5.08 and any applicable securities Laws. The respective rights, preferences, privileges, and restrictions of the Series A Preferred Stock and the Common Stock are as stated
in the Company Charter Documents (including the Certificate of Designations) or as otherwise provided by applicable Law. As of the Closing, all of the Acquired Shares and the shares of Common Stock issuable upon conversion of any of the Acquired
Shares and any accrued and compounded dividends have been duly reserved for issuance. 
 Section 3.15 Certain Material
Indebtedness. Neither the Company nor any of its Subsidiaries is, as of the date of this Agreement, in default in the payment of any material indebtedness or in default under the Notes or the Indenture. 

Section 3.16 Investment Company Status. Neither the Company nor any of its Subsidiaries is, and immediately after the sale
of the Acquired Shares hereunder, none of the Company nor any of its Subsidiaries will be, required to be registered as an “investment company” under the Investment Company Act of 1940, as amended. 

Section 3.17 Ability to Pay Dividends. The Company is not party to any material Contract, and is not subject to any
provision in the Company Charter Documents or resolutions of the Board that, in each case, by its terms prohibits or prevents the Company from paying dividends in form and the amounts contemplated by the Certificate of Designations. 

  
 20 

 Section 3.18 IP; Security. The Company and its Subsidiaries
(i) exclusively own their proprietary Intellectual Property and IT Assets, free and clear of all Liens other than Permitted Liens; (ii) do not infringe the Intellectual Property of any Person; and (iii) take commercially reasonable
actions to protect the integrity, continuous operation, redundancy and security of the IT Assets used in their business (and all data, including personal data, processed thereby), in each case, except as would not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect. Since February 1, 2019, there have been no violations, breaches, outages, corruptions or unauthorized uses of, or unauthorized access to same, except for instances that were
resolved without material cost, liability or the duty to notify any other Person, except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

Section 3.19 No Other Company Representations or Warranties. Except for the representations and warranties made by the
Company in this Article III (as modified by the Company Disclosure Letter) and in any certificate delivered pursuant to Article VI, neither the Company nor any other Person acting on its behalf makes any other express or implied
representation or warranty with respect to the Series A Preferred Stock, the Common Stock, the Company or any of its Subsidiaries or their respective businesses, operations, properties, assets, liabilities, condition (financial or otherwise) or
prospects, notwithstanding the delivery or disclosure to the Investor or its Representatives of any documentation, forecasts or other information with respect to any one or more of the foregoing, and the Investor acknowledges the foregoing. In
particular, and without limiting the generality of the foregoing, except for the representations and warranties made by the Company in this Article III (as modified by the Company Disclosure Letter) and in any certificate delivered pursuant
to Article VI, neither the Company nor any other Person makes or has made any express or implied representation or warranty to the Investor or its Representatives with respect to (a) any financial projection, forecast, estimate, budget
or prospect information relating to the Company, any of its Subsidiaries or their respective businesses or (b) any oral or written information presented to the Investor or its Representatives in the course of its due diligence investigation of
the Company, the negotiation of this Agreement or the course of the Transactions or any other transactions or potential transactions involving the Company and the Investor. 

Section 3.20 No Other Investor Representations or Warranties. Except for the representations and warranties
expressly set forth in Article IV and in any certificate delivered pursuant to Article VI, the Company hereby acknowledges that neither the Investor nor any other Person, (a) has made or is making any other express or implied
representation or warranty with respect to the Investor or any of its Affiliates or their respective businesses, operations, assets, liabilities, condition (financial or otherwise) or prospects, including with respect to any information provided or
made available to the Company or any of its Representatives or any information developed by the Company or any of its Representatives or (b) will have or be subject to any liability or indemnification obligation to the Company resulting from
the delivery, dissemination or any other distribution to the Company or any of its Representatives, or the use by the Company or any of its Representatives, of any information, documents, estimates, projections, forecasts or other forward-looking
information, business plans or other material developed by or provided or made available to the Company or any of its Representatives, including in due diligence materials, in anticipation or contemplation of any of the Transactions or any other
transactions or potential transactions involving the Company and the Investor. The Company, on behalf of itself and on behalf of its respective Affiliates, expressly waives any such claim relating to the foregoing matters. For the avoidance of
doubt, nothing in this Section 3.20 will limit any representations or warranties of any Permitted Investor Transferee in any Joinder. 

  
 21 

 ARTICLE IV 

Representations and Warranties of the Investor 

The Investor represents and warrants to the Company, as of the date of this Agreement and as of the Closing Date (except to the extent made
only as of a specified date, in which case such representation and warranty is made as of such date): 
 Section 4.01 Organization;
Standing. The Investor is duly organized, validly existing and in good standing under the Laws of its jurisdiction of organization and the Investor has all requisite power and authority necessary to carry on its business as it is now
being conducted and, except (other than with respect to the Investor’s due organization and valid existence) as would not, individually or in the aggregate, reasonably be expected to have an Investor Material Adverse Effect. The Investor is
duly licensed or qualified to do business and is in good standing in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or
qualification necessary, except where the failure to be so licensed, qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have an Investor Material Adverse Effect. 

Section 4.02 Authority; Noncontravention. The Investor has all necessary power and authority to execute and deliver this
Agreement and the other Transaction Documents, to perform its obligations hereunder and thereunder and to consummate the Transactions. The execution, delivery and performance by the Investor of this Agreement and the other Transaction Documents and
the consummation by the Investor of the Transactions have been duly authorized and approved by all necessary action on the part of the Investor, and no further action, approval or authorization by any of its stockholders, partners, members or other
equity owners, as the case may be, is necessary to authorize the execution, delivery and performance by the Investor of this Agreement and the other Transaction Documents and the consummation by the Investor of the Transactions. This Agreement has
been and at the Closing, the other Transaction Documents will be, duly executed and delivered by the Investor and, assuming due authorization, execution and delivery hereof or thereof, as applicable, by the Company and the other parties hereto or
thereto, constitutes (or in the case of the other Transaction Documents, at the Closing will constitute) a legal, valid and binding obligation of the Investor, enforceable against it in accordance with its terms, subject to the Bankruptcy and Equity
Exception. Neither the execution and delivery of this Agreement or the other Transaction Documents by the Investor, nor the consummation of the Transactions by the Investor, nor performance or compliance by the Investor with any of the terms or
provisions hereof or thereof, will (i) conflict with or violate any provision of the certificate or articles of incorporation, bylaws or other comparable charter or organizational documents of the Investor or (ii) assuming that the
authorizations, consents and approvals referred to in Section 4.03 are obtained prior to the Closing Date and the filings referred to in Section 4.03 are made and any waiting periods with respect
to such filings have terminated or expired prior to the Closing Date, (x) violate any Law or Judgment applicable to 

  
 22 

 
the Investor or any of its Subsidiaries or (y) violate or constitute a default (or constitute an event which, with notice or lapse of time or both, would violate or constitute a default)
under any of the terms, conditions or provisions of any Contract to which the Investor or any of its Subsidiaries is a party or accelerate the Investor’s or any of its Subsidiaries’, if applicable, obligations under any such Contract,
except, in the case of clause (ii), as would not, individually or in the aggregate, reasonably be expected to have an Investor Material Adverse Effect. 

Section 4.03 Governmental Approvals. Except for (a) the filing by the Company of the Certificate of
Designations with the Secretary of State of the State of Delaware and (b) filings required under, and compliance with other applicable requirements of, the HSR Act, if required, no consent or approval of, or filing, license, permit or
authorization, declaration or registration with, any Governmental Authority is necessary for the execution and delivery of this Agreement and the other Transaction Documents by the Investor, the performance by the Investor of its obligations
hereunder and thereunder and the consummation by the Investor of the Transactions, other than such other consents, approvals, filings, licenses, permits, authorizations, declarations or registrations that, if not obtained, made or given, would not,
individually or in the aggregate, reasonably be expected to have an Investor Material Adverse Effect. 
 Section 4.04
Financing. At the Closing, the Investor will have available funds necessary to consummate the purchase of the Acquired Shares and pay its Pro Rata Share of the Purchase Price payable by such Investor, in each case, on the terms and
conditions contemplated by this Agreement. As of the date of this Agreement, the Investor is not aware of any reason why the funds sufficient to pay its Pro Rata Share of the Purchase Price will not be available on the Closing Date. 

Section 4.05 Brokers and Other Advisors. No broker, investment banker, financial advisor or other Person is entitled to any
broker’s, finder’s, financial advisor’s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of the Investor or
any of its Affiliates, except for Persons, if any, whose fees and expenses will be paid by the Investor (or pursuant to the expense reimbursement provisions hereof). 

Section 4.06 Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking
Statements and Business Plans. In connection with the due diligence investigation of the Company by the Investor and its Representatives, the Investor and its Representatives have received and may continue to receive from the Company and
its Representatives certain estimates, projections, forecasts and other forward-looking information, as well as certain business plan information containing such information, regarding the Company and its Subsidiaries and their businesses and
operations. The Investor hereby acknowledges that there are uncertainties inherent in attempting to make such estimates, projections, forecasts and other forward-looking statements, as well as in such business plans, with which the Investor is
familiar, that the Investor is making its own evaluation of the adequacy and accuracy of all estimates, projections, forecasts and other forward-looking information, as well as such business plans, so furnished to the Investor (including the
reasonableness of the assumptions underlying such estimates, projections, forecasts, forward-looking information or business plans), and that except for the representations and warranties made by the Company in Article III of this Agreement
(as modified by the Company Disclosure Letter) delivered in connection with this Agreement, the Investor will have no claim against the Company and its Subsidiaries, or any of their respective Representatives with respect thereto. 

  
 23 

 Section 4.07 Purchase for Investment. The Investor acknowledges that the
Series A Preferred Stock and the Common Stock issuable upon the conversion of the Series A Preferred Stock have not been registered under the Securities Act or under any state or other applicable securities Laws. The Investor (a) acknowledges
that it is acquiring the Series A Preferred Stock and the Common Stock issuable upon the conversion of the Series A Preferred Stock pursuant to an exemption from registration under the Securities Act solely for investment with no intention to
distribute any of the foregoing to any Person, (b) will not sell, transfer or otherwise dispose of any Series A Preferred Stock and the Common Stock issuable upon the conversion of the Series A Preferred Stock, except in compliance with this
Agreement and the registration requirements or exemption provisions of the Securities Act and any other applicable securities Laws, (c) has such knowledge and experience in financial and business matters and in investments of this type that it
is capable of evaluating the merits and risks of its investment in the Series A Preferred Stock and the Common Stock issuable upon the conversion of the Series A Preferred Stock and of making an informed investment decision, (d) is an
“accredited investor” (as that term is defined by Rule 501 of the Securities Act), and (e) (i) has been furnished with or has had access to all the information that it considers necessary or appropriate to make an informed investment
decision with respect to the Series A Preferred Stock and the Common Stock issuable upon the conversion of the Series A Preferred Stock, (ii) has had an opportunity to discuss with the Company and its Representatives the intended business and
financial affairs of the Company and to obtain information necessary to verify any information furnished to it or to which it had access and (iii) can bear the economic risk of (x) an investment in the Series A Preferred Stock and the
Common Stock issuable upon the conversion of the Series A Preferred Stock indefinitely and (y) a total loss in respect of such investment. 

Section 4.08 No Other Investor Representations or Warranties. Except for the representations and warranties made by the
Investor in this Article IV and in any certificate delivered pursuant to Article VI, neither the Investor nor any other Person acting on its behalf makes any other express or implied representation or warranty with respect to the
Investor or any of its Affiliates or their respective businesses, operations, properties, assets, liabilities, condition (financial or otherwise) or prospects, notwithstanding the delivery or disclosure to the Company or its Representatives of any
documentation, forecasts or other information with respect to any one or more of the foregoing, and the Company acknowledges the foregoing. In particular, and without limiting the generality of the foregoing, except for the representations and
warranties made by the Investor in this Article IV and in any certificate delivered pursuant to Article VI, neither the Investor nor any other Person makes or has made any express or implied representation or warranty to the Company or
its Representatives with respect to (a) any financial projection, forecast, estimate, budget or prospect information relating to the Investor, any of its Affiliates or their respective businesses or (b) any oral or written information
presented to the Company or its Representatives in the course of the negotiation of this Agreement or the course of the Transactions or any other transactions or potential transactions involving the Investor and the Company. 

  
 24 

 Section 4.09 No Other Company Representations or Warranties. Except for
the representations and warranties expressly set forth in Article III (as modified by the Company Disclosure Letter) and in any certificate delivered pursuant to Article VI, the Investor hereby acknowledges that neither the Company nor
any of its Subsidiaries, nor any other Person, (a) has made or is making any other express or implied representation or warranty with respect to the Series A Preferred Stock, the Common Stock, the Company or any of its Subsidiaries or their
respective businesses, operations, assets, liabilities, condition (financial or otherwise) or prospects, including with respect to any information provided or made available to the Investor or any of its Representatives or Affiliates or any
information developed by the Investor or any of its Representatives or Affiliates, and none of the Investor, its Affiliates or any of its or their Representatives has relied, is relying, or will rely on any other representations, warranties, or
other statements, or the accuracy or completnes thereof, or (b) will have or be subject to any liability or indemnification obligation to the Investor resulting from the delivery, dissemination or any other distribution to the Investor or any
of its Representatives or Affiliates, or the use by the Investor or any of its Representatives, of any information, documents, estimates, projections, forecasts or other forward-looking information, business plans or other material developed by or
provided or made available to the Investor or any of its Representatives, including in due diligence materials, or management presentations (formal or informal), in anticipation or contemplation of any of the Transactions and the Investor, on behalf
of itself and on behalf of its respective Affiliates, expressly waives any such claim relating to the foregoing matters. 
 ARTICLE V 

Additional Agreements 

Section 5.01 Negative Covenants. Except as required by applicable Law or the regulations or requirements of any stock
exchange or regulatory organization applicable to the Company or any of its Subsidiaries, Judgment or to comply with any notice from a Governmental Authority, as expressly contemplated, required or permitted by this Agreement or as described in
Section 5.01 of the Company Disclosure Letter, (i) during the period from the date of this Agreement until the Closing (or such earlier date on which this Agreement may be terminated pursuant to
Section 7.01), (1) unless the Investor otherwise consents in writing (such consent not to be unreasonably withheld, delayed or conditions), the Company shall, and shall cause its Subsidiaries to, use their commercially
reasonable efforts to maintain and preserve in all material respects its existing relationships with its customers, employees, independent contractors and other business relationships having material business dealings with the Company or any of its
Subsidiaries and (2) unless the Investor otherwise consents in writing (such consent not to be unreasonably withheld, delayed or conditioned), the Company shall not and shall cause its Subsidiaries not to: 

(a) other than the authorization and issuance of the Series A Preferred Stock to the Investor Parties and the consummation of the other
Transactions, pursuant to the Notes or shares required to be issued pursuant to any earn-out existing in any Contract to which the Company or any of its Subsidiaries is a party as of the date of this
Agreement, issue, sell or grant any shares of its capital stock or other equity or voting interests, or any securities or rights convertible into, exchangeable or exercisable for, or evidencing the right to subscribe for any shares of its capital
stock or other equity or voting interests, or any rights, warrants or options to purchase any shares of its capital stock or other equity or voting interests; provided that the Company may issue or grant shares of Common Stock or other
securities in the ordinary course of business pursuant to the terms of a Company Plan in effect on the date of this Agreement; 

  
 25 

 (b) redeem, purchase or otherwise acquire any of its outstanding shares of capital stock or
other equity or voting interests, or any rights, warrants or options to acquire any shares of its capital stock or other equity or voting interests other than in connection with (w) transactions involving only wholly owned Subsidiaries of the
Company, (x) repurchases or reacquisitions shares of Common Stock pursuant to the Company’s right to repurchase or reacquire shares of Common Stock held by employees or other service providers of the Company or its Subsidiaries in
connection with termination of such Person’s employment or engagement by the Company or its Subsidiaries, (y) the relinquishment of shares by employees or other service providers of the Company or its Subsidiaries in payment of withholding
tax upon the settlement of Company RSUs, or (z) the cashless or net exercise of Company Stock Options, in each case of clauses (x), (y) and (z), pursuant to the terms of such awards; 

(c) solely with respect to the Company, establish a record date for, declare, set aside for payment or pay any dividend on, or make any other
distribution in respect of, any shares of its capital stock or other equity or voting interests; 
 (d) split, combine, subdivide,
recapitalize, reclassify or like change to any shares of its capital stock or other equity or voting interests; 
 (e) amend or supplement
the Company Charter Documents or make any material amendments to the organizational documents of any of the Company’s Subsidiaries, in each case in a manner that adversely affects the Series A Preferred Stock, or take or authorize any action to
wind up its affairs or dissolve; 
 (f) enter into any new, or amend, terminate or renew in any material respect, any material Contract
between the Company or one of its Subsidiaries, on the one hand, and any of its Affiliates (other than the Company’s Subsidiaries) or any officer or director of the Company or any of its Subsidiaries, on the other hand, outside the ordinary
course of business; 
 (g) make any material change in the Company’s or its Subsidiaries’ financial accounting principles, except
as required by changes in GAAP (or any interpretation thereof) or in applicable Law; or 
 (h) agree or commit to do any of the foregoing.

 Section 5.02 Reasonable Best Efforts; Filings. (a) Subject to the terms and conditions of this Agreement, each of the
Company and the Investor Parties shall cooperate with each other and use (and shall cause their Affiliates to use) their respective reasonable best efforts (unless, with respect to any action, another standard of performance is expressly provided
for herein) to promptly (i) take, or cause to be taken, all actions, and do, or cause to be done, and assist and cooperate with each other in doing, all things necessary, proper or advisable to obtain the expiration or termination of the
waiting period under the HSR Act to the extent applicable to such Investor Party and cause the conditions to Closing to be satisfied as promptly as reasonably practicable and to consummate and make effective, in the most expeditious manner
reasonably practicable, the Transactions, including preparing and filing promptly and fully all 

  
 26 

 
documentation to effect all necessary filings, notices, petitions, statements, registrations, submissions of information, applications and other documents, (ii) obtain all approvals,
consents, registrations, waivers, permits, authorizations, orders and other confirmations or non-objections from any Governmental Authority or third party necessary, proper or advisable to consummate the
Transactions and (iii) execute and deliver any additional instruments necessary to consummate the Transactions and (iv) defend or contest in good faith any Action brought by a third party that could otherwise prevent or impede, interfere
with, hinder or delay in any material respect the consummation of the Transactions. 
 (b) The Company and the Investor Parties shall, and
shall cause their ultimate parent entities to, (i) make an appropriate filing of a Notification and Report Form (“HSR Form”) pursuant to the HSR Act if a filing under the HSR Act is required for such Investor Party with respect
to the Transactions (which shall request, if legally available, the early termination of any waiting period applicable to the Transactions under the HSR Act) (and the Company shall also make an appropriate filing of an HSR Form with respect to any
Permitted Investor Transferee within ten (10) Business Days of the date of this Agreement and shall thereafter take the other actions required by this Section 5.02(b) in connection therewith) and, with respect to HSR, in any event within
ten (10) Business Days after the date of this Agreement, and (ii) supply as promptly as reasonably practicable any additional information and documentary material that may be requested pursuant to the HSR Act, in connection with such other
filings or by any Governmental Authority, and use reasonable best efforts to promptly take any and all steps necessary to avoid or eliminate each and every impediment and obtain all consents that may be required pursuant to the HSR Act, in
connection with such other filings or other applicable Law, so as to enable the parties hereto to consummate the Transactions. Notwithstanding anything to the contrary in this Section 5.02, nothing in this
Section 5.02 or this Agreement shall require or obligate any Investor Party to, and the Company shall not, without prior written consent of the Investor Parties, agree, propose, commit to, or effect, or otherwise be
required, by consent decree, hold separate, or otherwise, any sale, divestiture, hold separate, or any other action otherwise limiting the freedom of action in any respect with respect to any businesses, products, rights, services, licenses, assets,
or interest therein, of (A) the Investor Party or any Affiliate (including, with respect to the Investor, KKR & Co. Inc. and the KKR Sponsor (each, “KKR”) and their respective Affiliates and any investment funds or
investment vehicles affiliated with, or managed or advised by, KKR or any portfolio company (as such term is commonly understood in the private equity industry) or investment of KKR), or (ii) the Company or any its Affiliates or subsidiaries.

 (c) Each of the Company and the Investor Parties shall, and shall cause their Affiliates to, use their respective reasonable best efforts
to (i) cooperate in all respects with the other party in connection with any filing or submission with a Governmental Authority in connection with the Transactions and in connection with any investigation or other inquiry by or before a
Governmental Authority relating to the Transactions (including to determine whether a Governmental Authority has jurisdiction over the Transactions), (ii) keep the other party informed in all material respects and on a reasonably timely basis
of any material communication received by the Company, the Investor Parties or their Affiliates, as the case may be, from or given by the Company, the Investor Parties or their Affiliates, as the case may be, to the Federal Trade Commission
(“FTC”), the Department of Justice (“DOJ”) or any other Governmental Authority, in each case regarding the Transactions, (iii) subject to applicable Laws relating to the

  
 27 

 
exchange of information, consult with the other party with respect to information relating to such party and its respective Subsidiaries, as the case may be, that appears in any filing made with,
or written materials submitted to, any Governmental Authority in connection with the Transactions, other than “4(c) and 4(d) documents” as that term is used in the rules and regulations under the HSR Act and other confidential information
contained in the HSR Form and (iv) to the extent permitted by the FTC, the DOJ or such other applicable Governmental Authority, give the other party the opportunity to attend and participate in meetings and conferences with the FTC, DOJ, or any
other applicable Governmental Authority. Any documents or other materials provided pursuant to this Section 5.02(c) may be redacted or withheld as necessary to address reasonable privilege or confidentiality concerns, and
to remove references concerning the valuation of the Company or other competitively sensitive material, and the parties may, as each deems advisable, reasonably designate any material provided under this Section 5.02(c) as
“outside counsel only material”. 
 Section 5.03 Corporate Actions. (a) At any time that any Series A Preferred
Stock is outstanding, the Company shall: 
 (i) from time to time take all lawful action within its control to cause the
authorized capital stock of the Company to include a sufficient number of authorized but unissued shares of Common Stock to satisfy the conversion requirements of all shares of the Series A Preferred Stock then outstanding and all accrued and unpaid
dividends thereon; and 
 (ii) not effect any voluntary deregistration under the Exchange Act or any voluntary delisting of
the Common Stock from the NYSE other than in connection with a Change of Control (as defined in the Certificate of Designations) with respect to which each holder of Series A Preferred Stock has elected to exercise its conversion rights or Change of
Control Put (as defined in the Certificate of Designations) under Section 9 of the Certificate of Designations and the Company agrees to satisfy, or will otherwise cause the satisfaction in full of its obligations under Section 9 of the
Certificate of Designations. 
 (b) Prior to the Closing, the Company shall file with the Secretary of State of the State of Delaware the
Certificate of Designations in the form attached hereto as Exhibit A, with such changes thereto as the parties may reasonably agree. 

(c) If any occurrence since the date of this Agreement until the Closing would have resulted in an adjustment to the Conversion Rate pursuant
to the Certificate of Designations if the Series A Preferred Stock had been issued and outstanding since the date of this Agreement, the Company shall adjust the Conversion Rate, effective as of the Closing, in the same manner as would have been
required by the Certificate of Designations if the Series A Preferred Stock had been issued and outstanding since the date of this Agreement. 

(d) The Company shall not adopt any stockholder rights agreement, “poison pill” or similar anti-takeover agreement or plan that
prohibits the Investor Parties from taking any of the actions permitted by or exercising their rights under this Agreement or the Certificate of Designations. 

  
 28 

 Section 5.04 Public Disclosure. The Investor Parties shall, and shall
cause their respective Affiliates to, consult with the Company before issuing, and give each other the opportunity to review and comment upon, any press release or other public statements with respect to the Transaction Documents or the
Transactions, and shall not, and shall cause their respective Affiliates not to, issue any such press release or make any such public statement prior to such consultation, except as may be required by applicable Law, Judgment, court process or the
rules and regulations of any national securities exchange or national securities quotation system. The initial announcement (the “Initial Press Release”) with respect to the Transaction Documents or the Transactions shall be
mutually agreed between the Investor and the Company. The Company shall consult with the Investor Designee, and give the Investor Designee the opportunity to review and comment upon, any press release, respect to the Transaction Documents or the
Transactions (other than with respect to the Initial Press Release, which will be subject to the prior sentence). Notwithstanding the forgoing, this Section 5.04 shall not apply to any press release or other public
statement made by the Company or the Investor Parties (a) which does not contain any information relating to the Transactions that has not been previously announced or made public in accordance with the terms of this Agreement or (b) is
made in the ordinary course of business and does not relate specifically to the signing of the Transaction Documents or the Transactions. Notwithstanding anything to the contrary in this Agreement or the Confidentiality Agreement, in no event shall
either this Section 5.04, Section 5.05 or any provision of the Confidentiality Agreement limit disclosure by any Investor Party, any Permitted Investor Transferee or any of their Affiliates of ordinary course
communications regarding this Agreement and the Transactions to its existing or prospective general and limited partners, equityholders, members, managers and investors of any Affiliates of such Person who are subject to a confidentiality obligation
with respect thereto, or disclosing public information about the Transactions on their websites in the ordinary course of business consistent with past practice or as part of any sales and Transfers to any
co-investors. 
 Section 5.05 Confidentiality. The Investor will, and will cause
its Affiliates and Representatives who actually receive Confidential Information to, keep confidential any information (including oral, written and electronic information) concerning the Company, its Subsidiaries or its Affiliates that may be
furnished to the Investor, its Affiliates or its or their respective Representatives by or on behalf of the Company or any of its Representatives pursuant to this Agreement, including any such information provided pursuant to
Section 5.15 of this Agreement (“Confidential Information”) and to use the Confidential Information solely for the purposes of monitoring, administering or managing the Investor Parties’ investment in
the Company made pursuant to this Agreement; provided that Confidential Information will not include information that (a) was or becomes available to the public other than as a result of a breach of any confidentiality obligation in this
Agreement by the Investor or its Affiliates or their respective Representatives, (b) was or becomes available to the Investor or its Affiliates or their respective Representatives from a source other than the Company or its Representatives;
provided that such source is reasonably believed by the Investor or such Affiliates not to be subject to an obligation of confidentiality (whether by agreement or otherwise), (c) at the time of disclosure is already in the possession of the
Investor or its Affiliates or their respective Representatives from a source other than the Company or any of its Subsidiaries or any of their respective Representatives, (d) was independently developed by the Investor or its Affiliates or
their respective Representatives without reference to, incorporation of, or other use of any Confidential Information or (e) from and after the Closing, the Investor’s participation in the 

  
 29 

 
transactions contemplated by this Agreement; provided that the Investor may disclose Confidential Information (i) to its attorneys, accountants, consultants and financial and other
professional advisors to the extent necessary to obtain their services in connection with its investment in the Company, (ii) to any Permitted Transferee or prospective purchaser of any Acquired Shares from the Investor, or prospective
financing sources in connection with the syndication and marketing of any Permitted Loan, in each case, as long as such prospective purchaser or lender, as applicable, agrees to be bound by similar confidentiality or
non-disclosure terms as are contained in this Agreement (with the Company as an express third party beneficiary of such agreement), (iii) to any Affiliate, partner, member, limited partners, prospective
partners or co-investors, or related investment fund of the Investor and their Affiliates and their respective directors, officers, employees, consultants, financing sources and representatives, in each case
in the ordinary course of business (provided that the recipients of such confidential information are directed to abide by the confidentiality and non-disclosure obligations contained herein), (iv) as may be
reasonably determined by the Investor to be necessary in connection with the Investor’s enforcement of its rights in connection with this Agreement or its investment in the Company, or (v) as may otherwise be required by law or legal,
judicial or regulatory process; and provided, further, that (x) any breach of the confidentiality and use terms herein by any Person to whom the Investor and its Permitted Transferees may disclose Confidential Information pursuant
to clauses (i) and (iii) of the preceding proviso shall be attributable to such Investor Party for purposes of determining such Investor Party’s compliance with this Section 5.05, except those who have entered
into a separate confidentiality or non-disclosure agreement or obligation with the Company and (y) that the Investor takes commercially reasonable steps (at the Company’s sole expense) to minimize
the extent of any required disclosure described in clause (v) of the preceding proviso. The Confidentiality Agreement, dated as of February 25, 2021, by and between Kohlberg Kravis Roberts & Co. L.P. and the Company (the
“Confidentiality Agreement”) shall terminate simultaneously with the Closing in accordance with its terms. Except for any Confidential Information that any Permitted Investor Transferee (or its Affiliates) received prior to Closing,
which shall be subject to the confidentiality restrictions (and exceptions) set forth above, for a period of 12 months from the Closing Date, mutatis mutandis, the provisions of this Section 5.05 shall not apply to any Permitted Investor
Transferee (or its Permitted Transferees and Affiliates), and notwithstanding the foregoing, from and after the Closing such Persons are entitled to disclose the information permitted to be disclosed pursuant to the last sentence of
Section 5.04. 
 Section 5.06 NYSE Listing of Shares. To the extent the Company has not done so prior
to the date of this Agreement, the Company shall, as promptly as practicable following the date of this Agreement and in any event, prior to the Closing, cause the aggregate number of shares of Common Stock issuable upon the conversion of the
Acquired Shares (including any accrued and unpaid dividends thereon, assuming conversion of the Acquired Shares on the seventh anniversary of the Closing Date) to be approved for listing on the NYSE. From time to time following the Closing Date, the
Company shall cause the number of shares of Common Stock issuable upon conversion or redemption of the then outstanding shares of Series A Preferred Stock and any accrued dividends thereon to be approved for listing on the NYSE prior to such
issuance. 

  
 30 

 Section 5.07 Standstill. Each Investor Party agrees with the Company, severally
and not jointly, that, until the applicable Standstill Expiration Date, without the prior written approval of the Board, such Investor Party shall not, directly or indirectly, and shall cause its Affiliates not to: 

(a) acquire, offer or seek to acquire, agree to acquire or make a proposal to acquire, whether by private or open market purchase, a block
trade, a tender or exchange offer, beneficial ownership of, or any economic interest in, any right to direct the voting or disposition of, or any other right with respect to any debt or equity securities or direct or indirect rights to acquire any
debt or equity securities of the Company, any securities convertible into or exchangeable for any such debt or equity securities, any options puts, calls, swaps or other derivative or convertible instruments, hedging contracts or other derivative
securities or contracts or instruments in any way related to the price of shares of Common Stock (solely to the extent that, after giving effect to such acquisition, such Investor Party and its Affiliates would beneficially own, in the aggregate,
greater than 1% of the then outstanding Common Stock (excluding any shares of Series A Preferred Stock or Common Stock issued in connection with the conversion of the Series A Preferred Stock)) or 10% of any tranche of any debt securities; 

(b) (i) make or in any way encourage or participate in any “solicitation” of “proxies” or consents (whether or not
relating to the election or removal of directors), as such terms are used in the rules of the SEC (but without regard to the exclusion set forth in Rule 14a-1(l)(2)(iv)), to vote, or knowingly seek to advise,
encourage or influence any Person with respect to voting of, any voting securities of the Company or any of its Subsidiaries or any securities convertible or exchangeable into or exercisable for any such securities, (ii) request, call or seek
to call (or, for the avoidance of doubt, publicly support another Person’s request or call for) a meeting of the Company’s stockholders or action by written consent (or the setting of a record date therefor), (iii) initiate or be the
proponent of any stockholder proposal for action by the Company’s stockholders, (iv) seek, alone or in concert with others, election to or to place a representative on the Board or nominate or propose the nomination of, or recommend the
nomination of, any candidate to the Board, except as expressly set forth herein or in the Certificate of Designation, (v) seek, alone or in concert with others (including through any “withhold” or similar campaign), the removal of any
director from the Board (other than, in the case of the KKR Investor Group, the Investor Designee), or (vi) become a “participant” in any contested “solicitation” (as such terms are defined or used under the Exchange Act)
for the election of directors with respect to the Company; 
 (c) make any public announcement with respect to, or offer, seek, propose or
indicate an interest in (in each case with or without conditions), either alone or in concert with others, any merger, consolidation, business combination, tender or exchange offer, recapitalization, reorganization or purchase of more than 50% of
the assets, properties or securities of the Company or any Subsidiary of the Company, or any other extraordinary transaction involving the Company or any Subsidiary of the Company or any of their respective securities, or enter into any discussions,
negotiations, arrangements, understandings or agreements (whether written or oral) with any other Person regarding any of the foregoing (it being understood that the foregoing shall not restrict any Investor Parties from tendering shares, receiving
payment for shares or otherwise participating in any such transaction on the same basis as other stockholders of the Company); 

  
 31 

 (d) otherwise act, alone or in concert with others, to seek to control or influence, in any
manner, the management, board of directors or business, of the Company or any of its Subsidiaries, including (i) controlling or changing the Board or management of the Company, including any plans or proposals to declassify the Board or to
change the number or term of directors or to fill any vacancies on the Board (except as permitted herein or in the Certificate of Designations with respect to the Investor Designee), (ii) any material change in the capitalization, capital allocation
policy or dividend policy of the Company, or (iii) seeking to have the Company waive or make amendments or modifications to the Company’s certificate of incorporation or bylaws, or other actions that may impede or facilitate the
acquisition of control of the Company by any person; 
 (e) make any proposal or statement of inquiry or disclose any intention, plan or
arrangement inconsistent with any of the foregoing; 
 (f) advise, assist, knowingly encourage or direct any Person to do, or to advise,
assist, knowingly encourage or direct any other Person to do, any of the foregoing; 
 (g) take any action that would require the Company to
make a public announcement regarding the possibility of a transaction or any of the events described in this Section 5.07; 

(h) enter into any agreements, arrangements or understandings with any third party (including security holders of the Company, but excluding,
for the avoidance of doubt, any Investor Party) with respect to any of the foregoing, including forming, joining or in any way participating in a “group” (as defined in Section 13(d)(3) of the Exchange Act) with any third party in
connection with any of the foregoing; 
 (i) request the Company or any of its Representatives, directly or indirectly, to amend or waive any
provision of this Section 5.07; provided that this clause shall not prohibit any Investor Party from making a confidential request to the Company seeking an amendment or waiver of the provisions of this
Section 5.07, which the Company may accept or reject in its sole discretion, so long as any such request is made in a manner that does not require public disclosure thereof by any Person; 

(j) make any public disclosure, announcement or statement with an intent to specifically disparage current or former Board members (in their
capacity as such) or the Company’s management (in their capacity as such) or strategy, operations, financial results or any transactions involving the Company or any of its Subsidiaries, except for such statements made with the Company’s
prior written consent, or that are supportive of the Company’s management and Board or that are otherwise consistent with the provisions of this Agreement; provided, however, that the foregoing provisions shall not be violated by (A) any
general statement about market, industry or economic circumstances, conditions or trends, (B) any statement required to be made by applicable Law, (C) any statement protected by the whistleblower-protection provisions of any applicable
Law, (D) any statement that is made in response to legal process or in the context of any Action by or before any Governmental Authority or arbitrator (including any such Action to enforce the terms of the this Agreement or other such Action in
connection with the transactions contemplated hereby), (E) any statement that is reasonably necessary in connection with the enforcement of rights under this Agreement, or any other written agreement involving the parties, or (F) any statement
that is made by the Investor Designee in his or her capacity as such made in good faith. 

  
 32 

 (k) contest the validity of this Section 5.07 or make, initiate,
take or participate in any demand, Action (legal or otherwise) or proposal to amend, waive or terminate any provision of this Section 5.07; 

provided, however, that nothing in this Section 5.07 will (1) limit any Investor Party’s ability to vote,
Transfer or Hedge (subject to this Agreement, including Section 5.08), convert shares of Series A Preferred Stock into Common Stock (subject to Section 6 of the Certificate of Designations), privately make and submit
to the Board any proposal that is intended by such Investor Party to be made and submitted on a non-publicly disclosed or announced basis (and would not reasonably be expect to require public disclosure by any
Person), participate in rights offerings made by the Company to all holders of its Common Stock, receive any dividends or similar distributions with respect to any securities of the Company held by such Investor Party, tender shares of Common Stock
or Series A Preferred Stock into any tender or exchange offer (subject to Section 5.08), effect an adjustment to the Conversion Rate pursuant to the Certificate of Designations or otherwise exercise rights under its Common
Stock or Series A Preferred Stock that are not the subject of this Section 5.07 or (2) limit the ability of the Investor Director to vote or otherwise exercise his or her legal duties or otherwise act in his or her
capacity as a member of the Board. 
 For purposes of this Section 5.07, the “Standstill Expiration Date” with
respect to (a) any Permitted Investor Transferee and its Permitted Transferees shall mean the first anniversary of the Closing Date and (b) the Investor and its Permitted Transferees shall mean 180 days after the later of (i) the
first day on which the Investor Parties have no rights (or has irrevocably waived their right) to designate or nominate for election an Investor Designee under Section 5.10(a) and (ii) the first day on which the
Investor and its Permitted Transferees, together with its respective Affiliates, no longer beneficially owns shares of Series A Preferred Stock and/or shares of Common Stock that represent in the aggregate and on an as converted basis, at least 25%
of the number of Acquired Shares beneficially owned by the Investor Parties, on an as converted basis, as of immediately following the Closing (for the avoidance of doubt, any shares of Series A Preferred Stock purchased by any Permitted Investor
Transferees shall not be considered owned by the Investor Parties as of or immediately following the Closing). 
 Section 5.08
Transfer Restrictions. (a) Except as otherwise permitted in this Agreement, including Section 5.08(b), until the expiration of the Lock-Up Period, each Investor
Party agrees with the Company, severally and not jointly, that such Investor Party will not Transfer any Series A Preferred Stock or any Common Stock issued upon conversion of the Series A Preferred Stock or Hedge any Series A Preferred Stock or
Common Stock. 
 (b) Notwithstanding Section 5.08(a), each Investor Party shall be permitted to Transfer any
portion or all of their Series A Preferred Stock or Common Stock issued or issuable upon conversion of the Series A Preferred Stock at any time under the following circumstances: 

  
 33 

 (i) Transfers to any Permitted Transferees (but only if the transferee
executes and delivers to the Company a Joinder in the form set forth in Exhibit D (or as may otherwise be reasonably agreed by the Company) agreeing to be bound by the terms of this Agreement) and if the transferee and the transferor agree
for the express benefit of the Company that the transferee shall Transfer the Series A Preferred Stock or Common Stock so Transferred back to the transferor at or before such time as the transferee ceases to be a Permitted Transferee of the
transferor; 
 (ii) Transfers pursuant to a merger, tender offer or exchange offer or other business combination, acquisition
of assets or similar transaction or any change of control transaction involving the Company or any Subsidiary that, in each case, is approved by the Board (other than an Excluded Repurchase (as defined in the Certificate of Designation) prior to the
one-year anniversary of the Closing); 
 (iii) Transfers pursuant to a tender offer
or exchange offer that is (A)approved by the Board (other than an Excluded Repurchase (as defined in the Certificate of Designation) prior to the one-year anniversary of the Closing), (B) for less than all of
the outstanding shares of Common Stock of the Company (other than an Excluded Repurchase (as defined in the Certificate of Designation) prior to the one-year anniversary of the Closing) or (C) part of a two-step transaction in which a tender offer is followed by a second step merger, in which the consideration to be received in the first step of such transaction is not identical to the amount or form of
consideration to be received in the second step merger; 
 (iv) Transfers to the Company or any of its Subsidiaries or that
have been approved in writing by the Board; 
 (v) Transfers after commencement by the Company or a significant subsidiary
(as such term is defined in Rule 12b-2 under the Exchange Act) of the Company of bankruptcy, insolvency or other similar proceedings; and 

(vi) Transfers in connection with a bona fide loan or other financing arrangement, in each case entered into with a nationally
recognized financial institution, including a pledge to such a financial institution to secure a bona fide debt financing and any foreclosure by such financial institution or transfer to such financial institution in lieu of foreclosure and
subsequent sale of the securities (each, a “Permitted Loan”). Nothing contained in this Agreement or the Registration Rights Agreement shall prohibit or otherwise restrict the ability of any lender (or its securities’
affiliate) or collateral agent to foreclose upon, or accept a Transfer in lieu of foreclosure, and sell, dispose of or otherwise Transfer the Series A Preferred Stock and/or shares of Common Stock issued upon conversion of Series A Preferred Stock
(including shares of Common Stock received upon conversion or redemption of the Series A Preferred Stock following foreclosure or Transfer in lieu of foreclosure on a Permitted Loan) mortgaged, hypothecated and/or pledged to secure the obligations
of the borrower following an event of default under a Permitted Loan. Subject to the preceding provisions of this clause (vi) and Section 5.08(c), in the event that any lender or other creditor under a Permitted Loan
transaction (including any agent or trustee on their behalf) or any Affiliate of the 

  
 34 

 
foregoing exercises any rights or remedies in respect of the Series A Preferred Stock or the shares of Common Stock issuable or issued upon conversion of the Series A Preferred Stock or any other
collateral for any Permitted Loan, no lender, creditor, agent or trustee on their behalf or affiliate of any of the foregoing (other than, for the avoidance of doubt, any Investor Party or its Affiliates) shall be entitled to any rights or have any
obligations or be subject to any transfer restrictions or limitations hereunder except and to the extent for those expressly provided for in Registration Rights Agreement. 

(c) Notwithstanding Sections 5.08(a) and (b), each Investor Party will not at any time knowingly (after reasonable inquiry),
directly or indirectly (without the prior written consent of the Board), Transfer any Series A Preferred Stock or Common Stock issued or issuable upon conversion of the Series A Preferred Stock (x) to a Competitor or an Activist Shareholder,
(y) any Person (other than the Company or its Subsidiaries) that, together with its Affiliates, to the knowledge of such Investor Party at the time it enters into such transaction (after reasonable inquiry), would hold 5% or more of the
outstanding Common Stock after giving effect to such transfer, and (z) in connection with any Excluded Repurchase (as defined in the Certificate of Designation); provided, that (i) these restrictions shall not apply to Transfers
into the public market pursuant to a bona fide, broadly distributed underwritten public offering, in each case made pursuant to the Registration Rights Agreement or through a bona fide sale to the public without registration effectuated pursuant to
Rule 144 under the Securities Act and (ii) in connection with a Transfer of shares of Series A Preferred Stock or Common Stock issued upon conversion of the Series A Preferred Stock in connection with any foreclosure or exercise of remedies
under a Permitted Loan. None of the Investor Parties shall be deemed to have breached its obligations under this Section 5.08(c) as it relates to any Activist Shareholder with respect to a Transfer of Series A Preferred
Stock or Common Stock issued upon conversion of the Series A Preferred Stock to any Person so long as such Investor Party acts in good faith, based on generally available public information and the advice of its financial advisors, to determine
whether such Person is an Activist Shareholder. 
 (d) Any attempted Transfer in violation of this Section 5.08
shall be null and void ab initio. 
 Section 5.09 Legend. (a) All certificates or other instruments
representing the Acquired Shares or Common Stock issued upon conversion of the Acquired Shares will bear a legend substantially to the following effect: 

THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF
ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A REGISTRATION STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT
OR SUCH LAWS. 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER RESTRICTIONS SET FORTH IN AN INVESTMENT AGREEMENT,
DATED AS OF APRIL 7, 2021, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER. 

  
 35 

 (b) (i) Upon request of any Investor Party, upon receipt by the Company of an opinion
of counsel reasonably satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state securities Laws, the Company shall promptly cause the first paragraph of the legend to be removed
from any certificate for Series A Preferred Stock or Common Stock to be Transferred in accordance with the terms of this Agreement and (ii) the second paragraph of the legend shall be removed upon the expiration of such transfer restrictions
set forth in this Agreement (and, for the avoidance of doubt, immediately prior to any termination of this Agreement). 
 Section 5.10
Election of Directors. (a) Effective as of the Closing, the Company will increase the size of the Board in order to appoint John Park (the “Initial Investor Director Designee”) to the Board to serve as a
Class III director of the Company for a term expiring at the 2023 annual meeting of the Company’s stockholders and until his or her successor is duly elected and qualified. 

(b) Upon the occurrence of the Fall-Away of Investor Board Rights, at the request of the Board, the Investor Director shall immediately resign,
and the KKR Investor Group shall cause such Investor Director immediately to resign from the Board and any committee thereof effective as of the date of the Fall-Away of Investor Board Rights, and the KKR Investor Group shall no longer have any
rights under this Section 5.10, including, for the avoidance of doubt, any designation or nomination rights under Section 5.10(c). Investor shall provide prompt written notice to the Company upon
occurrence of the Fall-Away of Investor Board Rights. 
 (c) Following the Closing and until the occurrence of the Fall-Away of Investor
Board Rights, at any annual meeting of the Company’s stockholders at which the term of the Investor Director shall expire, the KKR Investor Group shall have the right to designate an Investor Designee to the Board at such annual meeting for
election to the Board at such annual meeting. The Company shall include the Investor Designee designated by the KKR Investor Group in accordance with this Section 5.10(c) in the Company’s slate of nominees for the
applicable annual meeting of the Company’s stockholders and shall recommend that the holders of Common Stock vote in favor of any such Investor Designee’s election and shall support the Investor Designee in a manner no less rigorous and
favorable than the manner in which the Company supports its other nominees in the aggregate. Without the prior written consent of the KKR Investor Group, so long as such KKR Investor Group is entitled to designate an Investor Designee for election
to the Board in accordance with this Section 5.10, the Board shall not remove the Investor Director from his or her directorship (except as required by Law, the Certificate of Designations or the Company Charter Documents
or as required by the Company’s governance and similar policies applicable to all directors). 
 (d) In the event of the death,
disability, resignation or removal of the Investor Director as a member of the Board (other than resignation pursuant to Section 5.10(b)), the KKR Investor Group, if it is entitled to nominate a director pursuant to this
Section 5.10, may designate an Investor Designee to replace such Investor Director and, subject to Section 5.10(e) and any applicable provisions of the DGCL, the Company shall cause such Investor
Designee to fill such resulting vacancy. 

  
 36 

 (e) The Company’s obligations to have any Investor Designee elected to the Board or any
committee thereof or nominate any Investor Designee for election as a director at any meeting of the Company’s stockholders pursuant to this Section 5.10, as applicable, shall in each case be subject to such Investor
Designee’s satisfaction of all requirements regarding service as a director of the Company under applicable Law and stock exchange rules regarding service as a director of the Company and all other criteria and qualifications for service as a
director applicable to all directors of the Company, including the Company’s Code of Business Conduct and Ethics, Corporate Governance Guidelines and insider Trading Policy. The KKR Investor Group will cause each Investor Designee to make
himself or herself reasonably available for interviews and to consent to such reference and background checks or other investigations as the Board may reasonably request to determine the Investor Designee’s eligibility and qualification to
serve as a director of the Company. No Investor Designee shall be eligible to serve on the Board if he or she has been involved in any of the events enumerated under Item 2(d) of Schedule 13D under the Exchange Act or Item 401(f) of Regulation S-K under the Securities Act, is a “Bad Actor” as defined in Rule 506(d)(1)(i)-(viii) promulgated under the Securities Act or is subject to any Judgment prohibiting service as a director of any public
company. As a condition to any Investor Designee’s election to the Board or nomination for election as a director of the Company at any meeting of the Company’s stockholders, the KKR Investor Group and the Investor Designee must provide to
the Company: 
 (i) all information requested by the Company that is required to be or is customarily disclosed for
directors, candidates for directors and their respective Affiliates and Representatives in a proxy statement or other filings in accordance with applicable Law, any stock exchange rules or listing standards or the Company Charter Documents or
corporate governance guidelines, in each case, relating to the Investor Designee’s election as a director of the Company or the Company’s operations in the ordinary course of business; 

(ii) all information requested by the Company in connection with assessing eligibility and other criteria applicable to
directors or satisfying compliance and legal or regulatory obligations, in each case, relating to the Investor Designee’s nomination or election, as applicable, as a director of the Company or the Company’s operations in the ordinary
course of business; and 
 (iii) an undertaking in writing by the Investor Designee to be subject to, bound by and duly
comply with the Company’s Corporate Governance Guidelines, Code of Business Conduct, and Ethics, Stock Ownership Guidelines (which shall be deemed satisfied by the KKR Investor Group’s ownership of Acquired Shares) and Insider Trading
Policy with such changes thereto (or such successor policies) as are applicable to all other directors, in each case, as such changes or successor policies are adopted in good faith by the Board of Directors, and do not by their terms materially,
adversely and disproportionately impact the Investor Designee relative to all other directors; provided that no such code of conduct or Insider Trading Policy shall restrict any Transfer of securities by any member of the KKR Investor Group
or any of their respective Affiliates (other than with respect to the Investor Director solely in his or her individual capacity). 

  
 37 

 (f) Subject to Section 10.10(e), the Company shall, effective as
of the Closing and until the occurrence of the Fall-Away of Investor Board Rights, cause each of the Audit Committee of the Board and the Compensation Committee of the Board to include the Investor Director. 

(g) The Company shall indemnify each Investor Director and provide the Investor Director with director and officer insurance to the same extent
as it indemnifies and provides such insurance to other members of the Board, pursuant to the Company Charter Documents, the DGCL or otherwise. The Company acknowledges and agrees that it (1) is the indemnitor of first resort (i.e., its
obligations to the Investor Director are primary and any obligation of the KKR Investor Group or their Affiliates to advance expenses or to provide indemnification for the same expenses or liabilities incurred by any Investor Director are secondary)
and (2) shall be required to advance the amount of expenses incurred by the Investor Director and shall be liable for the amount of all expenses and liabilities incurred by the Investor Director, in each case to the same extent as it
indemnifies and provides such insurance to other members of the Board, pursuant to the Company Charter Documents, the DGCL or otherwise, without regard to any rights the Investor Director may have against the KKR Investor Group or their Affiliates.

 (h) Prior to the Fall-Away of Investor Board Rights, the Company shall not decrease the size of the Board or the Audit Committee or the
Compensation Committee of the Board without, in each case, the consent of the KKR Investor Group if such decrease would require the resignation of the Investor Designee from the Board or such committee thereof. 

(i) The parties hereto agree that the Investor Director shall be entitled to reimbursement from the Company for the reasonable out-of-pocket fees or expenses incurred in connection with his or her service as a director of the Board, in each case, in a manner consistent with the Company’s
practices with respect reimbursement for other members of the Board, including reimbursement pursuant to customary indemnification arrangements. The Investor Director shall not be entitled to receive any other compensation from the Company for his
or her service, including compensation to which the Investor Director would otherwise be entitled pursuant to the Company’s outside director compensation policy. 

Section 5.11 Voting. Upon the expiration or termination of the applicable waiting period (if any) under the HSR Act and
until September 30, 2024, subject to any applicable Law, stock exchange rules or listing standards: 
 (a) At each meeting of the
stockholders of the Company (including, if applicable, through the execution of one or more written consents if stockholders of the Company are requested to vote through the execution of an action by written consent in lieu of any such annual or
special meeting of stockholders of the Company) and at every postponement or adjournment thereof, each Investor Party shall take such action as may be required so that all of the shares of Series A Preferred Stock and Common Stock beneficially
owned, directly or indirectly, by such Investor Party or its controlled Affiliates and entitled to vote at such meeting 

  
 38 

 
of stockholders are voted, or consent is given or revoked, in the same manner as recommended by the Board with respect to the election or removal of directors and any Company or stockholder
proposal other than (i) any proposal that would, relative to any holder of Common Stock, disproportionately adversely affect the rights of any holder of Series A Preferred Stock or Common Stock issued upon conversion of the Series A Preferred
Stock; provided, that for the avoidance of doubt, no transaction constituting a Change of Control (as defined in the Certificate of Designations) shall be deemed to disproportionately adversely affect the rights of any holder of Series A
Preferred Stock or Common Stock issued upon conversion of the Series A Preferred Stock; and (ii) any of the matters set forth in Sections 13(b)(i) through (iv) of the Certificate of Designations. For the avoidance of doubt, each Investor
Party shall ensure they are entitled to vote each share of Series A Preferred Stock or Common Stock issued upon conversion of the Series A Preferred Stock, which is then held by such Investor Party (subject to Section 5.08) on the applicable
record date for each meeting of stockholders or solicitation of consents in lieu of a meeting. 
 (b) Each Investor Party shall be present,
in person or by proxy, at all meetings of the stockholders of the Company so that all shares of Series A Preferred Stock or Common Stock beneficially owned by such Investor Party or its controlled Affiliates may be counted for the purposes of
determining the presence of a quorum and voted in accordance with Section 5.11(a) at such meetings (including at any adjournments or postponements thereof). The foregoing provision shall also apply to the execution by such
Persons of any consent in lieu of a meeting of holders of shares of Common Stock or Series A Preferred Stock. 
 (c) The provisions of
Section 5.11(a) shall not apply to the exclusive consent and voting rights of the holders of Series A Preferred Stock set forth in Section 13(b) of the Certificate of Designations. 

Section 5.12 Tax Matters. (a) The Company and its paying agent shall be entitled to deduct and withhold Taxes on all
payments on the Series A Preferred Stock or Common Stock or other securities issued upon conversion of the Series A Preferred Stock to the extent required by the Code, Treasury Regulations or other applicable Law. Promptly following the date of this
Agreement or, in the case of a Permitted Transferee, the date such Permitted Transferee first acquires any Series A Preferred Stock or Common Stock or other securities issued upon conversion of the Series A Preferred Stock, each Investor Party shall
deliver to the Company or its paying agent a duly executed, accurate and properly completed Internal Revenue Service (“IRS”) Form W-9 or an appropriate
IRS Form W-8, as applicable. If the information on any such form provided by such Investor Party changes, or upon the Company’s reasonable request, such Investor Party shall provide the Company
with an updated version of such form. 
 (b) Absent a change in law or a contrary determination (as defined in Section 1313(a) of the
Code), the Investor Parties and the Company agree not to treat (i) the Series A Preferred Stock as “preferred stock” within the meaning of Section 305 of the Code and Treasury Regulation
Section 1.305-5 for United States federal income tax and withholding tax purposes, and shall not take a position inconsistent with such treatment and (ii) any Accrued Dividends, Compounded Dividends
(each, as defined in the Certificate of Designations) or any accrued amounts thereon as dividend for U.S. federal income tax purposes and applicable state and local tax purposes unless and until such dividends are declared and paid as Cash Dividends
(as defined in the Certificate of Designations). 

  
 39 

 (c) The Company shall pay any and all documentary, stamp and similar issue or transfer Tax
due on (x) the issue of the Series A Preferred Stock and (y) the issue of shares of Common Stock upon conversion of the Series A Preferred Stock. However, in the case of conversion of Series A Preferred Stock, the Company shall not be
required to pay any Tax or duty that may be payable in respect of any Transfer involved in the issue and delivery of shares of Common Stock or Series A Preferred Stock to a beneficial owner other than the beneficial owner of the Series A Preferred
Stock immediately prior to such conversion, and no such issue or delivery shall be made unless and until the person requesting such issue has paid to the Company the amount of any such Tax or duty, or has established to the satisfaction of the
Company that such Tax or duty has been paid. 
 (d) Upon any Investor Party’s reasonable request, and to the extent permitted by
applicable Law, the Company shall provide a duly executed and correctly completed statement, in accordance with Treasury Regulations Sections 1.897-2(h) and
1.1445-2(c)(3) (or any successor Treasury Regulations thereto), that the Series A Preferred Stock is not a U.S. real property interest. 

Section 5.13 Use of Proceeds. The Company shall use the proceeds from the issuance and sale of the Acquired Shares for
stock buy-backs and general corporate purposes. 
 Section 5.14 KKR Sponsor. 

(a) Notwithstanding anything to the contrary set forth in this Agreement, none of the terms or provisions of this Agreement (including, for the
avoidance of doubt, Section 5.07) shall in any way limit the activities of KKR Sponsor or any of its Affiliates, other than the Investor Parties Affiliated with the KKR Sponsor, in their businesses distinct from the
investment business of KKR Sponsor (the “Excluded Sponsor Parties”), so long as (i) no such Excluded Sponsor Party or any of its Representatives is acting on behalf of or at the direction of any Investor Party with respect to
any matter that otherwise would violate any term or provision of this Agreement and (ii) no Confidential Information is made directly available to any Excluded Sponsor Party or any of its Representatives who are not involved in the investment
business of KKR Sponsor by or on behalf of any Investor Party or any of their Representatives, except with respect to any such Representative who is (x) compliance personnel for compliance purposes and
(y) non-compliance personnel of KKR Sponsor who are directors or officers of, or function in a similar oversight role at, such Affiliate as long as Confidential Information is not otherwise disclosed to
such Affiliate. 
 (b) The Investor and the Company agree and acknowledge that, subject to applicable Law and Section 5.05 herein, the
Investor Director designated by the KKR Investor Group may share Confidential Information about the Company and its Subsidiaries with such KKR Sponsor and its Affiliates subject to adequate procedures being maintained to prevent such information
being used in connection with the purchase or sale of securities of the Company in violation of applicable Law. 

  
 40 

 (c) The Investor Parties and the Company hereby agree that, to the maximum extent permitted
by Law, when any Investor Party takes any action under this Agreement to give or withhold its consent, such Investor Party shall have no duty (fiduciary or other) to consider the interests of the Company or the other stockholders of the Company and
may act exclusively in its own interest; provided, however, that the foregoing shall in no way affect the obligations of the parties hereto to comply with the provisions of this Agreement. For the avoidance of doubt, the foregoing sentence shall not
limit or otherwise affect the fiduciary duties of the Investor Director or Investor Designee. 
 Section 5.15 Financing
Cooperation. If requested by any Investor Party, the Company will provide the following cooperation in connection with such Investor Party obtaining any Permitted Loan: (i) entering into an issuer agreement (an “Issuer
Agreement”) with each lender in customary form in connection with such transactions (which agreement may include, without limitation, agreements and obligations of the Company relating to procedures and specified time periods for effecting
Transfers and/or conversions upon foreclosure, agreements to not hinder or delay exercises of remedies on foreclosure, acknowledgments regarding corporate policy, if applicable, certain acknowledgments regarding securities Law status of the pledge
arrangements and a specified list of Competitors) and subject to the consent of the Company (which will not be unreasonably withheld or delayed), with such changes thereto as are requested by such lender and customary for similar financings,
(ii) using commercially reasonable efforts to (A) remove any restrictive legends on certificates representing pledged Series A Preferred Stock or Common Stock issued upon conversion of Series A Preferred Stock and depositing such pledged
Series A Preferred Stock or Common Stock issued upon conversion of Series A Preferred Stock in book entry form on the books of The Depository Trust Company when eligible to do so (and providing any necessary indemnities to the transfer agent in
connection therewith) or (B) without limiting the generality of clause (A), if such Series A Preferred Stock is eligible for resale under Rule 144A, depositing such pledged Series A Preferred Stock in book entry form on the books of The
Depository Trust Company or other depository with customary Rule 144A restrictive legends in lieu of the legends specified in Section 5.09(a) above, (iii) if so requested by such lender or counterparty, as applicable, (x) re-registering the pledged Series A Preferred Stock or Common Stock issued upon conversion of Series A Preferred Stock in the name of the relevant lender, counterparty, custodian or similar party to a
Permitted Loan, with respect to Permitted Loans solely as securities intermediary and only to the extent such Investor Party or its Affiliates continues to beneficially own such pledged Series A Preferred Stock or Common Stock issued upon conversion
of Series A Preferred Stock or (y) certificating the pledged Series A Preferred Stock or Common Stock issued upon conversion of Series A Preferred Stock, (iv) entering into customary triparty agreements with each lender and such Investor
Party relating to the delivery of the Series A Preferred Stock or Common Stock issued upon conversion of Series A Preferred Stock to the relevant lender for crediting to the relevant collateral accounts upon funding of the loan and payment of the
purchase price including a right for such lender as a third party beneficiary of the Company’s obligations under hereunder to issue the Series A Preferred Stock or Common Stock issued upon conversion of Series A Preferred Stock upon payment of
the purchase price therefor in accordance with the terms of this Agreement and (v) such other cooperation and assistance as such Investor Party may reasonably request (which cooperation and assistance, for the avoidance of doubt, shall not
include any requirements that the Company deliver information, compliance certificates or any other materials typically provided by borrowers to lenders) that will not 

  
 41 

 
unreasonably disrupt the operation of the Company’s business. Notwithstanding anything to the contrary in the preceding sentence, the Company’s obligation to deliver an Issuer Agreement
is conditioned on such Investor Party certifying to the Company in writing that (A) the loan agreement with respect to which the Issuer Agreement is being delivered constitutes a Permitted Loan being entered into in accordance with this
Agreement, the Investor has pledged the Series A Preferred Stock and/or the underlying shares of Common Stock as collateral to the lenders under such Permitted Loan and that the execution of such Permitted Loan and the terms thereof do not violate
the terms of this Agreement, (B) to the extent applicable, whether the registration rights under the Registration Rights Agreement are being assigned to the lenders under that Permitted Loan and (C) such Investor Party acknowledges and
agrees that the Company will be relying on such certificate when entering into the Issuer Agreement and any inaccuracy in such certificate will be deemed a breach of this Agreement. The Investor Parties acknowledge and agree that the statements and
agreements of the Company in an Issuer Agreement are solely for the benefit of the applicable lenders party thereto and that in any dispute between the Company and the Investor Parties under this Agreement, the Investor Parties shall not be entitled
to use the statements and agreements of the Company in an Issuer Agreement against the Company. 
 Section 5.16 Exclusivity.
Until the earlier of the Closing or the termination of this Agreement, without the prior written consent of the Investor, neither the Company nor any of its Subsidiaries shall, directly or indirectly, take (and the Company shall not authorize or
permit any directors, officers or employees of the Company to take and shall not permit any of its Affiliates or representatives to take) any action to (i) encourage (including by way of furnishing
non-public information), solicit, initiate or facilitate any Competing Securities Issuance, (ii) enter into any agreement with respect to any Competing Securities Issuance or enter into any agreement,
arrangement or understanding requiring it to abandon, terminate or fail to consummate any of the Transactions or (iii) participate in any way in discussions or negotiations with, or furnish any information to, any Person in connection with, or
take any other action to facilitate any inquiries or the making of any proposal that constitutes, or would reasonably be expected to lead to, any Competing Securities Issuance. Prior to the Closing, the Company shall use reasonable best efforts to
take all actions reasonably necessary to ensure that the directors, officers and employees of the Company or any of its Subsidiaries, do not, and to the extent within the Company’s control, other Affiliates or representatives do not take or do
any of the actions referenced in the immediately foregoing sentence. Upon execution of this Agreement and prior to the Closing, unless the Investor otherwise consents in writing, the Company shall, if applicable, cease immediately and cause to be
terminated any and all existing discussions or negotiations with any parties conducted heretofore with respect to any Competing Securities Issuance. In the event that a Change of Control (as defined in the Certificate of Designations) is consummated
prior to the Closing, the Company will pay to each Investor Party their Pro Rata Share of an amount equal to the Make-Whole Amount (as defined in the Certificate of Designations) (assuming for these purposes all shares of Series A Preferred Stock
had been issued to the Investor Parties immediately prior to the Change of Control). 

  
 42 

 Section 5.17 Preemptive Rights. 

(a) From and after the Closing and so long as the 50% Beneficial Ownership Requirement with respect to such Investor Party is satisfied, if the
Company makes any public or non-public offering of any capital stock of, other equity or voting interests in, or equity-linked securities of, the Company or any securities that are convertible or exchangeable
into (or exercisable for) capital stock of, other equity or voting interests in, or equity-linked securities of, the Company (collectively “Preemptive Securities”), including, for the purposes of this
Section 5.18, warrants, options or other such rights (any such security, a “New Security”) (other than (1) issuances of Preemptive Securities to directors, officers, employees, consultants or other
agents of the Company, (2) issuances of Preemptive Securities pursuant to an employee stock option plan, management incentive plan, restricted stock plan, stock purchase plan or stock ownership plan or similar benefit plan, program or
agreement, (3) issuances made as consideration for any acquisition (by sale, merger in which the Company is the surviving corporation, or otherwise) by the Company or any of its Subsidiaries of equity in, or assets of, another Person, business
unit, division or business, (4) issuances of any securities issued as a result of a stock split, stock dividend, reclassification or reorganization or similar event, (5) issuances of Preemptive Securities in connection with a bona fide
research, collaboration, technology license, development, OEM, marketing or other strategic partnership or commercial arrangement with a Person that is not an Affiliate of the Company or any of its Subsidiaries (other than (x) any such
strategic partnership or commercial arrangement with a private equity firm or similar financial institution or (y) an issuance the primary purpose of which is the provision of financing), (6) securities issued pursuant to the conversion,
exercise or exchange of Series A Preferred Stock issued to the Investor Parties, and (7) shares of a Subsidiary of the Company issued to the Company or a wholly owned Subsidiary of the Company), each Investor Party shall be afforded the
opportunity to acquire from the Company such Investor Party’s Preemptive Rights Portion of such New Securities for the same price as that offered to the other purchasers of such New Securities; provided, that the Investor Party shall not
be entitled to acquire any New Securities pursuant to this Section 5.17 to the extent the issuance of such New Securities to the Investor Parties would require approval of the stockholders of the Company as a result of the
status, if applicable, of any Investor Party as an Affiliate of the Company or pursuant to the rules and listing standards of the NYSE (including NYSE Listed Company Manual Section 312.03(c)), in which case the Company may consummate the
proposed issuance of New Securities to other Persons prior to obtaining approval of the stockholders of the Company (subject to compliance by the Company with Section 5.18(f) below). 

(b) Subject to the foregoing proviso in Section 5.18(a), the amount of New Securities that each Investor Party shall
be entitled to purchase in the aggregate shall be determined by multiplying (1) the total number of New Securities by (2) a fraction, the numerator of which is the number of shares of Acquired Shares and/or shares of Common Stock issued
upon conversion of Acquired Shares (in the aggregate and on an as converted basis) held by such Investor Party, as of such date, and the denominator of which is the aggregate number of shares of Common Stock held by all stockholders of the Company
(on an as converted basis) outstanding as of such date (the “Preemptive Rights Portion”). 
 (c) If the Company proposes to
offer New Securities, it shall give each Investor Party written notice of its intention, describing the anticipated price (or range of anticipated prices), anticipated amount of New Securities and other material terms and timing upon which the
Company proposes to offer the same (including, in the case of a registered public offering and to the extent possible, a copy of the prospectus included in the registration statement filed with respect to such offering) at least seven
(7) Business Days prior to such issuance (or, in the case of a registered public offering, at least seven (7) Business Days prior to the 

  
 43 

 
commencement of such registered public offering) (provided that, to the extent the terms of such offering cannot reasonably be provided seven (7) Business Days prior to such issuance,
notice of such terms may be given as promptly as reasonably practicable but in any event prior to such issuance). The Company may provide such notice to such Investor Party on a confidential basis prior to public disclosure of such offering. Other
than in the case of a registered public offering, such Investor Party may notify the Company in writing at any time on or prior to the second (2nd) Business Day immediately preceding the date of
such issuance (or, if notice of all such terms has not been given prior to the second (2nd) Business Day immediately preceding the date of such issuance, at any time prior to such issuance) whether such Investor Party will exercise such preemptive
rights and as to the amount of New Securities such Investor Party desires to purchase, up to the maximum amount calculated pursuant to Section 5.18(b). In the case of a registered public offering, any Investor Party may
notify the Company in writing at any time prior to the second (2nd) Business Day immediately preceding the date of commencement of such registered public offering (or, if notice of all such terms has not been given prior to the second (2nd) Business
Day immediately preceding the date of commencement of such registered public offering, at any time prior to the date of commencement of such registered public offering) whether such Investor Party will exercise such preemptive rights and as to the
amount of New Securities such Investor Party desires to purchase, up to the maximum amount calculated pursuant to Section 5.18(b). Such notice to the Company shall constitute a binding commitment by such Investor Party to
purchase the amount of New Securities so specified at the price and other terms set forth in the Company’s notice to it. Subject to receipt of the requisite notice of such issuance by the Company, the failure of such Investor Party to respond
prior to the time a response is required pursuant to this Section 5.18(c) shall be deemed to be a waiver of such Investor Party’s purchase rights under this Section 5.18 only with respect to
the offering described in the applicable notice. 
 (d) Each Investor Party shall purchase the New Securities that it has elected to purchase
under this Section 5.18 concurrently with the related issuance of such New Securities by the Company (subject to the receipt of any required approvals from any Governmental Authority to consummate such purchase by such
Investor Party); provided, that if such related issuance is prior to the twentieth (20th) Business Day following the date on which such Investor Party has notified the Company that it has elected to purchase New Securities pursuant to this
Section 5.18, then each Investor Party shall purchase such New Securities within twenty (20) Business Days following the date of the related issuance. If the proposed issuance by the Company of securities which gave
rise to the exercise by the Investor Parties of their preemptive rights pursuant to this Section 5.18 shall be terminated or abandoned by the Company without the issuance of any New Securities, then the purchase rights of
the Investor Parties pursuant to this Section 5.18 shall also terminate as to such proposed issuance by the Company (but not any subsequent or future issuance), and any funds in respect thereof paid to the Company by the
Investor Parties in respect thereof shall be promptly refunded in full. 
 (e) In the case of the offering of securities for consideration in
whole or in part other than cash, including securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall be deemed to be the fair value thereof as reasonably determined by
the Board; provided, however, that such fair value as determined by the Board shall not exceed the aggregate market price of the securities being offered as of the date the Board authorizes the offering of such securities. 

  
 44 

 (f) The Investor Parties shall not entitled to acquire any New Securities pursuant to this
Section 5.18 to the extent such issuance would require the Company to obtain stockholder approval in respect of the issuance of such New Securities to the Investor Parties as a result of any such Investor Party’s
status, if applicable, as an Affiliate of the Company or pursuant to the rules and listing standards of the NYSE (including NYSE Listed Company Manual Section 312.03(c)). In the event any Investors Party is not entitled to acquire any New
Securities pursuant to this Section 5.18(f) the Company shall, upon such Investor Party’s reasonable request delivered to the Company in writing within seven (7) Business Days following its receipt of the written
notice of such issuance to such Investor Party pursuant to Section 5.18(c), at such Investor Party’s election, (i) waive the restrictions set forth in Section 5.07(a) solely to the extent
necessary to permit such Investor Party to acquire such number of New Securities equivalent to its Preemptive Rights Portion of such issuance such Investor Party would have been entitled to purchase had it been entitled to acquire such New
Securities pursuant to Section 5.18(a)-(c); (ii) consider and discuss in good faith modifications proposed by such Investor Party to the terms and conditions of such portion of the New Securities which would otherwise
be issued to such Investor Party such that the Company would not be required to obtain stockholder approval in respect of the issuance of such New Securities as so modified; and/or (ii) solely to the extent that stockholder approval is required
in connection with the issuance of New Securities to Persons other than such Investor Party, use reasonable best efforts to seek stockholder approval in respect of the issuance of any New Securities to such Investor Party. 

(g) The election by any Investor Party to not exercise its subscription rights under this Section 5.18 in any one
instance shall not affect its rights as to any subsequent proposed issuance. 
 (h) The Company and the Investor Parties shall cooperate in
good faith to facilitate the exercise of the Investor Parties’ rights pursuant to this Section 5.18 including using reasonable best efforts to secure any required approvals or consents. 

Section 5.18 Available Registration Statement. The Company will not effect a Mandatory Conversion (as defined in the Certificate
of Designations) if any Investor Party holds or would hold upon such Mandatory Conversion (or any earlier conversion following the dates of the Notice of Mandatory Conversion (as defined in the Certificate of Designations)) shares of Common Stock
that are Registrable Securities unless as of the date of Notice of Mandatory Conversion and as of the Mandatory Conversion Date (as defined in the Certificate of Designations) there is an Available Registration Statement covering resale of such
shares of Common Stock by the Investor Parties. 
 Section 5.19 Section 16 Matters. If the Company
becomes a party to a consolidation, merger or other similar transaction, or if the Company proposes to take or omit to take any other action under Section 5.18 (including granting to the Investor Parties or their respective
Affiliates the right to participate in any issuance of securities) or otherwise or if there is any event or circumstance that may result in the Investor, its Affiliates and/or the Investor Director being deemed to have made a disposition or
acquisition of equity securities of the Company or derivatives thereof for purposes of Section 16 of the Exchange Act (including the purchase by the Investor or any of its Affiliates of any securities under
Section 5.18), and if the 

  
 45 

 
Investor Director is serving on the Board at such time or has served on the Board during the preceding six (6) months (i) the Board or a committee thereof composed solely of two or more “non-employee directors” as defined in Rule 16b-3 of the Exchange Act will pre-approve such acquisition or disposition of
equity securities of the Company or derivatives thereof for the express purpose of exempting the Investor and its Affiliates’ and the Investor Director’s interests (for the KKR Investor Group and/or their respective Affiliates, to the
extent such persons may be deemed to be “directors by deputization”) in such transaction from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder and (ii) if the transaction
involves (A) a merger or consolidation to which the Company is a party and the Common Stock is, in whole or in part, converted into or exchanged for equity securities of a different issuer, (B) a potential acquisition or deemed
acquisition, or disposition or deemed disposition, by the Investor, its Affiliates, and/or the Investor Director of equity securities of such other issuer or derivatives thereof and (C) an Affiliate or other designee of the Investor or any of
its Affiliates will serve on the board of directors (or its equivalent) of such other issuer pursuant to the terms of an agreement to which the Company is a party (or if the Investor notifies the Company of such service a reasonable time in advance
of the closing of such transactions), then if the Company requires that the other issuer pre-approve any acquisition of equity securities or derivatives thereof for the express purpose of exempting the
interests of any director or officer of the Company or any of its subsidiaries in such transactions from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder, the Company shall require that
such other issuer pre-approve any such acquisitions of equity securities or derivatives thereof for the express purpose of exempting the interests of the Investor, its Affiliates and the Investor Director (for
the KKR Investor Group and/or their respective Affiliates, to the extent such persons may be deemed to be “directors by deputization” of such other issuer) in such transactions from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. 
 Section 5.20 CUSIP. No later than the first (1) anniversary of
Closing, the Company will obtain appropriate and effective CUSIPs for the shares of Series A Preferred Stock. 
 ARTICLE VI 

Conditions to Closing 

Section 6.01 Conditions to the Obligations of the Company and the Investors. The respective obligations of each of the
Company and the Investor to effect the Closing shall be subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing Date of the following condition: 

(a) no temporary or permanent Judgment shall have been enacted, promulgated, issued, entered, amended or enforced by any Governmental Authority
nor shall any proceeding brought by a Governmental Authority seeking any of the foregoing be pending, or any applicable Law shall be in effect enjoining or otherwise prohibiting consummation of the Transactions (collectively,
“Restraints”). 
 Section 6.02 Conditions to the Obligations of the Company. The obligations of the
Company to effect the Closing shall be further subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing Date of the following conditions: 

  
 46 

 (a) the representations and warranties of the Investor Parties set forth in this Agreement
shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of such date (except to the extent expressly made as of an earlier date, in which case as of
such earlier date); 
 (b) the Investor Parties shall have complied with or performed in all material respects its obligations required to be
complied with or performed by it pursuant to this Agreement at or prior to the Closing; and 
 (c) the Company shall have received a
certificate, signed on behalf of each Investor Party (including any Permitted Investor Transferees) by a duly authorized officer thereof, certifying that, with respect to such Investor Party the conditions set forth in
Section 6.02(a) and Section 6.02(b) have been satisfied; provided that with respect to any Permitted Investor Transferee, the foregoing references in clauses (a) and (b) above to “this
Agreement” shall be deemed to refer to the Joinder that such Permitted Investor Transferee (and the Company) executed and delivered. 

Section 6.03 Conditions to the Obligations of the Investor. The obligations of the Investor to effect the Closing shall be
further subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing Date of all of the conditions set forth below: 

(a) the representations and warranties of the Company (i) set forth in Sections 3.01(a), 3.02, 3.03(a), 3.10,
3.11, 3.12, 3.14 and 3.17 and the first sentence of Section 3.13 shall be true and correct (disregarding all qualifications or limitations as to “materiality”, “Material Adverse Effect” and
words of similar import set forth therein) in all material respects as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of such date (except to the extent expressly made as of an earlier date, in
which case as of such earlier date), (ii) set forth in Section 3.06(b) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of
such date and (iii) set forth in this Agreement, other than in Sections 3.01(a), 3.02, 3.03(a), 3.06(b), 3.10 3.11, 3.12, 3.14 and 3.17 and the first sentence of
Section 3.13, shall be true and correct (disregarding all qualifications or limitations as to “materiality”, “Material Adverse Effect” and words of similar import set forth therein) as of the date of this Agreement
and as of the Closing Date with the same effect as though made on and as of such date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except, in the case of this clause (iii), where the failure to
be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; 

(b) the Company shall have complied with or performed in all material respects its obligations required to be complied with or performed by it
pursuant to this Agreement at or prior to the Closing; 
 (c) the Investor shall have received a certificate, signed on behalf of the Company
by a duly authorized officer thereof, certifying that the conditions set forth in Section 6.03(a) and 6.03(b) have been satisfied; 

  
 47 

 (d) prior to the Closing, the Company shall have duly adopted and filed with the Secretary
of State of the State of Delaware the Certificate of Designations, and a certified copy thereof shall have been delivered to the Investor; and 

(e) prior to the Closing, the Board shall have taken all actions necessary and appropriate to cause to be elected or appointed to the Board,
effective immediately following the Closing, the Initial Investor Director Designee. 
 ARTICLE VII 

Termination; Survival 

Section 7.01 Termination. This Agreement may be terminated and the Transactions abandoned at any time prior to the Closing
or, with respect to Section 7.01(f), at any time prior to or after the Closing: 
 (a) by the mutual written consent of the Company and
the Investor; 
 (b) by either the Company or the Investor upon written notice to the other, if the Closing has not occurred on or prior to
May 21, 2021 (the “Termination Date”); provided that the right to terminate this Agreement under this Section 7.01(b) shall not be available to any party if any breach by such party of its
representations and warranties set forth in this Agreement or the failure of such party to perform any of its obligations under this Agreement has been a principal cause of or primarily resulted in the events specified in this
Section 7.01(b); 
 (c) by either the Company or the Investor if any Restraint enjoining or otherwise prohibiting
consummation of the Transactions shall be in effect and shall have become final and non-appealable prior to the Closing Date; provided that the right to terminate this Agreement pursuant to
Section 7.01(c) shall not be available to any party unless such party has complied in all material respects with its obligations under Section 5.02; 

(d) by the Investor if the Company shall have breached any of its representations or warranties or failed to perform any of its covenants or
agreements set forth in this Agreement, which breach or failure to perform (i) would give rise to the failure of a condition set forth in Section 6.03(a) or Section 6.03(b) and (ii) is
incapable of being cured prior to the Termination Date, or if capable of being cured, shall not have been cured within thirty (30) calendar days (but in no event later than the Termination Date) following receipt by the Company of written
notice of such breach or failure to perform from the Investor stating the Investor’s intention to terminate this Agreement pursuant to this Section 7.01(d) and the basis for such termination; provided that the
Investor shall not have the right to terminate this Agreement pursuant to this Section 7.01(d) if the Investor is then in material breach of any of its representations, warranties, covenants or agreements hereunder which
breach would give rise to the failure of a condition set forth in Section 6.02(a) or Section 6.02(b); 

(e) by the Company if any of the Investor Parties shall have breached any of their respective representations or warranties or failed to
perform any of its covenants or agreements set forth in this Agreement or any Joinder, which breach or failure to perform (i) would give rise to the failure of a condition set forth in Section 6.02(a) or
Section 6.02(b) and (ii) 

  
 48 

 
is incapable of being cured prior to the Termination Date, or if capable of being cured, shall not have been cured within thirty (30) calendar days (but in no event later than the
Termination Date) following receipt by the Investor of written notice of such breach or failure to perform from the Company stating the Company’s intention to terminate this Agreement pursuant to this Section 7.01(e)
and the basis for such termination; provided that the Company shall not have the right to terminate this Agreement pursuant to this Section 7.01(e) if the Company is then in material breach of any of its
representations, warranties, covenants or agreements hereunder which breach would give rise to the failure of a condition set forth in Section 6.03(a) or Section 6.03(b); or 

(f) automatically, without any action by the Company or any Investor Party, concurrently with the consummation of a Change of Control (as
defined in the Certificate of Designations) (with the effectiveness of such termination prior to the Closing subject to payment of the Make-Whole Amount to the Investor Parties pursuant to Section 5.16). 

Section 7.02 Effect of Termination. Any termination of this Agreement as provided in Section 7.01
(other than any termination pursuant to Section 7.01(f)), shall be effective upon delivery of written notice thereof to the other party, specifying the provision hereof pursuant to which such termination is made, and this
Agreement shall forthwith become null and void (other than this Section 7.02 and Article VIII, all of which shall survive termination of this Agreement and the Confidentiality Agreement (which shall survive in
accordance with its terms except as otherwise provided herein), and, in the event a Change of Control (as defined in the Certificate of Designations) is consummated prior to the Closing, the Company’s obligation to pay the Make-Whole Amount (as
defined in the Certificate of Designations) pursuant to Section 5.16 shall survive in accordance with its terms with the effectiveness of any such termination subject to such payment being made), and there shall be no
liability on the part of the Investor or the Company in connection with this Agreement, except that no such termination shall relieve any party hereto from liability for damages to another party resulting from a Willful Breach of any representation,
warranty, covenant or agreement in this Agreement prior to the date of termination or from Fraud. Notwithstanding any other provision set forth in this Agreement, except in the case of Fraud, whether or not this Agreement is terminated (a) no
Investor shall have any such liability in excess of the Pro Rata Share of the Purchase Price paid by such Investor at Closing and (b) the Company shall not have any such liability in excess of the Purchase Price. 

Section 7.03 Survival. All of the covenants or other agreements of the parties contained in this Agreement, other than
those that by their terms are to be performed following the Closing (which shall survive the Closing until fully performed or fulfilled or this Agreement is otherwise terminated pursuant to Section 7.01(f)), unless and to the extent that non-compliance with such covenants or agreements is waived in writing by the party entitled to such performance). The representations and warranties made herein shall survive for one (1) year following the
Closing Date and shall then expire; provided that nothing herein shall relieve any party of liability for any inaccuracy or breach of such representation or warranty to the extent that any good faith allegation of such inaccuracy or breach is
made in writing prior to such expiration by a Person entitled to make such claim pursuant to the terms and conditions of this Agreement. For the avoidance of doubt, claims may be made with respect to the breach of any representation, warranty or
covenant until the applicable survival period therefor as described above expires. 

  
 49 

 ARTICLE VIII 

Miscellaneous 

Section 8.01 Amendments; Waivers. Subject to compliance with applicable Law, this Agreement may be amended or supplemented
in any and all respects only by written agreement of the parties hereto. 
 Section 8.02 Extension of Time, Waiver, Etc. The
Company and the Investor may, subject to applicable Law and pursuant to a written instrument delivered by such party, (a) waive any inaccuracies in the representations and warranties of the other party contained herein or in any document
delivered pursuant hereto, (b) extend the time for the performance of any of the obligations or acts of the other party contained herein or (c) waive compliance by the other party with any of the agreements contained herein applicable to
such party or, except as otherwise provided herein, waive any of such party’s conditions. Notwithstanding the foregoing, no failure or delay by the Company or any Investor Party in exercising any right hereunder shall operate as a waiver
thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right hereunder. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if
set forth in an instrument in writing signed on behalf of such party. 
 Section 8.03 Assignment. Neither this Agreement nor any
of the rights, interests or obligations hereunder shall be assigned, in whole or in part, by operation of Law or otherwise, by any of the parties hereto without the prior written consent of the other party hereto; provided, however,
that (a) the Investor may assign the rights to purchase at the Closing up to 350,000 shares of Series A Preferred Stock to the Persons, and in the amounts, set forth on Section 8.03 of the Company Disclosure Letter
(any such Person, a “Permitted Investor Transferee”), (b) the Investor and any Permitted Investor Transferee may assign its rights, interests and obligations under this Agreement, in whole or in part (including the right to purchase
the Acquired Shares at the Closing in accordance with Section 2.02) to one or more of their respective Permitted Transferees or as otherwise contemplated by Section 5.08, and (c) in the event of such assignment,
the assignee shall agree in writing to be bound by the provisions of this Agreement, including the rights, interests and obligations so assigned (including, in the case of the Permitted Investor Transferees, by executing and delivering to the
Company a joinder in the form attached hereto as Exhibit C (such applicable joinder, a “Joinder”)); provided that no such assignment will relieve any Investor Party of its obligations hereunder at or prior to the
Closing except at the Closing to the extent that a portion of the Purchase Price is paid by any such assignee; provided, further, that no party hereto shall assign any of its obligations hereunder with the primary intent of avoiding,
circumventing or eliminating such party’s obligations hereunder. The Company agrees that if the Investor assigns any of its rights, interests and obligations hereunder at or prior to the Closing to a Permitted Investor Transferee in accordance
with Section 8.03(a), at the Closing, the Company shall execute and deliver the applicable Joinder to the Permitted Investor Transferee and issue the Acquired Shares to any such Permitted Investor Transferee its applicable
Pro Rata Share of the Acquired Shares upon receipt of the 

  
 50 

 
applicable Pro Rata Share of the Purchase Price by or on behalf of such Permitted Investor Transferee. Subject to the immediately preceding sentence, this Agreement shall be binding upon, inure
to the benefit of, and be enforceable by, the parties hereto and their respective successors and permitted assigns. Following the Closing, (i) the KKR Investor Group shall not be responsible (and shall have no liability) for any actions taken
by any Permitted Investor Transferees (and their respective Permitted Transferees), (ii) all obligations or rights pursuant to this Agreement applicable to such Permitted Investor Transferee (and its Permitted Transferees) shall be deemed to be
directly between such Permitted Investor Transferee (and its Permitted Transferees) and the Company, and (iii) the Company shall have the right to and shall enforce the terms and conditions of this Agreement directly against such Permitted
Investor Transferees (and their respective Permitted Transferees). 
 Section 8.04 Counterparts. This Agreement may be
executed in one or more counterparts (including by facsimile or electronic mail), each of which shall be deemed to be an original but all of which taken together shall constitute one and the same agreement, and shall become effective when one or
more counterparts have been signed by each of the parties hereto and delivered to the other parties hereto. 
 Section 8.05 Entire
Agreement; No Third Party Beneficiaries; No Recourse. (a) This Agreement, including the Company Disclosure Letter, together with the Confidentiality Agreement, the Registration Rights Agreement and the Certificate of Designations,
constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, among the parties and their Affiliates, or any of them, with respect to the subject matter hereof and thereof. 

(b) No provision of this Agreement shall confer upon any Person other than the parties hereto and their permitted assigns any rights or
remedies hereunder, except that the Non-Recourse Parties shall be third party beneficiaries of this Section 8.05(b). This Agreement may only be enforced against, and any claims or
causes of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement may only be made against the entities that are expressly identified as parties hereto, including
entities that become parties hereto after the date of this Agreement or that agree in writing for the benefit of the Company to be bound by the terms of this Agreement applicable to the Investor Parties, and no former, current or future
equityholders, controlling persons, directors, officers, employees, general or limited partner, member, manager, advisor, agents, successors, assigns or Affiliates of any party hereto or any former, current or future equityholder, controlling
person, director, officer, employee, general or limited partner, member, manager, advisor, agent successors, assigns or Affiliate of any of the foregoing (each, a “Non-Recourse Party”) shall
have any liability for any obligations or liabilities of the parties to this Agreement or for any claim (whether in tort, contract or otherwise) based on, in respect of, or by reason of, the transactions contemplated hereby or in respect of any
representations (whether written or oral) made or alleged to be made in connection herewith, and no personal liability shall attach to, be imposed upon or otherwise be incurred by the Non-Recourse Parties
through the Investor or otherwise, whether by or through attempted piercing of the corporate (or partnership or limited liability company) veil, by the enforcement of any assessment or by any legal or equitable proceeding, by virtue of any statute,
regulation or applicable Law, or otherwise, except for the Company’s rights against KKR Sponsor under the Confidentiality Agreement. Without limiting the rights of any party against the other parties hereto, in no event shall any party or any
of its Affiliates seek to enforce this Agreement against, make any claims for breach of this Agreement against, or seek to recover monetary damages from, any Non-Recourse Party. 

  
 51 

 Section 8.06 Governing Law; Jurisdiction. (a) This Agreement and all
matters, claims or Actions (whether at law, in equity, in Contract, in tort or otherwise) based upon, arising out of or relating to this Agreement or the negotiation, execution or performance of this Agreement (collectively, the “Relevant
Matters”), shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under any applicable conflict of Laws principles. 

(b) All Actions arising out of or relating to any Relevant Matter shall be heard and determined in the Chancery Court of the State of Delaware
(or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over any Action, any state or federal court within the State of Delaware) and the parties hereto hereby irrevocably submit to the exclusive jurisdiction and venue of
such courts in any such Action and irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such Action. The consents to jurisdiction and venue set forth in this Section 8.06
shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this Section 8.06(b) and shall not be deemed to confer rights on any Person
other than the parties hereto. Each party hereto agrees that service of process upon such party in any Action arising out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in
Section 8.09 of this Agreement. The parties hereto and the Parties hereby waive any right to stay or dismiss any action or proceeding in connection with any Relevant Matter brought before the foregoing courts on the basis
of (i) any claim that it is not personally subject to the jurisdiction of the above-named courts for any reason or that it or any of its property is immune from the above-described legal process, (ii) that such action or proceeding is
brought in an inconvenient forum, that venue for the action or proceeding is improper or that this Agreement may not be enforced in or by such courts, or (iii) any other defense that would hinder or delay the levy, execution or collection of
any amount to which any Party hereto is entitled pursuant to any final judgment of any court having jurisdiction. The parties hereto agree that a final judgment in any such Action shall be conclusive and may be enforced in other jurisdictions by
suit on the judgment or in any other manner provided by applicable Law; provided that nothing in the foregoing shall restrict any party’s rights to seek any post-judgment relief regarding, or any appeal from, a final trial court
judgment. 
 Section 8.07 Specific Enforcement. The parties hereto agree that irreparable damage for which monetary
relief, even if available, would not be an adequate remedy, would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached, including if the parties hereto fail to take
any action required of them hereunder to cause the Closing to occur. The parties acknowledge and agree that (a) the parties shall be entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches or
threatened breaches of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in Section 8.06 without proof of damages or otherwise (in each case, subject to the terms and
conditions of this Section 8.07), this being in addition to any other remedy to which they are entitled under this Agreement and (b) the right of specific enforcement is an integral part of the Transactions and without
that right, 

  
 52 

 
neither the Company nor the Investor would have entered into this Agreement. The parties hereto agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to
Law or inequitable for any reason, and agree not to assert that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at Law. The parties hereto acknowledge and agree that any party
seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this Section 8.07 shall not be required to provide any
bond or other security in connection with any such order or injunction. 
 Section 8.08 WAIVER OF JURY TRIAL. EACH PARTY
ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE IN CONNECTION WITH ANY RELEVANT MATTER IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO ANY RELEVANT MATTER. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR
ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ACTION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER,
(C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 8.08. 

Section 8.09 Notices. All notices, requests and other communications to any party hereunder shall be in writing and shall
be deemed given if delivered personally, emailed (which is confirmed) or sent by overnight courier (providing proof of delivery) to the parties at the following addresses: 

(a) If to the Company, at: 

Box, Inc. 
 900 Jefferson Ave.

 Redwood City, California 94063 

Attention:    David Leeb 

Email:          dleeb@box.com 

  
 53 

 with a copy (which shall not constitute notice) to: 

Wilson Sonsini Goodrich & Rosati, P.C. 

650 Page Mill Road 
 Palo Alto,
CA 94304 
 Attn:              Jose Macias 

                      Martin
Korman 

                      Erik
Franks 
 Email:           jmacias@wsgr.com 

                      
mkorman@wsgr.com 

                      
efranks@wsgr.com 
 with a copy (which shall not constitute notice) to: 

Wilson Sonsini Goodrich & Rosati, P.C. 

One Market Plaza, Spear Tower, Suite 3300 

San Francisco, CA 94105 

Attention:     Rich Mullen 

Email:           rich.mullen@wsgr.com 

(b) If to the Investor, at: 
 KKR
Credit Advisors (US) LLC 
 555 California Street, 50th Floor 

San Francisco, CA 94104 

Email:          creditmiddleoffice@kkr.com 

                     
kkrcreditlegal@kkr.com 
 with a copy (which shall not constitute notice) to: 

Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 
 New York,
NY 10017 
 Attention:    Marni J. Lerner 

                    Ravi Purushotham 

Email:          mlerner@stblaw.com 

                     
rpurushotham@stblaw.com 
 (c) If to another Investor Party, to the address(es) and e-mail(s) set
forth in such Investor Party’s Joinder; 
 or such other address or email address as such party may hereafter specify by like notice to the other
parties hereto. All such notices, requests and other communications shall be deemed received on the date of actual receipt by the recipient thereof if received prior to 5:00 p.m. local time in the place of receipt and such day is a Business Day
in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding Business Day in the place of receipt. 

  
 54 

 Section 8.10 Severability. If any term, condition or other provision of
this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, provisions and conditions of this Agreement shall nevertheless remain in
full force and effect. Upon such determination that any term, condition or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original
intent of the parties as closely as possible to the fullest extent permitted by applicable Law. 
 Section 8.11 Expenses.
Contingent upon the occurrence of the Closing, the Investor Parties shall be entitled to receive reimbursement for all reasonable and documented out-of-pocket costs and
expenses of Investor and the Permitted Investor Transferees, including fees and disbursements of counsel, financial advisors and accountants, incurred through the Closing in connection with this Agreement and the Transactions that are invoiced to
the Company promptly following the Closing Date, up to a maximum amount of $750,000 in the aggregate. To the extent invoiced prior to the Closing Date, the Company shall pay such costs and expenses at the Closing. Subject to the foregoing, and
except as otherwise expressly provided herein, all costs and expenses, including fees and disbursements of counsel, financial advisors and accountants, incurred in connection with this Agreement and the Transactions shall be paid by the party
incurring such costs and expenses, whether or not the Closing shall have occurred. 
 Section 8.12 Interpretation.
(a) When a reference is made in this Agreement to an Article, a Section, Exhibit or Schedule, such reference shall be to an Article of, a Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated. The table of contents
and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words “include”, “includes” or
“including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation”. The words “hereof”, “herein” and “hereunder” and
words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement unless the context requires otherwise. The terms “or”, “any” and
“either” are not exclusive. The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply
“if”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. The words “made available to the Investor” and words of similar import refer to
documents delivered in Person or electronically to the Investor or its Representatives in each case no later than one (1) Business Day prior to the date of this Agreement. All accounting terms used and not defined herein shall have the
respective meanings given to them under GAAP. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. Any
agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of
agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes and references to all attachments thereto and instruments incorporated therein. Unless otherwise specifically indicated, all
references to “dollars” or “$” shall refer to the lawful money of the United States. References to a Person are also to its permitted assigns and successors. When calculating the period of time between which, within
which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded (and unless, otherwise required by Law, if the last day of such period is not a
Business Day, the period in question shall end on the next succeeding Business Day). 

  
 55 

 (b) The parties hereto have participated jointly in the negotiation and drafting of this
Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party
hereto by virtue of the authorship of any provision of this Agreement. 
 Section 8.13 Investor Representative. Each Investor
Party (other than any Permitted Investor Transferee or any of its Permitted Transferees) hereby consents to and authorizes (a) the appointment of the Investor as the Investor Representative hereunder (the “Investor
Representative”) and as the agent, proxy, and attorney-in-fact for and on behalf of such Investor Party, and (b) the taking by the Investor Representative
of any and all actions and the making of any decisions required or permitted by, or with respect to, this Agreement and the Transactions, including (i) the exercise of the power to agree to execute any consents under this Agreement and
(ii) to take all actions necessary in the judgment of the Investor Representative for the accomplishment of the foregoing and all of the other terms, conditions and limitations of this Agreement and the Transactions. Each Investor Party (other
than any Permitted Investor Transferee or any of its Permitted Transferees) shall be bound by the actions taken by the Investor Representative exercising the rights granted to it by this Agreement, and the Company shall be entitled to rely on any
such action or decision of the Investor Representative. If the Investor Representative shall resign or otherwise be unable to fulfill its responsibilities hereunder, the Investor Parties (other than any Permitted Investor Transferee or any of its
Permitted Transferees) shall appoint a new Investor Representative as soon as reasonably practicable by written consent of the KKR Investor Group by sending notice and a copy of the duly executed written consent appointing such new Investor
Representative to the Company. 
 Section 8.14 Not a Group; Independent Nature of Holders’ Obligations and
Rights. The Investor Parties and the Company agree that the arrangements contemplated by this Agreement are not intended to constitute the formation of a “group” (as defined in Section 13(d)(3) of the Exchange Act). Each Investor
Party agrees that, for purposes of determining beneficial ownership of such Investor Party and its Permitted Transferees, it shall disclaim any beneficial ownership by virtue of this Agreement of any Series A Preferred Stock or any Common Stock
issued upon conversion of the Series A Preferred Stock owned by the other Investor Parties (other than such Investor Party’s Permitted Transferees), and the Company agrees to recognize such disclaimer in its Exchange Act and Securities Act
reports. The obligations of each Investor Party under this Agreement are several and not joint with the obligations of any other Investor Party, and no Investor Party shall be responsible in any way for the performance of the obligations of any
other Investor Party under this Agreement. Nothing contained herein, and no action taken by any Investor Party pursuant hereto, shall be deemed to constitute the Investor Parties as, and the Company acknowledges that the Investor Parties do not so
constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Investor Parties are in any way acting in concert or as a group or 

  
 56 

 
entity with respect to such obligations or the transactions contemplated by this Agreement, and the Company acknowledges that the Investor Parties are not acting in concert or as a group by
virtue of this Agreement, and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement. Each Investor Party shall be entitled to independently protect and enforce its rights,
including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Investor Party to be joined as an additional party in any proceeding for such purpose. 

[Remainder of page intentionally left blank] 

  
 57 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and
delivered as of the date first above written. 
  

			
	BOX, INC.
		
	By:	 	 /s/ Aaron Levie

		 	Name: Aaron Levie
		 	Title:   Chief Executive Officer

 [Signature Page to Investment Agreement] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered as of
the date first above written. 
  

					
	INVESTOR:
	
	POWELL INVESTORS III L.P. 
		
	By:	 	 /s/ Jeffrey M. Smith

		 	Name:	 	Jeffrey M. Smith
		 	Title:	 	Authorized Signatory
	
	KKR-MILTON CREDIT HOLDINGS L.P. 
		
	By:	 	 /s/ Jeffrey M. Smith

		 	Name:	 	Jeffrey M. Smith
		 	Title:	 	Authorized Signatory
	
	KKR-NYC CREDIT C L.P. 
		
	By:	 	 /s/ Jeffrey M. Smith

		 	Name:	 	Jeffrey M. Smith
		 	Title:	 	Authorized Signatory
	
	TAILORED OPPORTUNISTIC CREDIT FUND 
		
	By:	 	 /s/ Jeffrey M. Smith

		 	Name:	 	Jeffrey M. Smith
		 	Title:	 	Authorized Signatory
	
	CPS HOLDINGS (US) L.P. 
		
	By:	 	 /s/ Saleena Goel

		 	Name:	 	Saleena Goel
		 	Title:	 	Vice President of CPS Holdings (US) GP LLC, the general partner of CPS Holdings (US) L.P.

 [Signature Page to Investment Agreement] 

 EXHIBIT A 

CERTIFICATE OF DESIGNATIONS OF 

SERIES A CONVERTIBLE PREFERRED STOCK, 

PAR VALUE $0.0001, 
 OF 

BOX, INC. 
 Pursuant to
Section 151 of the Delaware General Corporation Law (as amended, supplemented or restated from time to time, the “DGCL”), BOX, INC., a corporation organized and existing under the laws of the State of Delaware (the
“Company”), in accordance with the provisions of Section 103 of the DGCL, DOES HEREBY CERTIFY: 
 That, the Amended
and Restated Certificate of Incorporation of the Company, as filed with the Secretary of State of the State of Delaware (as amended, the “Certificate of Incorporation”), authorizes the issuance of 1,100,000,000 shares of capital
stock, consisting of 1,000,000,000 shares of class A common stock, par value $0.0001 per share (the “Common Stock”) and 100,000,000 shares of undesignated preferred stock, par value $0.0001 per share (“Preferred
Stock”); 
 That, subject to the Certificate of Incorporation, the board of directors of the Company (the “Board”)
is authorized to fix by resolution or resolutions the designations and the powers, including voting powers, if any, preferences and relative, participating, optional or other special rights, if any, and qualifications, limitations or restrictions
thereof, of any series of Preferred Stock, and to fix the number of shares constituting any such series. 
 That, pursuant to the authority
conferred upon the Board by the Certificate of Incorporation, the Board, on [•], 2021, adopted the following resolution designating a new series of Preferred Stock as “Series A Convertible Preferred Stock”: 

RESOLVED, that, pursuant to the authority vested in the Board in accordance with the provisions of Article IV of the Certificate of
Incorporation and the provisions of Section 151 of the DGCL, a series of Preferred Stock of the Company is hereby authorized, and the number of shares to be included in such series, and voting powers, designations, preferences and relative,
participating, optional or other special rights, and the qualifications, limitations and restrictions of the shares of Preferred Stock included in such series, shall be as follows: 

SECTION 1. Designation and Number of Shares. The shares of such series of Preferred Stock shall be designated as “Series A
Convertible Preferred Stock” (the “Series A Preferred Stock”). The number of authorized shares constituting the Series A Preferred Stock shall be 500,000. That number from time to time may be increased or
decreased (but not below the number of shares of Series A Preferred Stock then outstanding and subject to Section 13(b)(iii)) by further resolution duly adopted by the Board, or any duly authorized committee thereof and by
the filing of a certificate pursuant to the provisions of the DGCL stating that such increase or decrease, as applicable, has been so authorized. The Company shall not have the authority to issue fractional shares of Series A Preferred Stock. 

 SECTION 2. Ranking. The Series A Preferred Stock will rank, with respect to dividend
rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company: 

(a) on a parity basis with each other class or series of Capital Stock of the Company now existing or hereafter authorized, the
terms of which expressly provide that such class or series ranks on a parity basis with the Series A Preferred Stock as to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding
up of the affairs of the Company (such Capital Stock, “Parity Stock”); 
 (b) junior to each other class or
series of Capital Stock of the Company now existing or hereafter authorized, the terms of which expressly provide that such class or series ranks senior to the Series A Preferred Stock as to dividend rights and rights on the distribution of assets
on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company (such Capital Stock, “Senior Stock”); and 

(c) senior to the Common Stock and each other class or series of Capital Stock of the Company now existing or hereafter
authorized, the terms of which do not expressly provide that such class or series ranks on a parity basis with or senior to the Series A Preferred Stock as to dividend rights and rights on the distribution of assets on any voluntary or involuntary
liquidation, dissolution or winding up of the affairs of the Company (such Capital Stock, “Junior Stock”). 
 SECTION 3.
Definitions. As used herein for all purposes of this Certificate of Designations: 
 “Accrued Dividends” means, as
of any date, with respect to any share of Series A Preferred Stock, all Dividends that have accrued on such share pursuant to Section 4(b), whether or not declared, but that have not, as of such date, been paid, but
excluding any Compounded Dividends. 
 “Affiliate” means, as to any Person, any other Person that, directly or indirectly,
controls, or is controlled by, or is under common control with, such Person; provided, however, (i) that the Company and its Subsidiaries shall not be deemed to be Affiliates of any Investor Party or any of its Affiliates,
(ii) portfolio companies (as such term is customarily used among institutional investors) in which any Investor Party or any of its Affiliates has an investment (whether as debt or equity) shall not be deemed an Affiliate of such Investor Party
and (iii) the Excluded Sponsor Parties shall not be deemed to be Affiliates of any Investor Party, the Company or any of the Company’s Subsidiaries. For this purpose, “control” (including, with its correlative meanings,
“controlled by” and “under common control with”) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities
or partnership or other ownership interests, by contract or otherwise. 

  
 2 

 Any Person shall be deemed to “beneficially own”, to have
“beneficial ownership” of, or to be “beneficially owning” any securities (which securities shall also be deemed “beneficially owned” by such Person) that such Person is deemed to “beneficially
own” within the meaning of Rules 13d-3 and 13d-5 under the Exchange Act; provided that any Person shall be deemed to beneficially own any securities that
such Person has the right to acquire, whether or not such right is exercisable within sixty (60) days or thereafter (including assuming conversion of all Series A Preferred Stock, if any, owned by such Person to Common Stock). 

“Base Redemption Price” has the meaning set forth in Section 10(a)(i). 

“Board” has the meaning set forth in the recitals above. 

“Business Day” means any weekday that is not a day on which banking institutions in New York, New York are authorized or
required by law, regulation or executive order to be closed. 
 “Bylaws” means the Amended and Restated Bylaws of the
Company, as amended and as may be amended from time to time. 
 “Capital Stock” means, with respect to any Person, any and
all shares of, interests in, rights to purchase, warrants to purchase, options for, participations in or other equivalents of or interests in (however designated) stock issued by such Person. 

“Cash Dividend” has the meaning set forth in Section 4(c). 

“Certificate of Designations” means this Certificate of Designations relating to the Series A Preferred Stock, as it may be
amended from time to time. 
 “Certificate of Incorporation” has the meaning set forth in the recitals above. 

“Change of Control” means the occurrence of one of the following, whether in a single transaction or a series of
transactions: 
 (a) any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act),
other than the Company, its wholly-owned Subsidiaries and the employee benefit plans of the Company and its wholly-owned Subsidiaries, who files a Schedule TO or any schedule, form or report under the Exchange Act disclosing or with respect to whom
it otherwise becomes known (through public disclosure or otherwise) to the Company that such person or group has become the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of a majority of the total voting power of the Voting Stock of the Company, other than as a result of a transaction in which (1) the holders of securities
that represented 100% of the Voting Stock of the Company immediately prior to such transaction are substantially the same as the holders of securities that represent a majority of the Voting Stock of the surviving Person or its Parent Entity
immediately following such transaction and (2) the holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction own directly or indirectly Voting Stock of the surviving Person or its
Parent Entity in substantially the same proportion to each other as immediately prior to such transaction; 

  
 3 

 (b) the merger or consolidation of the Company with or into another Person or the merger of
another Person with or into the Company, or the sale, transfer or lease of all or substantially all of the assets of the Company (determined on a consolidated basis), whether in a single transaction or a series of related transactions, to another
Person, or any recapitalization, reclassification or other transaction (other than the filing of any amendment to the Certificate of Incorporation solely to change the title of the Class A Common Stock from “Class A Common Stock”
to “Common Stock” or a change in par value) in which all or substantially all of the Common Stock is exchanged for or converted into cash, securities or other property, other than a transaction following which (1) in the case of a
merger or consolidation transaction, holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction own directly or indirectly (in substantially the same proportion to each other as immediately
prior to such transaction, other than changes in proportionality as a result of any cash/stock election provided under the terms of the definitive agreement regarding such transaction) at least a majority of the voting power of the Voting Stock of
the surviving Person or Parent Entity in such merger or consolidation transaction immediately after such transaction, and (2) in the case of a sale, transfer or lease of all or substantially all of the assets of the Company, other than to a
Subsidiary or a Person that becomes a Subsidiary of the Company; or 
 (c) shares of Common Stock or shares of any other Capital Stock of the
Company into which the Series A Preferred Stock is convertible are not listed for trading on any United States national securities exchange or cease to be traded in contemplation of a de-listing (other than as
a result of a transaction described in clause (b) above). 
 “Change of Control Effective Date” has the meaning set
forth in Section 9(b). 
 “Change of Control Purchase Date” means, with respect to each share of
Series A Preferred Stock, (i) in the case of a conversion pursuant to Section 9(a), the date on which the Company issues the shares of Common Stock upon conversion of such share and (ii) in the case of a Change of
Control Redemption, the date on which the Company makes the payment in full of the Change of Control Redemption Price for such share to the Holder thereof or to the Transfer Agent, irrevocably, for the benefit of such Holder. 

“Change of Control Redemption” has the meaning set forth in Section 9(a). 

“Change of Control Redemption Price” has the meaning set forth in Section 9(a). 

“Common Stock” has the meaning set forth in the recitals above. 

“close of business” means 5:00 p.m. (New York City time). 

“Closing Price” of the Common Stock on any date of determination means the closing sale price or, if no closing sale price is
reported, the last reported sale price, of the shares of the Common Stock on the NYSE on such date. If the Common Stock is not traded on the NYSE on any date of determination, the Closing Price of the Common Stock on such date of determination means
the closing sale price as reported in the composite transactions for the principal United States securities exchange or automated quotation system on which the Common Stock is so listed or quoted, or, if no closing sale price is reported, the last
reported sale price on the principal United States securities exchange or automated quotation system on which 

  
 4 

 
the Common Stock is so listed or quoted, or if the Common Stock is not so listed or quoted on a United States securities exchange or automated quotation system, the last quoted bid price for the
Common Stock in the over-the-counter market as reported by OTC Markets Group Inc. or any similar organization, or, if that bid price is not available, the market price
of the Common Stock on that date as determined by an Independent Financial Advisor retained by the Company for such purpose. 

“Code” means the Internal Revenue Code of 1986, as amended. 

“Common Stock” has the meaning set forth in the recitals above. 

“Company” has the meaning set forth in the recitals above. 

“Company Redemption Right” has the meaning set forth in Section 10(a)(i). 

“Compounded Dividend Record Date” has the meaning set forth in Section 4(d). 

“Compounded Dividend Ratio” has the meaning set forth in Section 4(c). 

“Compounded Dividends” has the meaning set forth in Section 4(c). 

“Constituent Person” has the meaning set forth in Section 12(a). 

“Conversion Agent” means the Transfer Agent acting in its capacity as conversion agent for the Series A Preferred Stock, and
its successors and assigns. 
 “Conversion Date” has the meaning set forth in Section 8(a). 

“Conversion Notice” has the meaning set forth in Section 8(a)(i). 

“Conversion Price” means, for each share of Series A Preferred Stock, a dollar amount equal to $1,000 divided by the
Conversion Rate. 
 “Conversion Rate” means, for each share of Series A Preferred Stock, [•] shares of Common Stock,
subject to adjustment as set forth herein. 
 “Current Market Price” per share of Common Stock, as of any date of
determination, means the arithmetic average of the VWAP per share of Common Stock for each of the ten (10) consecutive full Trading Days ending on the Trading Day immediately preceding such day, appropriately adjusted to take into account the
occurrence during such period of any event described in Section 11. 
 “DGCL” has the meaning set
forth in the recitals above. 

  
 5 

 “Distributed Property” has the meaning set forth in
Section 11(a)(iv). 
 “Distribution Transaction” means any distribution of equity securities of a
Subsidiary of the Company to holders of Common Stock, whether by means of a spin-off, split-off, redemption, reclassification, exchange, stock dividend, share
distribution, rights offering or similar transaction. 
 “Dividend Payment Date” means March 31, June 30,
September 30 and December 31 of each year; provided that if any such Dividend Payment Date is not a Business Day, then the applicable Dividend shall be payable on the next Business Day immediately following such Dividend Payment
Date, without any interest. 
 “Dividend Payment Period” means in respect of any share of Series A Preferred
Stock the period from and including the Issuance Date of such share to but excluding the next Dividend Payment Date and, subsequently, in each case the period from and including any Dividend Payment Date to but excluding the next Dividend Payment
Date. 
 “Dividend Rate” means 3.0% or, to the extent and during the period with respect to which such rate has been
adjusted as provided in Section 9(g), such adjusted rate. 
 “Dividend Record Date” has the
meaning set forth in Section 4(d). 
 “Dividends” has the meaning set forth in
Section 4(a). 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Exchange Property” has the meaning set forth in Section 12(a). 

“Excluded Repurchase” means the repurchase of up to $500,000,000 of shares of Common Stock in the aggregate by the Company as
described in the Company’s public statements made in connection with the announcement of the transactions contemplated by the Investment Agreement. 

“Excluded Sponsor Parties” has the meaning set forth in the Investment Agreement. 

“Expiration Date” has the meaning set forth in Section 11(a)(iii). 

“Fair Market Value” means, with respect to any security or other property, the fair market value of such security or other
property as reasonably determined in good faith by the Board, or an authorized committee thereof, (i) after consultation with an Independent Financial Advisor, as to any security or other property with a Fair Market Value of less than
$50,000,000, or (ii) otherwise using an Independent Financial Advisor to provide a valuation opinion. 

  
 6 

 “Holder” means a Person in whose name the shares of the Series A Preferred
Stock are registered, which Person shall be treated by the Company, Transfer Agent, Registrar, paying agent and Conversion Agent as the absolute owner of the shares of Series A Preferred Stock for the purpose of making payment and settling
conversions and for all other purposes; provided that, to the fullest extent permitted by law, no Person that has received shares of Series A Preferred Stock in violation of the Investment Agreement shall be a Holder, the Transfer Agent,
Registrar, paying agent and Conversion Agent, as applicable, shall not, unless directed otherwise by the Company, recognize any such Person as a Holder and the Person in whose name the shares of the Series A Preferred Stock were registered
immediately prior to such transfer shall remain the Holder of such shares. 
 “Holder Redemption Right” has the meaning
specified in Section 10(b). 
 “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act
of 1976, as amended, and the rules and regulations promulgated thereunder. 
 “Implied Quarterly Dividend Amount” means,
with respect to any share of Series A Preferred Stock, as of any date, the product of (a) the Liquidation Preference of such share on the first day of the applicable Dividend Payment Period (or in the case of the first Dividend Payment Period
for such share, as of the Issuance Date of such share) multiplied by (b) one fourth of the Dividend Rate applicable on such date. 

“Independent Financial Advisor” means an accounting, appraisal, investment banking firm or consultant of nationally
recognized standing; provided, however, that such firm or consultant is not an Affiliate of the Company. 
 “Initial
Change of Control Notice” has the meaning set forth in Section 9(b). 
 “Investment
Agreement” means that certain Investment Agreement between the Company and the Investors dated as of April 7, 2021, as it may be amended, supplemented or otherwise modified from time to time, with respect to certain terms and conditions
concerning, among other things, the rights of and restrictions on the Holders. 
 “Investors” has the meaning set forth in
the Investment Agreement. 
 “Investor Parties” means each Investor and each Permitted Transferee of each Investor to whom
shares of Series A Preferred Stock or Common Stock are transferred pursuant to Section 5.08(b)(i) of the Investment Agreement. 

“Issuance Date” means, with respect to any share of Series A Preferred Stock, the date of issuance of such share. 

“Junior Stock” has the meaning set forth in Section 2(c). 

“Liquidation Preference” means, with respect to any share of Series A Preferred Stock, as of any date, $1,000 per share, as
may be increased for any Compounded Dividends, from time to time. 
 “Make-Whole Amount” means an amount in cash equal to
the Compounded Dividends that would have been payable on such share of Series A Preferred Stock from and after the Change of Control Purchase Date through and including the fifth (5th) anniversary
of the Original Issue Date, as if such share of Series A Preferred Stock had been outstanding for such period. For the avoidance of doubt, the “Make-Whole Amount” shall not include any Accrued Dividends that are paid pursuant to
Section 9(a)(y). 

  
 7 

 “Mandatory Conversion” has the meaning set forth in
Section 7(a). 
 “Mandatory Conversion Date” has the meaning set forth in
Section 7(a). 
 “Mandatory Conversion Price” means 200% of the Conversion Price, as adjusted
pursuant to the provisions of Section 11(a). The Mandatory Conversion Price shall initially be $[•]. 

“Market Disruption Event” means any of the following events: 

(a) any suspension of, or limitation imposed on, trading of the Common Stock by any exchange or quotation system on which the
Closing Price is determined pursuant to the definition of the term “Closing Price” (the “Relevant Exchange”) during the one-hour period prior to the close of trading for the regular
trading session on the Relevant Exchange (or for purposes of determining the VWAP per share of Common Stock, any period or periods aggregating one half-hour or longer during the regular trading session on the relevant day) and whether by reason of
movements in price exceeding limits permitted by the Relevant Exchange as to securities generally, or otherwise relating to the Common Stock or options contracts relating to the Common Stock on the Relevant Exchange; or 

(b) any event that disrupts or impairs (as determined by the Company in its reasonable discretion) the ability of market
participants during the one-hour period prior to the close of trading for the regular trading session on the Relevant Exchange (or for purposes of determining the VWAP per share of Common Stock, any period or
periods aggregating one half-hour or longer during the regular trading session on the relevant day) in general to effect transactions in, or obtain market values for, the Common Stock on the Relevant Exchange or to effect transactions in, or obtain
market values for, options contracts relating to the Common Stock on the Relevant Exchange. 
 “Notice of Company
Redemption” has the meaning set forth in Section 10(a)(ii). 
 “Notice of Holder
Redemption” has the meaning set forth in Section 10(b). 
 “Notice of Mandatory
Conversion” has the meaning set forth in Section 7(b). 
 “NYSE” means the New York
Stock Exchange. 
 “Officer’s Certificate” means a certificate signed by the Chief Executive Officer,
the Chief Financial Officer, the Secretary, or any President or Vice President of the Company (whether or not designated by a number or numbers or word or words added before or after the title “President” or “Vice President”).

 “Original Issuance Date” means the Closing Date, as defined in the Investment Agreement. 

  
 8 

 “Parent Entity” means, with respect to any Person, any other Person of
which such first Person is a direct or indirect wholly owned Subsidiary. 
 “Parity Stock” has the meaning set forth in
Section 2(a). 
 “Permitted Investor Transferee” has the meaning set forth in the Investment
Agreement. 
 “Permitted Transferee” has the meaning set forth in the Investment Agreement. 

“Person” means any individual, corporation, estate, partnership, joint venture, association, joint-stock company, limited
liability company, trust, unincorporated organization or any other entity. 
 “Preferred Stock” has the meaning set forth
in the recitals above. 
 “Record Date” means, with respect to any dividend, distribution or other transaction or event in
which holders of Common Stock have the right to receive any cash, securities or other property or in which Common Stock is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of
holders of Common Stock entitled to receive such cash, securities or other property (whether such date is fixed by the Board or by statute, contract or otherwise). 

“Redemption Date” means, with respect to each share of Series A Preferred Stock, the date on which the Company makes the
payment in full of the Redemption Price for each such share either to the Holder of such share or to the Transfer Agent, irrevocably, for the benefit of such Holder. 

“Redemption Price” has the meaning set forth in Section 10(a)(i). 

“Registrar” means the Transfer Agent acting in its capacity as registrar for the Series A Preferred Stock, and its successors
and assigns. 
 “Relevant Exchange” has the meaning set forth in the definition of the term “Market Disruption
Event”. 
 “Reorganization Event” has the meaning set forth in Section 12(a). 

“Required Number of Shares” has the meaning set forth in Section 9(g). 

“Senior Stock” has the meaning set forth in Section 2(b). 

“Series A Preferred Stock” has the meaning set forth in Section 1. 

“Subsidiary”, when used with respect to any Person, means any corporation, limited liability company, partnership,
association, trust or other entity of which (i) securities or other ownership interests representing more than 50% of the ordinary voting power (or, in the case of a partnership, more than 50% of the general partnership interests) or
(ii) sufficient voting rights to elect at least a majority of the board of directors or other governing body are, as of such date, owned by such Person or one or more Subsidiaries of such Person or by such Person and one or more Subsidiaries of
such Person. 

  
 9 

 “Trading Day” means a Business Day on which the Relevant Exchange is
scheduled to be open for business and on which there has not occurred a Market Disruption Event. 
 “Trading Period” has
the meaning set forth in Section 7(a). 
 “Transfer Agent” means the Person acting as Transfer
Agent, Registrar and paying agent and Conversion Agent for the Series A Preferred Stock, and its successors and assigns. The Transfer Agent initially shall be Computershare Trust Company, N.A. 

“Trigger Event” has the meaning set forth in Section 11(a)(vii). 

“Voting Share Cap” means, for each share of Series A Preferred Stock held by a Holder, a number of shares of Common Stock
equal to the Liquidation Preference of such share divided by $[•] as adjusted proportionately to account for any adjustment to the Conversion Rate pursuant to Section 11. 

“Voting Stock” means (i) with respect to the Company, the Common Stock, the Series A Preferred Stock (subject to the
limitations set forth herein) and any other Capital Stock of the Company having the right to vote generally in any election of directors of the Board and (ii) with respect to any other Person, all Capital Stock of such Person having the right
to vote generally in any election of directors of the board of directors of such Person or other similar governing body. 

“VWAP” per share of Common Stock on any Trading Day means the per share volume-weighted average price as displayed under the
heading Bloomberg VWAP on Bloomberg (or, if Bloomberg ceases to publish such price, any successor service reasonably chosen by the Company) page “BOX <equity> AQR” (or its equivalent successor if such page is not available) in
respect of the period from the open of trading on the relevant Trading Day until the close of trading on such Trading Day (or if such volume-weighted average price is unavailable, the market price of one share of Common Stock on such Trading Day
determined, using a volume-weighted average method, by an Independent Financial Advisor retained for such purpose by the Company). 

SECTION 4. Dividends. (a) Holders shall be entitled to receive dividends of the type and in the amount determined as set forth in
this Section 4 (such dividends, “Dividends”). 

  
 10 

 (b) Accrual of Dividends. Dividends on each share of Series A Preferred Stock
(i) shall accrue on a daily basis from and including the Issuance Date of such share, whether or not declared and whether or not the Company has assets legally available to make payment thereof, at a rate equal to the Dividend Rate as further
specified below and (ii) shall be payable quarterly in arrears, if, as and when authorized by the Board, or any duly authorized committee thereof, and declared by the Company, to the extent not prohibited by law, on each Dividend Payment Date,
commencing on the first Dividend Payment Date following the Issuance Date of such share. The amount of Dividends accruing with respect to any share of Series A Preferred Stock for any day shall be determined by dividing (x) the Implied
Quarterly Dividend Amount as of such day by (y) the actual number of days in the Dividend Payment Period in which such day falls; provided that if during any Dividend Payment Period any Compounded Dividends in respect of one or more
prior Dividend Payment Periods are paid in cash, then after the date of such payment the amount of Dividends accruing with respect to any share of Series A Preferred Stock for any day shall be determined by dividing (x) the Implied Quarterly
Dividend Amount (recalculated to take into account such payment of Compounded Dividends) by (y) the actual number of days in such Dividend Payment Period. The amount of Dividends payable with respect to any share of Series A Preferred Stock for
any Dividend Payment Period shall equal the sum of the daily Dividend amounts accrued in accordance with the prior sentence of this Section 4(b) with respect to such share during such Dividend Payment Period. For the
avoidance of doubt, for any share of Series A Preferred Stock with an Issuance Date that is not a Dividend Payment Date, the amount of Dividends payable with respect to the initial Dividend Payment Period for such share shall equal the product of
(A) the daily accrual determined as specified in the prior sentence, assuming a full Dividend Payment Period in accordance with the definition of such term, and (B) the number of days from and including such Issuance Date to but excluding
the next Dividend Payment Date. 
 (c) Payment of Dividend. With respect to any Dividend Payment Date, the Company may pay, to the
extent permitted by applicable law, in its sole discretion, Dividends on each share of Series A Preferred Stock in cash (a “Cash Dividend”), if, as and when authorized by the Board, or any duly authorized committee thereof;
provided that Cash Dividend payments shall be aggregated per Holder and shall be made to the nearest cent (with $.005 being rounded upward). With respect to any Dividend Payment Date for which the Company does not for any reason (including
because payment of any such Cash Dividends are prohibited by law) pay in cash all Dividends that accumulated during the relevant Dividend Payment Period, any such accumulated and unpaid Dividends on a share of the Series A Preferred Stock
(“Compounded Dividends”) will (whether or not earned or declared) become part of the Liquidation Preference of such share of the Series A Preferred Stock as of the applicable Dividend Payment Date. Any Compounded Dividends that
remain unpaid as of any determination date shall increase the Liquidation Preference in accordance with the definition of “Liquidation Preference”. With respect to any Dividend Payment Date where the Company does not pay in cash all
Dividends that accumulated during the relevant Dividend Payment Period, the proportion of any Compounded Dividend to Dividend in respect of any Holder (the “Compounded Dividend Ratio”) shall be the same as the Compounded Dividend
Ratio with respect to each Dividend paid to each other Holder that is entitled to a Dividend on such Dividend Payment Date. Compounded Dividends in respect of any prior Dividend Payment Periods may be paid on any date (whether or not such date is a
Dividend Payment Date) if, as and when authorized by the Board, or any duly authorized committee thereof as declared by the Company and any such payment will reduce, on a
dollar-for-dollar basis, the Liquidation Preference in respect of the Series A Preferred Stock such payments are made; provided that the Company may not pay in cash any
Accrued Dividends or Compounded Dividends after a Conversion Notice has been delivered to the Conversion Agent hereunder. Notwithstanding anything herein to the contrary, no Dividend may be declared unless paid in cash (it being understood that no
Dividends may be declared in paid in securities or otherwise “in kind”). 

  
 11 

 (d) Record Date. The record date for payment of Dividends that are declared and paid
on any relevant Dividend Payment Date will be the close of business on the fifteenth (15th) day of the calendar month which contains the relevant Dividend Payment Date (each, a “Dividend Record Date”), and the record date for
payment of any Compounded Dividends that were not declared and paid on any relevant Dividend Payment Date will be the close of business on the date that is established by the Board, or a duly authorized committee thereof, as such, which will not be
more than forty-five (45) days prior to the date on which such Dividends are paid (each, an “Compounded Dividend Record Date”), in each case whether or not such day is a Business Day. 

(e) Priority of Dividends. So long as any shares of Series A Preferred Stock remain outstanding, unless full Dividends and Compounded
Dividends on all outstanding shares of Series A Preferred Stock that have accrued from and including the date of issuance have been declared and paid in cash, or have been or contemporaneously are declared and a sum sufficient for the payment of
those Dividends and Compounded Dividends has been or is set aside for the benefit of the Holders, the Company may not declare any cash dividend on, or make any cash distributions relating to, Junior Stock or Parity Stock, or redeem, purchase,
acquire (either directly or through any Subsidiary) or make a liquidation payment relating to, any Junior Stock or Parity Stock, other than: 

(i) purchases, redemptions or other acquisitions of shares of Junior Stock in connection with any employment contract, benefit
plan or other similar arrangement with or for the benefit of current or former employees, officers, directors or consultants; 

(ii) purchases of Junior Stock through the use of the proceeds of a substantially contemporaneous sale of other shares of
Junior Stock; 
 (iii) as a result of an exchange or conversion of any class or series of Parity Stock or Junior Stock for
any other class or series of Parity Stock (in the case of Parity Stock) or Junior Stock (in the case of Parity Stock or Junior Stock); 

(iv) purchases of fractional interests in shares of Parity Stock or Junior Stock pursuant to the conversion or exchange
provisions of such Parity Stock or Junior Stock or the security being converted or exchanged; 
 (v) payment of any dividends
in respect of Junior Stock where the dividend is in the form of the same stock or rights to purchase the same stock as that on which the dividend is being paid; 

(vi) distributions of Junior Stock or rights to purchase Junior Stock; or 

  
 12 

 (vii) any dividend in connection with the implementation of a
shareholders’ rights or similar plan, or the redemption, repurchase or exchange of any rights under any such plan. 
 Notwithstanding
the foregoing, for so long as any shares of Series A Preferred Stock remain outstanding, if dividends are not declared and paid in full upon the shares of Series A Preferred Stock and any Parity Stock, all dividends declared upon shares of Series A
Preferred Stock and any Parity Stock will be declared on a proportional basis so that the amount of dividends declared per share will bear to each other the same ratio that all accrued and unpaid dividends as of the end of the most recent Dividend
Payment Period per share of Series A Preferred Stock and accrued and unpaid dividends as of the end of the most recent dividend period per share of any Parity Stock bear to each other. 

(f) Participating Dividends. Subject to the provisions of this Section 4, dividends or distribution may be
authorized by the Board, or any duly authorized committee thereof, and declared and paid by the Company, or any duly authorized committee thereof, on any Junior Stock and Parity Stock from time to time (a “Common Dividend”);
provided that at the time of such authorization, the Board or such committee authorizes an equivalent dividend or distribution on the Series A Preferred Stock (a “Participating Dividend”) such that (1) the Record Date
and the payment date for such Participating Dividend occur on the same respective date as the Record Date and payment date for such Common Dividend and (2) the kind and amount of consideration payable per share of Series A Preferred Stock in
such Participating Dividend is the same kind and amount of consideration that would be payable in the Common Dividend in respect of a number of shares of Common Stock that would be issuable upon conversion of a share of Series A Preferred Stock
(pursuant to Section 6 without regard to any of the limitations on convertibility contained therein) immediately prior to the Record Date for such Common Dividend. 

(g) Conversion Following a Record Date. If the Conversion Date for any shares of Series A Preferred Stock is prior to the close of
business on a Dividend Record Date or a Compounded Dividend Record Date, the Holder of such shares will not be entitled to any dividend in respect of such Dividend Record Date or Compounded Dividend Record Date, as applicable, other than through the
inclusion of Accrued Dividends and Compounded Dividends in the Liquidation Preference as of the Conversion Date in the calculation under Section 6(a) or Section 7(a), as applicable. Subject to the
last sentence of Section 4(c), if the Conversion Date for any shares of Series A Preferred Stock is after the close of business on a Dividend Record Date or an Compounded Dividend Record Date but prior to the corresponding
payment date for such dividend, the Holder of such shares as of such Dividend Record Date or Compounded Dividend Record Date, as applicable, shall be entitled to receive such dividend, notwithstanding the conversion of such shares prior to the
applicable Dividend Payment Date; provided that the amount of such Dividend or Compounded Dividend shall not be included for the purpose of determining the amount of Accrued Dividends or the Liquidation Preference under
Section 6(a) or Section 7(a), as applicable, with respect to such Conversion Date. 

  
 13 

 SECTION 5. Liquidation Rights. (a) Liquidation. In the event of any
voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the Holders shall be entitled, out of assets legally available therefor, before any distribution or payment out of the assets of the Company may be made
to or set aside for the holders of any Junior Stock, and subject to the rights of the holders of any Senior Stock or Parity Stock and the rights of the Company’s existing and future creditors, to receive in full a liquidating distribution in
cash and in the amount per share of Series A Preferred Stock equal to the greater of (i) the sum of (A) the Liquidation Preference plus (B) the Accrued Dividends with respect to such share of Series A Preferred Stock as of the
date of such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company and (ii) the amount such Holders would have received had such Holders, immediately prior to such voluntary or involuntary liquidation,
dissolution or winding up of the affairs of the Company, converted such shares of Series A Preferred Stock into Common Stock (pursuant to Section 6 without regard to any of the limitations on convertibility contained
therein). Holders shall not be entitled to any further payments in the event of any such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company other than what is expressly provided for in this
Section 5 and will have no right or claim to any of the Company’s remaining assets. 
 (b) Partial
Payment. If in connection with any distribution described in Section 5(a) above, the assets of the Company or proceeds therefrom are not sufficient to pay in full the aggregate liquidating distributions required to be
paid pursuant to Section 5(a) to all Holders and the liquidating distributions payable to all holders of any Parity Stock, the amounts distributed to the Holders and to the holders of all such Parity Stock shall be paid pro
rata in accordance with the respective aggregate liquidating distributions to which they would otherwise be entitled if all amounts payable thereon were paid in full. 

(c) Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the sale,
conveyance, exchange or transfer (for cash, shares of stock, securities or other consideration) of all or substantially all of the property and assets of the Company shall not be deemed a voluntary or involuntary liquidation, dissolution or winding
up of the affairs of the Company, nor shall the merger, consolidation, statutory exchange or any other business combination transaction of the Company into or with any other Person or the merger, consolidation, statutory exchange or any other
business combination transaction of any other Person into or with the Company be deemed to be a voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. 

SECTION 6. Right of the Holders to Convert. 

(a) Each Holder shall have the right, at such Holder’s option, subject to the conversion procedures set forth in
Section 8, to convert each share of such Holder’s Series A Preferred Stock at any time into (i) the number of shares of Common Stock equal to the quotient of (A) the sum of the Liquidation Preference and the
Accrued Dividends with respect to such share of Series A Preferred Stock as of the applicable Conversion Date divided by (B) the Conversion Price as of the applicable Conversion Date plus (ii) cash in lieu of fractional
shares as set out in Section 11(h); provided that no such conversion by any Holder shall be permitted until the expiration or early termination of the applicable waiting period, if any, under the HSR Act with respect
to any conversion of the Series A Preferred Stock by such Holder. The right of conversion may be exercised as to all or any portion of such Holder’s Series A Preferred Stock from time to time; provided that, in each case, no right of
conversion may be exercised by a Holder in respect of fewer than 1,000 shares of Series A Preferred Stock (unless such conversion relates to all shares of Series A Preferred Stock held by such Holder). 

  
 14 

 (b) The Company shall at all times reserve and keep available out of its authorized and
unissued Common Stock, solely for issuance upon the conversion of the Series A Preferred Stock, such number of shares of Common Stock as shall from time to time be issuable upon the conversion of all the shares of Series A Preferred Stock then
outstanding. Any shares of Common Stock issued upon conversion of Series A Preferred Stock shall be duly authorized, validly issued, fully paid and nonassessable. 

SECTION 7. Mandatory Conversion by the Company. (a) So long as a Shelf Registration Statement (as defined in the Registration Rights
Agreement) is in effect (to the extent it is required to be in effect under the Registration Rights Agreement), at any time after the three (3) year anniversary of the Original Issuance Date, if the VWAP per share of Common Stock was greater
than the Mandatory Conversion Price for (x) each of at least twenty (20) Trading Days in any period of thirty (30) consecutive Trading Days (such thirty (30) consecutive Trading Day period, the “Trading Period”)
and (y) the last Trading Day of such Trading Period, the Company may elect to convert (a “Mandatory Conversion”) all of the outstanding shares of Series A Preferred Stock into shares of Common Stock (the date selected by the
Company for any Mandatory Conversion pursuant to this Section 7(a), the “Mandatory Conversion Date”). In the case of a Mandatory Conversion, each share of Series A Preferred Stock then outstanding shall be
converted into (i) the number of shares of Common Stock equal to the quotient of (A) the sum of the Liquidation Preference and the Accrued Dividends with respect to such share of Series A Preferred Stock as of the Mandatory Conversion Date
divided by (B) the Conversion Price of such share in effect as of the Mandatory Conversion Date plus (ii) cash in lieu of fractional shares as set out in Section 11(h). 

(b) Notice of Mandatory Conversion. If the Company elects to effect a Mandatory Conversion, the Company shall, within ten
(10) Business Days following the completion of the applicable thirty (30) day Trading Period referred to in Section 7(a) above, provide notice of the Mandatory Conversion to each Holder (such notice, a
“Notice of Mandatory Conversion”). For the avoidance of doubt, a Notice of Mandatory Conversion does not limit a Holder’s right to convert on a Conversion Date prior to the Mandatory Conversion Date. The Mandatory Conversion
Date selected by the Company shall be no less than ten (10) Business Days and no more than twenty (20) Business Days after the date on which the Company provides the Notice of Mandatory Conversion to the Holders. The Notice of Mandatory
Conversion shall state, as appropriate: 
 (i) the Mandatory Conversion Date selected by the Company; and 

(ii) the Conversion Rate as expected to be in effect on the Mandatory Conversion Date, the number of shares Series A Preferred
Stock to be converted from such Holder, the number of shares of Common Stock to be issued to such Holder upon conversion of each such share of Series A Preferred Stock and the Liquidation Preference and amount of Accrued Dividends expected as of the
Mandatory Conversion Date. 

  
 15 

 SECTION 8. Conversion Procedures and Effect of Conversion. (a) Conversion
Procedure. A Holder must do each of the following in order to convert shares of Series A Preferred Stock pursuant to this Section 8(a): 

(i) in the case of a conversion pursuant to Section 6(a), complete and manually sign the conversion
notice provided by the Conversion Agent (the “Conversion Notice”), and deliver such notice to the Conversion Agent; provided that a Conversion Notice may be conditional on the completion of a Change of Control or other
corporate transaction; 
 (ii) deliver to the Conversion Agent the certificate or certificates (if any) representing the
shares of Series A Preferred Stock to be converted; 
 (iii) if required, furnish appropriate endorsements and transfer
documents; and 
 (iv) if required, pay any stock transfer, documentary, stamp or similar taxes not payable by the Company
pursuant to Section 21. 
 The “Conversion Date” means (A) with respect to conversion of any
shares of Series A Preferred Stock at the option of any Holder pursuant to Section 6(a), the date on which such Holder complies with the procedures in this Section 8(a) (including the satisfaction
of any conditions to conversion set forth in the Conversion Notice) and (B) with respect to Mandatory Conversion pursuant to Section 7(a), the Mandatory Conversion Date. 

(b) Effect of Conversion. Effective immediately prior to the close of business on the Conversion Date applicable to any shares of Series
A Preferred Stock, Dividends shall no longer accrue or be declared on any such shares of Series A Preferred Stock, and such shares of Series A Preferred Stock shall cease to be outstanding. 

(c) Record Holder of Underlying Securities as of Conversion Date. The Person or Persons entitled to receive the Common Stock and, to the
extent applicable, cash, securities or other property issuable upon conversion of Series A Preferred Stock on a Conversion Date shall be treated for all purposes as the record holder(s) of such shares of Common Stock and/or cash, securities or other
property as of the close of business on such Conversion Date. As promptly as practicable on or after the Conversion Date and, if applicable, compliance by the applicable Holder with the relevant procedures contained in
Section 8(a) (and in any event no later than three (3) Trading Days thereafter; provided however that, if a written notice from the Holder in accordance with Section 8(a)(i)
specifies a date of delivery for any shares of Common Stock, such shares shall be delivered on the date so specified, which shall be no earlier than the second (2nd) Business Day immediately following the date of such notice and no later than the
seventh (7th) Business Day thereafter), the Company shall issue the number of whole shares of Common Stock issuable upon conversion (and deliver payment of cash in lieu of fractional shares as set out in Section 11(h)) and,
to the extent applicable, any cash, securities or other property issuable thereon. Such delivery of shares of Common Stock, securities or other property shall be made by book-entry or, at the request of the Holder, by delivering a notice to the
Conversion Agent, through the facilities of The Depositary Trust Company or in certificated form. Any such certificate or certificates shall be delivered by the Company to the appropriate Holder on a book-entry basis, through the facilities of The
Depositary Trust Company, or by mailing certificates 

  
 16 

 
evidencing the shares to the Holders, in each case at their respective addresses as set forth in the Conversion Notice (in the case of a conversion pursuant to
Section 6(a)) or in the records of the Company or as set forth in a notice from the Holder to the Conversion Agent, as applicable (in the case of a Mandatory Conversion). In the event that a Holder shall not by written
notice designate the name in which shares of Common Stock (and payments of cash in lieu of fractional shares) and, to the extent applicable, cash, securities or other property to be delivered upon conversion of shares of Series A Preferred Stock
should be registered or paid, or the manner in which such shares, cash, securities or other property should be delivered, the Company shall be entitled to register and deliver such shares, securities or other property, and make such payment, in the
name of the Holder and in the manner shown on the records of the Company. 
 (d) Status of Converted or Reacquired Shares. Shares of
Series A Preferred Stock converted in accordance with this Certificate of Designations, or otherwise acquired by the Company in any manner whatsoever, shall be retired promptly after the conversion or acquisition thereof and shall not be reissued as
shares of such series. All such shares shall, upon their retirement and any filing required by the DGCL, become authorized but unissued shares of Preferred Stock, without designation as to series until such shares are once more designated as part of
a particular series by the Board pursuant to the provisions of the Certificate of Incorporation. 
 (e) Partial Conversion. In case
any certificate for shares of Series A Preferred Stock shall be surrendered for partial conversion, the Company shall, at its expense, execute and deliver to or upon the written order of the Holder of the certificate so surrendered a new certificate
for the shares of Series A Preferred Stock not converted. 
 SECTION 9. Change of Control. (a) Holder Rights Upon Change of
Control. Upon the occurrence of a Change of Control, each Holder of outstanding shares of Series A Preferred Stock may, at such Holder’s election, effective as of immediately prior to the Change of Control, convert all or a portion
of its shares of Series A Preferred Stock pursuant to Section 6(a), provided that if the Holder does not make such an election with respect to all of its shares of Series A Preferred Stock, the Company shall redeem (the
“Change of Control Redemption”) all of such Holder’s shares of Series A Preferred Stock that have not been so converted at a purchase price per share of Series A Preferred Stock, payable in cash, equal to the greater of
(A) the sum of (x) the Liquidation Preference of such share of Series A Preferred Stock, plus (y) the Accrued Dividends in respect of such share of Series A Preferred Stock as of the applicable Change of Control Purchase Date
plus (z) if the Change of Control occurs before the fifth (5th) anniversary of the Original Issue Date, the Make-Whole Amount and (B) the amount of cash and the Fair Market Value
of any other property that the Holder would have received if such Holder had converted such share of Series A Preferred Stock into Common Stock immediately prior to the Change of Control (the greater of (A) and (B), the “Change of
Control Redemption Price”); provided that the Company shall only be required to pay the Change of Control Redemption Price to the extent such purchase can be made out of funds legally available therefor in accordance
with Section 9(g). 

  
 17 

 (b) Initial Change of Control Notice. On or before the twentieth (20th) Business Day
prior to the effective date of a Change of Control (the “Change of Control Effective Date”) (or, if later, promptly after the Company discovers that a Change of Control may occur), a written notice (the “Initial Change of
Control Notice”) shall be sent by or on behalf of the Company to the Holders as they appear in the records of the Company, which notice shall contain (i) the date on which the Change of Control is anticipated to be effected (or, if
applicable, the date on which a Schedule TO or other schedule, form or report disclosing a Change of Control was filed), (ii) a description of the material terms and conditions of the Change of Control and (iii) the then applicable Conversion
Rate. No later than ten (10) Business Days prior to the Change of Control Effective Date as set forth in the Initial Change of Control Notice (or, if the Change of Control has already occurred as provided in the Initial Change of Control
Notice, promptly, but no later than the tenth (10th) Business Day following receipt thereof), any Holder that desires to exercise its rights pursuant to Section 9(a)
shall notify the Company in writing thereof and shall specify (x) whether such Holder is electing to exercise its right to convert all or a portion of its shares of Series A Preferred Stock pursuant to Section 9(a),
and (y) the number of shares of Series A Preferred Stock subject thereto. 
 (c) Final Change of Control Redemption Notice.
Within two (2) days prior to the Change of Control Effective Date (or if the Company discovers later than such date that a Change of Control has occurred, promptly following the date of such discovery), a final written notice shall be sent by
or on behalf of the Company to the Holders as they appear in the records of the Company on the Business Day immediately prior to the date such notice is sent, which notice shall contain: 

(i) a statement setting forth in reasonable detail the calculation of the Change of Control Redemption Price with respect to
such Holder; 
 (ii) the Change of Control Purchase Date, which shall be no later than 60 days after such notice is sent;
provided, that a reasonable amount of time shall be provided between delivery of such notice and the Change of Control Purchase Date to allow such Holder to comply with the instructions delivered pursuant to
Section 9(c)(iii) below; and 
 (iii) the instructions a Holder must follow to receive the Change
of Control Redemption Price in connection with such Change of Control. 
 (d) Change of Control Redemption Procedure. To receive the
Change of Control Redemption Price, a Holder must surrender to the Transfer Agent in accordance with the instructions delivered pursuant to Section 9(c)(iii), the certificates representing the shares of Series
A Preferred Stock to be repurchased by the Company or lost stock affidavits therefor, to the extent applicable. 
 (e) Delivery upon
Change of Control Redemption. Upon a Change of Control Redemption, subject to Section 9(g) and Section 9(j) below, the Company (or its successor) shall deliver or cause to be delivered to the
Holder by wire transfer of immediately available funds, the Change of Control Redemption Price for such Holder’s shares of Series A Preferred Stock. 

(f) Treatment of Shares. Until a share of Series A Preferred Stock is redeemed by the payment or deposit in full of the applicable
Change of Control Redemption Price as provided in Section 9(i), such share of Series A Preferred Stock will remain outstanding and will be entitled to all of the powers, designations, preferences and other
rights provided herein; provided that no such shares of Series A Preferred Stock may be converted into shares of Common Stock following the Change of Control Effective Date. 

  
 18 

 (g) Sufficient Funds. If the Company shall not have sufficient funds legally
available under the DGCL to redeem all shares of Series A Preferred Stock required under Section 9(a) (the “Required Number of Shares”), the Company shall (i) redeem, pro rata among the Holders (for
the avoidance of doubt, other than any shares that have been converted into Common Stock in accordance with Section 9(a)), a number of shares of Series A Preferred Stock with an aggregate Change of Control Redemption Price
equal to the amount legally available for the purchase of shares of Series A Preferred Stock under the DGCL and (ii) purchase any shares of Series A Preferred Stock not purchased because of the foregoing limitations at the applicable Change of
Control Redemption Price as soon as practicable after the Company is able to make such purchase out of assets legally available for the purchase of such share of Series A Preferred Stock. The inability of the Company (or its successor) to make a
purchase payment for any reason shall not relieve the Company (or its successor) from its obligation to effect any required purchase when, as and if permitted by applicable law. If the Company fails to pay the Change of Control Redemption Price in
full when due in accordance with this Section 9 in respect of some or all of the shares or Series A Preferred Stock to be repurchased pursuant to the Change of Control Redemption, the Company will pay Dividends on such
shares not repurchased at a Dividend Rate of 8% per annum until such shares are repurchased, payable quarterly in arrears on each Dividend Payment Date, for the period from and including the first Dividend Payment Date (or the Issuance Date, as
applicable) upon which the Company fails to pay the Change of Control Redemption Price in full when due in accordance with this Section 9 through but not including the latest of the day upon which the Company pays the
Change of Control Redemption Price in full in accordance with this Section 9; provided, that, if the Company does not have sufficient funds legally available under the DGCL to pay such Dividends in cash as required
by this sentence, such Dividends will accrue with respect to the applicable shares of Series A Preferred Stock pursuant to Section 4. Notwithstanding the foregoing, in the event a Holder exercises a Change of Control
Redemption pursuant to this Section 9 at a time when the Company is restricted or prohibited (contractually or otherwise) from redeeming some or all of the Series A Preferred Stock subject to the Change of Control
Redemption, the Company will use its commercially reasonable efforts to obtain the requisite consents to remove or obtain an exception or waiver to such restrictions or prohibition. Nothing herein shall limit a Holder’s right to pursue any
other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to comply with its obligations under this
Section 9. 
 (h) Change of Control Agreements. The Company shall not enter into any agreement for a
transaction constituting a Change of Control unless (i) such agreement provides for or does not interfere with or prevent (as applicable) the exercise by the Holders of their Change of Control Redemption in a manner that is consistent with and
gives effect to this Section 9, and (ii) the acquiring or surviving Person in such Change of Control represents or covenants, in form and substance reasonably satisfactory to the Board acting in good faith, that at the
closing of such Change of Control that such Person shall have sufficient funds (which may include, without limitation, cash and cash equivalents on the Company’s balance sheet, the proceeds of any debt or equity financing, available lines of
credit or uncalled capital commitments) to consummate such Change of Control and the payment of the Change of Control Redemption Price in respect of shares of Series A Preferred Stock that have not been converted into Common Stock prior to the
Change of Control Effective Date pursuant to Section 6, Section 7 or this Section 9, as applicable. 

  
 19 

 (i) With respect to any share of Series A Preferred Stock to be redeemed by the Company
pursuant to the Change of Control Redemption and which has been redeemed in accordance with the provisions of this Section 9, or for which the Company has irrevocably deposited an amount equal to the Change of Control
Redemption Price in respect of such share with the Transfer Agent, (i) Dividends shall cease to accrue on such share, (ii) such share shall no longer be deemed outstanding and (iii) all rights with respect to such share shall cease
and terminate other than the rights of the Holder thereof to receive the Change of Control Redemption Price therefor. 
 (j) Notwithstanding
anything to the contrary contained in this Section 9, in the event of a Change of Control Redemption, the Company shall only pay the Change of Control Redemption Price in cash required above after paying in full in cash all obligations of the
Company and its subsidiaries under any credit agreement, indenture or similar agreement evidencing indebtedness for borrowed money (including the termination of all commitments to lend, to the extent required by such credit agreement, indenture or
similar agreement), which requires prior payment of the obligations thereunder (and termination of commitments thereunder, if applicable) as a condition to the payment of such Change of Control Redemption Price in cash. 

SECTION 10. Redemption. (a) Redemption at the Option of the Company. 

(i) At any time on or after the five (5)-year anniversary of the Original Issuance Date, the Company shall have the right (the
“Company Redemption Right”) to redeem, ratably, in whole or, from time to time in part, the shares of Series A Preferred Stock of any Holder outstanding at such time at a redemption price equal to (A) the sum of (x) the
Liquidation Preference of the shares of Series A Preferred Stock to be redeemed plus (y) the Accrued Dividends with respect to such shares of Series A Preferred Stock as of the applicable Redemption Date (such price, the “Base
Redemption Price”), multiplied by (B) (1) if the Redemption Date occurs at any time on or after the fifth (5th) anniversary of the Original Issuance Date and prior to
the sixth (6th) anniversary of the Original Issuance Date, 105%, (2) if the Redemption Date occurs at any time on or after the sixth (6th)
anniversary of the Original Issuance Date and prior to the seventh (7th) anniversary of the Original Issuance Date, 102%, or (3) if the Redemption Date occurs at any time on or after the
seventh (7th) anniversary of the Original Issuance Date, 100% (such price, the “Redemption Price”). Notwithstanding the foregoing, the Company will not exercise the Company
Redemption Right, or otherwise send a Notice of Company Redemption, in respect of the redemption of any Series A Preferred Stock pursuant to this Section 10 unless the Company has sufficient funds legally available to fully
pay the Redemption Price in respect of all shares of Series A Preferred Stock called for redemption. The Redemption Price shall be payable in cash. If fewer than all of the shares of Series A Preferred Stock then outstanding are to be redeemed
pursuant to this Section 10(a), then such redemption shall occur on a pro rata basis with respect to all Holders based on the total number of shares of Series A Preferred Stock then held by such Holder relative to
the total number of shares of Series A Preferred Stock then outstanding. 

  
 20 

 (ii) To exercise the Company Redemption Right pursuant to this
Section 10(a), the Company shall deliver written notice thereof (a “Notice of Company Redemption”) to the Holders and the Transfer Agent at least ten (10) days prior to the Redemption Date designated
therein for such redemption. The Notice of Company Redemption shall contain instructions whereby Holders will surrender to the Transfer Agent certificates (if any) representing all shares of Series A Preferred Stock specified in the Notice of
Company Redemption to be redeemed by the Company. The Company shall deliver or cause to be delivered to each Holder that has complied with the instructions set forth in such Notice of Company Redemption, cash by wire transfer in an amount equal to
the Redemption Price of the shares of Series A Preferred Stock in respect of which such Holder has complied with such instructions in accordance herewith. 

(iii) Prior to any Redemption, each Holder of outstanding shares of Series A Preferred Stock may, at such Holder’s
election, effective prior to such Redemption on a date designated by the Holder, convert all or a portion of its shares of Series A Preferred Stock pursuant to Section 6(a). 

(b) At any time on or after the seven (7)-year anniversary of the Original Issuance Date, each Holder shall have the right (the “Holder
Redemption Right”) to cause the Company to redeem, ratably, in whole or, from time to time in part, the shares of Series A Preferred Stock of such Holder outstanding at such time at a redemption price equal to the Base Redemption Price. To
exercise the Holder Redemption Right pursuant to this Section 10(b), a Holder shall deliver written notice thereof (a “Notice of Holder Redemption”) to the Company (which may be delivered prior to the seven
(7)-year anniversary of the Original Issuance Date and provide for a redemption on or after the seven (7)-year anniversary of the Original Issuance Date). The Company shall notify all other Holders of the receipt of such notice within five
(5) days following receipt of the Notice of Holder Redemption and in such notice set out the date on which the Company shall redeem the shares of Series A Preferred Stock set forth in the Notice of Holder Redemption and any other shares for
which the Company receives a Notice of Holder Redemption, which shall be no less than ten (10) days from the date of such notice, and no more than twenty (20) days from the date of such notice. For the avoidance of doubt, any Holder can
deliver multiple Notices of Holder Redemption, and the foregoing is not intended to limit the number of such Notices that a Holder may deliver. 

(c) Effect of Redemption. With respect to any share of Series A Preferred Stock specified to be redeemed by the Company pursuant to the
Company Redemption Right or the Holder Redemption Right and which has been redeemed in accordance with the provisions of this Section 10, or for which the Company has irrevocably deposited an amount equal to the Redemption
Price in respect of such share with the Transfer Agent, then (i) Dividends shall cease to accrue on such share, (ii) such share shall no longer be deemed outstanding and (iii) all rights with respect to such share shall cease and
terminate. 

  
 21 

 (d) Partial Redemption. In the event that the Company Redemption Right or Holder
Redemption Right is exercised with respect to shares of Series A Preferred Stock representing less than all the shares of Series A Preferred Stock held by a Holder, upon such redemption and following such Holder’s surrender to the Transfer
Agent of certificates (if any) representing such shares of Series A Preferred Stock specified to be redeemed by the Company, the Company shall execute and the Transfer Agent shall countersign and deliver to such Holder, at the expense of the
Company, a certificate representing the shares of Series A Preferred Stock held by the Holder as to which a Company Redemption Right or Holder Redemption Right was not exercised (or book-entry interests representing such shares). 

SECTION 11. Anti-Dilution Adjustments. (a) Adjustments. The Conversion Rate will be subject to adjustment, without
duplication, upon the occurrence of the following events, except that the Company shall not make any adjustment to the Conversion Rate if Holders of the Series A Preferred Stock participate, at the same time and upon the same terms as holders of
Common Stock and solely as a result of holding shares of Series A Preferred Stock, in any transaction described in this Section 11(a), without having to convert their Series A Preferred Stock, as if they held a number of
shares of Common Stock equal to the number of shares of Common Stock into which the shares of Series A Preferred Stock held by such Holder are convertible pursuant to Section 6 (determined without regard to any of the
limitations on convertibility contained therein): 
 (i) The issuance of Common Stock as a dividend or distribution to all or
substantially all holders of Common Stock, or a subdivision or combination of Common Stock or a reclassification of Common Stock into a greater or lesser number of shares of Common Stock, in which event the Conversion Rate shall be adjusted based on
the following formula: 
 CR1 =
CR0 x (OS1 / OS0) 

CR0 = the Conversion Rate in effect immediately prior to the close of business on
(i) the Record Date for such dividend or distribution, or (ii) the effective date of such subdivision, combination or reclassification 

CR1 = the new Conversion Rate in effect immediately after the close of business on
(i) the Record Date for such dividend or distribution, or (ii) the effective date of such subdivision, combination or reclassification 

OS0 = the number of shares of Common Stock outstanding immediately prior to the close
of business on (i) the Record Date for such dividend or distribution or (ii) the effective date of such subdivision, combination or reclassification 

OS1 = the number of shares of Common Stock that would be outstanding immediately after,
and solely as a result of, the completion of such event 
 Any adjustment made pursuant to this clause (i) shall be
effective immediately after the close of business on the Record Date for such dividend or distribution, or the effective date of such subdivision, combination or reclassification. If any such event is announced or declared but does not occur, the
Conversion Rate shall be readjusted, effective as of the date the Board announces that such event shall not occur, to the Conversion Rate that would then be in effect if such event had not been declared. 

  
 22 

 (ii) The dividend, distribution or other issuance to all or substantially
all holders of Common Stock of rights (other than rights, options or warrants distributed in connection with a stockholder rights plan (in which event the provisions of Section 11(a)(vii) shall apply)), options or warrants
entitling them to subscribe for or purchase shares of Common Stock for a period expiring forty-five (45) days or less from the date of issuance thereof, at a price per share that is less than the Current Market Price as of the Record Date for
such issuance, in which event the Conversion Rate will be increased based on the following formula: 
 CR1 = CR0 x [(OS0+X) / (OS0+Y)]

 CR0 = the Conversion Rate in effect immediately prior to the close of business on
the Record Date for such dividend, distribution or issuance 
 CR1 = the new
Conversion Rate in effect immediately following the close of business on the Record Date for such dividend, distribution or issuance 
 OS0 = the number of shares of Common Stock outstanding immediately prior to the close of business on the Record Date for such dividend, distribution or issuance 

X = the total number of shares of Common Stock issuable pursuant to such rights, options or warrants 

Y = the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants divided by the
Current Market Price as of the Record Date for such dividend, distribution or issuance. 
 For purposes of this clause (ii),
in determining whether any rights, options or warrants entitle the holders to purchase the Common Stock at a price per share that is less than the Current Market Price as of the Record Date for such dividend, distribution or issuance, there shall be
taken into account any consideration the Company receives for such rights, options or warrants, and any amount payable on exercise thereof, with the value of such consideration, if other than cash, to be the Fair Market Value thereof. 

Any adjustment made pursuant to this clause (ii) shall become effective immediately following the close of business on the
Record Date for such dividend, distribution or issuance. In the event that such rights, options or warrants are not so issued, the Conversion Rate shall be readjusted, effective as of the date the Board publicly announces its decision not to issue
such rights, options or warrants, to the Conversion Rate that would then be in effect if such dividend, distribution or issuance had not been declared. To the extent that such rights, options or warrants are not exercised prior to their expiration
or shares of Common Stock are otherwise not delivered pursuant to such rights, options or warrants upon the exercise of such rights, options or warrants, the Conversion Rate shall be readjusted to the Conversion Rate that would then be in effect had
the adjustments made upon the dividend, distribution or issuance of such rights, options or warrants been made on the basis of the delivery of only the number of shares of Common Stock actually delivered. 

  
 23 

 (iii) The Company or one or more of its Subsidiaries purchases Common Stock
pursuant to a tender offer or exchange offer (other than an Excluded Repurchase or exchange offer that constitutes a Distribution Transaction subject to Section 11(a)(v)) by the Company or a Subsidiary of the Company for
all or any portion of the Common Stock, or otherwise acquires Common Stock (except (1) in an open market purchase in compliance with Rule 10b-18 promulgated under the Exchange Act, (2) through an
“accelerated share repurchase” on customary terms, (3) in connection with tax withholding upon vesting or settlement of options, restricted stock units, performance share units or other similar equity awards or upon forfeiture or
cashless exercise of options or other equity awards or (4) an Excluded Repurchase) (a “Covered Repurchase”), if the cash and value of any other consideration included in the payment per share of Common Stock validly tendered,
exchanged or otherwise acquired through a Covered Repurchase exceeds the arithmetic average of the VWAP per share of Common Stock for each of the ten (10) consecutive full Trading Days commencing on, and including, the Trading Day next
succeeding the last day on which tenders or exchanges may be made pursuant to such tender or exchange offer (as it may be amended) or shares of Common Stock are otherwise acquired through a Covered Repurchase (the “Expiration
Date”), in which event the Conversion Rate shall be increased based on the following formula: 
 CR1 = CR0 x [(FMV + (SP1 x OS1))
/ (SP1 x OS0)] 
 CR0 = the Conversion Rate in effect immediately prior to the close of business on the Expiration Date 

CR1 = the new Conversion Rate in effect immediately after the close of business on the
Expiration Date 
 FMV = the Fair Market Value, on the Expiration Date, of all cash and any other consideration paid or payable for all
shares validly tendered or exchanged and not withdrawn, or otherwise acquired through a Covered Repurchase, as of the Expiration Date 
 OS0 = the number of shares of Common Stock outstanding immediately prior to the last time tenders or exchanges may be made pursuant to such tender or exchange offer (including the shares to be
purchased in such tender or exchange offer) or shares are otherwise acquired through a Covered Repurchase 
 OS1 = the number of shares of Common Stock outstanding immediately after the last time tenders or exchanges may be made pursuant to such tender or exchange offer (after giving effect to the purchase
of shares in such tender or exchange offer) or shares are otherwise acquired through a Covered Repurchase 
 SP1 = the arithmetic average of the VWAP per share of Common Stock for each of the ten (10) consecutive full Trading Days commencing on, and including, the Trading Day next succeeding the
Expiration Date 

  
 24 

 Such adjustment shall become effective immediately after the close of
business on the Expiration Date. If an adjustment to the Conversion Rate is required under this Section 11(a)(iii), delivery of any additional shares of Common Stock that may be deliverable upon conversion as a result of an
adjustment required under this Section 11(a)(iii) shall be delayed to the extent necessary in order to complete the calculations provided for in this Section 11(a)(iii). 

In the event that the Company or any of its Subsidiaries is obligated to purchase Common Stock pursuant to any such tender
offer, exchange offer or other commitment to acquire shares of Common Stock through a Covered Repurchase but is permanently prevented by applicable law from effecting any such purchases, or all such purchases are rescinded, then the Conversion Rate
shall be readjusted to be the Conversion Rate that would have been then in effect if such tender offer, exchange offer or Covered Repurchase had not been made. 

For the avoidance of doubt, the repurchase of shares of Common Stock described in this
Section 11(a)(iii) shall constitute a Covered Repurchase solely to the extent such repurchase exceeds the aggregate amount in the definition of “Excluded Repurchase”. 

(iv) The Company shall, by dividend or otherwise, distribute to all or substantially all holders of its Common Stock (other
than for cash in lieu of fractional shares), shares of any class of its Capital Stock, evidences of its indebtedness, assets, other property or securities, but excluding (A) dividends or distributions referred to in
Section 11(a)(i) or Section 11(a)(ii) hereof, (B) Distribution Transactions as to which Section 11(a)(v) shall apply, (C) dividends or
distributions paid exclusively in cash as to which Section 11(a)(vi) shall apply and (D) rights, options or warrants distributed in connection with a stockholder rights plan as to which
Section 11(a)(vii) shall apply (any of such shares of its Capital Stock, indebtedness, assets or property that are not so excluded are hereinafter called the “Distributed Property”), then, in each such case
the Conversion Rate shall be increased based on the following formula: 
 CR1 = CR0 x [SP0 / (SP0 – FMV)] 

CR0 = the Conversion Rate in effect immediately prior to the close of business on the
Record Date for such dividend or distribution 
 CR1 = the new Conversion Rate in
effect immediately after the close of business on the Record Date for such dividend or distribution 
 SP0 = the Current Market Price as of the Record Date for such dividend or distribution 

FMV = the Fair Market Value of the portion of Distributed Property distributed with respect to each outstanding share of Common Stock on the
Record Date for such dividend or distribution; provided that, if FMV is equal or greater than SP0, then in lieu of the foregoing adjustment, the Company shall distribute to each holder
of Series A Preferred Stock on the date the applicable Distributed Property is distributed to holders of Common Stock, but without requiring such holder to convert its shares of Series A Preferred Stock, in respect of each share of Series A
Preferred Stock held by such holder, the amount of Distributed Property such holder would have received had such holder owned a number of shares of Common Stock equal to the Conversion Rate on the Record Date for such dividend or distribution 

  
 25 

 Any adjustment made pursuant to this clause (iv) shall be effective
immediately after the close of business on the Record Date for such dividend or distribution. If any such dividend or distribution is declared but does not occur, the Conversion Rate shall be readjusted, effective as of the date the Board announces
that such dividend or distribution shall not occur, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. 

(v) The Company effects a Distribution Transaction, in which case the Conversion Rate in effect immediately prior to the
effective date of the Distribution Transaction shall be increased based on the following formula: 
 CR1 = CR0 x [(FMV + MP0) / MP0]

 CR0 = the Conversion Rate in effect immediately prior to the close of business on
the effective date of the Distribution Transaction 
 CR1 = the new Conversion Rate
in effect immediately after the close of business on the effective date of the Distribution Transaction 
 FMV = the arithmetic average of
the volume-weighted average prices for a share of the capital stock or other interest distributed to holders of Common Stock on the principal United States securities exchange or automated quotation system on which such capital stock or other
interest trades, as reported by Bloomberg (or, if Bloomberg ceases to publish such price, any successor service chosen by the Company) in respect of the period from the open of trading on the relevant Trading Day until the close of trading on such
Trading Day (or if such volume-weighted average price is unavailable, the market price of one share of such capital stock or other interest on such Trading Day determined, using a volume-weighted average method, by an Independent Financial Advisor
retained for such purpose by the Company), for each of the ten consecutive full Trading Days commencing with, and including, the effective date of the Distribution Transaction 

MP0 = the arithmetic average of the VWAP per share of Common Stock for each of the ten
(10) consecutive full Trading Days commencing on, and including, the effective date of the Distribution Transaction 

Such adjustment shall become effective immediately following the close of business on the effective date of the Distribution
Transaction. If an adjustment to the Conversion Rate is required under this Section 11(a)(v), delivery of any additional shares of Common Stock that may be deliverable upon conversion as a result of an adjustment required
under this Section 11(a)(v) shall be delayed to the extent necessary in order to complete the calculations provided for in this Section 11(a)(v). 

(vi) The Company makes a cash dividend or distribution to all or substantially all holders of the Common Stock, the Conversion
Rate shall be increased based on the following formula: 
 CR1 = CR0 x [SP0 / (SP0 – C)] 

  
 26 

 CR0 = the Conversion Rate in effect
immediately prior to the close of business on the Record Date for such dividend or distribution 
 CR1 = the new Conversion Rate in effect immediately after the close of business on the Record Date for such dividend or distribution 

SP0 = the Current Market Price as of the Record Date for such dividend or distribution

 C = the amount in cash per share of Common Stock the Company distributes to all or substantially all holders of its Common Stock;
provided that, if C is equal or greater than SP0, then in lieu of the foregoing adjustment, the Company shall pay to each holder of Series A Preferred Stock on the date the applicable
cash dividend or distribution is made to holders of Common Stock, but without requiring such holder to convert its shares of Series A Preferred Stock, in respect of each share of Series A Preferred Stock held by such holder, the amount of cash such
holder would have received had such holder owned a number of shares of Common Stock equal to the Conversion Rate on the Record Date for such dividend or distribution 

Any adjustment made pursuant to this clause (vi) shall be effective immediately after the close of business on the Record
Date for such dividend or distribution. If any dividend or distribution is declared but not paid, the Conversion Rate shall be readjusted, effective as of the date the Board announces that such dividend or distribution will not be paid, to the
Conversion Rate that would then be in effect if such had dividend or distribution not been declared. 
 (vii) If the Company
has a stockholder rights plan in effect with respect to the Common Stock on any Conversion Date, upon conversion of any shares of the Series A Preferred Stock, Holders of such shares will receive, in addition to the applicable number of shares of
Common Stock, the rights under such rights plan relating to such Common Stock, unless, prior to such Conversion Date, the rights have (i) become exercisable or (ii) separated from the shares of Common Stock (the first of such events to
occur, a “Trigger Event”), in which case, the Conversion Rate will be adjusted, effective automatically at the time of such Trigger Event, as if the Company had made a distribution of such rights to all holders of Common Stock as
described in Section 11(a)(ii) (without giving effect to the forty-five (45) day limit on the exercisability of rights, options or warrants ordinarily subject to such Section 11(a)(ii)),
subject to appropriate readjustment in the event of the expiration, termination or redemption of such rights prior to the exercise, deemed exercise or exchange thereof. Notwithstanding the foregoing, to the extent any such stockholder rights are
exchanged by the Company for shares of Common Stock or other property or securities, the Conversion Rate shall be appropriately readjusted as if such stockholder rights had not been issued, but the Company had instead issued such shares of Common
Stock or other property or securities as a dividend or distribution of shares of Common Stock pursuant to Section 11(a)(i) or Section 11(a)(iv), as applicable. 

  
 27 

 To the extent that such rights are not exercised prior to their expiration,
termination or redemption, the Conversion Rate shall be readjusted to the Conversion Rate that would then be in effect had the adjustments made upon the occurrence of the Trigger Event been made on the basis of the issuance of, and the receipt of
the exercise price with respect to, only the number of shares of Common Stock actually issued pursuant to such rights. 

Notwithstanding anything to the contrary in this Section 11(a)(vii), no adjustment shall be required
to be made to the Conversion Rate with respect to any Holder which is, or is an “affiliate” or “associate” of, an “acquiring person” under such stockholder rights plan or with respect to any direct or indirect
transferee of such Holder who receives Series A Preferred Stock in such transfer after the time such Holder becomes, or its affiliate or associate becomes, such an “acquiring person”. 

(b) Calculation of Adjustments. All adjustments to the Conversion Rate shall be calculated by the Company to the nearest 1/10,000th of
one share of Common Stock (or if there is not a nearest 1/10,000th of a share, to the next lower 1/10,000th of a share). No adjustment to the Conversion Rate will be required unless such adjustment would require an increase or decrease of at least
one percent of the Conversion Rate; provided, however, that any such adjustment that is not required to be made will be carried forward and taken into account in any subsequent adjustment; provided, further that any such
adjustment of less than one percent that has not been made will be made upon any Conversion Date or redemption or repurchase date. 
 (c)
When No Adjustment Required. (i) Except as otherwise provided in this Section 11, the Conversion Rate will not be adjusted for the issuance of Common Stock or any securities convertible into or exchangeable for
Common Stock or carrying the right to purchase any of the foregoing, or for the repurchase of Common Stock. 
 (ii) Except as
otherwise provided in this Section 11, the Conversion Rate will not be adjusted as a result of the issuance of, the distribution of separate certificates representing, the exercise or redemption of, or the termination or
invalidation of, rights pursuant to any stockholder rights plans. 
 (iii) No adjustment to the Conversion Rate will be made:

 (A) upon the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment
of dividends or interest payable on securities of the Company and the investment of additional optional amounts in Common Stock under any plan in which purchases are made at market prices on the date or dates of purchase, without discount, and
whether or not the Company bears the ordinary costs of administration and operation of the plan, including brokerage commissions; 

(B) upon the issuance of any shares of Common Stock or options or rights to purchase such shares pursuant to any present or
future employee, director or consultant benefit plan or program of or assumed by the Company or any of its Subsidiaries or of any employee agreements or arrangements or programs, including, without limitation, the Company’s 2015 Equity
Incentive Plan; 

  
 28 

 (C) upon the issuance of any shares of Common Stock pursuant to any option,
warrant, right, or exercisable, exchangeable or convertible security, including the Series A Preferred Stock; or 
 (D) for a
change in the par value of the Common Stock. 
 (d) Successive Adjustments. After an adjustment to the Conversion Rate under this
Section 11, any subsequent event requiring an adjustment under this Section 11 shall cause an adjustment to each such Conversion Rate as so adjusted. 

(e) Multiple Adjustments. For the avoidance of doubt, if an event occurs that would trigger an adjustment to the Conversion Rate
pursuant to this Section 11 under more than one subsection hereof, such event, to the extent fully taken into account in a single adjustment, shall not result in multiple adjustments hereunder; provided,
however, that if more than one subsection of this Section 11 is applicable to a single event, the subsection shall be applied that produces the largest adjustment. 

(f) Notice of Adjustments. Whenever the Conversion Rate is adjusted as provided under this Section 11, the
Company shall as soon as reasonably practicable following the occurrence of an event that requires such adjustment (or if the Company is not aware of such occurrence, as soon as reasonably practicable after becoming so aware): 

(i) compute the adjusted applicable Conversion Rate in accordance with this Section 11 and prepare
and transmit to the Conversion Agent an Officer’s Certificate setting forth the applicable Conversion Rate, the method of calculation thereof, and the facts requiring such adjustment and upon which such adjustment is based; and 

(ii) provide a written notice to the Holders of the occurrence of such event and a statement in reasonable detail setting forth
the method by which the adjustment to the applicable Conversion Rate was determined and setting forth the adjusted applicable Conversion Rate. 

(g) Conversion Agent. The Conversion Agent shall not at any time be under any duty or responsibility to any Holder to determine whether
any facts exist that may require any adjustment of the Conversion Rate or with respect to the nature or extent or calculation of any such adjustment when made, or with respect to the method employed in making the same. The Conversion Agent shall be
fully authorized and protected in relying on any Officer’s Certificate delivered pursuant to this Section 11(g) and any adjustment contained therein and the Conversion Agent shall not be deemed to have knowledge of any
adjustment unless and until it has received such certificate. The Conversion Agent shall not be accountable with respect to the validity or value (or the kind or amount) of any shares of Common Stock, or of any securities or property, that may at
the time be issued or delivered with respect to any Series A Preferred Stock and the Conversion Agent makes no representation with respect thereto. The Conversion Agent shall not be responsible for any failure of the Company to issue, transfer or
deliver any shares of Common Stock pursuant to the conversion of Series A Preferred Stock or to comply with any of the duties, responsibilities or covenants of the Company contained in this Section 11. 

  
 29 

 (h) Fractional Shares. No fractional shares of Common Stock will be delivered to the
Holders upon conversion. In lieu of fractional shares otherwise issuable, the Holders will be entitled to receive, at the Company’s sole discretion, either (i) an amount in cash equal to the fraction of a share of Common Stock multiplied
by the Closing Price of the Common Stock on the Trading Day immediately preceding the applicable Conversion Date or (ii) one additional whole share of Common Stock. In order to determine whether the number of shares of Common Stock to be
delivered to a Holder upon the conversion of such Holder’s shares of Series A Preferred Stock will include a fractional share, such determination shall be based on the aggregate number of shares of Series A Preferred Stock of such Holder that
are being converted and/or issued on any single Conversion Date or Change of Control Purchase Date. 
 SECTION 12. Adjustment for
Reorganization Events. 
 (a) Reorganization Events. In the event of: 

(i) any reclassification, statutory exchange, merger, consolidation or other similar business combination of the Company with
or into another Person, in each case, pursuant to which at least a majority of the total voting power of the Voting Stock of the Company is changed or converted into, or exchanged for, cash, securities or other property of the Company or another
Person; 
 (ii) any sale, transfer, lease or conveyance to another Person of all or a majority of the property and assets of
the Company, in each case pursuant to which the Common Stock is converted into cash, securities or other property; or 

(iii) any statutory exchange of securities of the Company with another Person (other than in connection with a merger or
acquisition) or reclassification, recapitalization or reorganization of the Common Stock into other securities; 
 other than, in each case, any such
transaction that constitutes a Change of Control, with respect to which, for the avoidance of doubt, the provisions of Section 9 shall apply (each of which is referred to as a “Reorganization Event”), each
share of Series A Preferred Stock outstanding immediately prior to such Reorganization Event will, without the consent of the Holders and subject to Section 12(d) and Section 13(b), remain
outstanding but shall become convertible into, out of funds legally available therefor, the number, kind and amount of securities, cash and other property (the “Exchange Property”) (without any interest on such Exchange Property and
without any right to dividends or distribution on such Exchange Property which have a record date that is prior to the applicable Conversion Date) that the Holder of such share of Series A Preferred Stock would have received in such Reorganization
Event had such Holder converted its shares of Series A Preferred Stock into the applicable number of shares of Common Stock immediately prior to the effective date of the Reorganization Event using the Conversion Rate applicable immediately prior to
the effective date of the Reorganization Event and the Liquidation Preference applicable at the time of such subsequent conversion; provided that the foregoing shall not apply if such Holder is a Person with which the Company consolidated or
into which the Company merged or which merged into the Company or to which such sale or transfer was made, as the case may be (any such Person, a “Constituent Person”), or an Affiliate of a Constituent Person, to the extent such
Reorganization Event provides for different treatment 

  
 30 

 
of Common Stock held by such Constituent Persons or such Affiliate thereof. If the kind or amount of securities, cash and other property receivable upon such Reorganization Event is not the same
for each share of Common Stock held immediately prior to such Reorganization Event by a Person (other than a Constituent Person or an Affiliate thereof), then for the purpose of this Section 12(a), the kind and amount of
securities, cash and other property receivable upon conversion following such Reorganization Event will be deemed to be the weighted average of the types and amounts of consideration received by the holders of Common Stock. 

(b) Successive Reorganization Events. The above provisions of this Section 12 shall similarly apply to
successive Reorganization Events and the provisions of Section 11 shall apply to any shares of Capital Stock received by the holders of the Common Stock in any such Reorganization Event. 

(c) Reorganization Event Notice. The Company (or any successor) shall, no less than thirty (30) days prior to the anticipated
effective date of any Reorganization Event, provide written notice to the Holders of such occurrence of such event and of the kind and amount of the cash, securities or other property that constitutes the Exchange Property. Failure to deliver such
notice shall not affect the operation of this Section 12. 
 (d) Reorganization Event Agreements. The
Company shall not enter into any agreement for a transaction constituting a Reorganization Event unless (i) such agreement provides for or does not interfere with or prevent (as applicable) conversion of the Series A Preferred Stock into the
Exchange Property in a manner that is consistent with and gives effect to this Section 12, and (ii) to the extent that the Company is not the surviving corporation in such Reorganization Event or will be dissolved in
connection with such Reorganization Event, proper provision shall be made in the agreements governing such Reorganization Event for the conversion of the Series A Preferred Stock into Capital Stock of the Person surviving such Reorganization Event
or such other continuing entity in such Reorganization Event. 
 SECTION 13. Voting Rights. 

(a) General. Except as provided in Section 13(b), Holders of shares of Series A Preferred Stock shall be
entitled to vote as a single class with the holders of the Common Stock and the holders of any other class or series of Capital Stock of the Company then entitled to vote with the Common Stock on all matters submitted to a vote of the holders of
Common Stock (and, if applicable, holders of any other class or series of Capital Stock of the Company); provided that no Holder of shares of Series A Preferred Stock shall be entitled to vote with the holders of Common Stock or any other
class or series of Capital Stock of the Company until the expiration or early termination of the applicable waiting period under the HSR Act, if a filing under the HSR Act is required for such Holder with respect to either its acquisition of such
shares of Series A Preferred Stock or any conversion of the Series A Preferred Stock. Each Holder shall be entitled to the number of votes equal to the product of (i) the largest number of whole shares of Common Stock into which all shares of
Series A Preferred Stock could be converted pursuant to Section 6 multiplied by (ii) a fraction the numerator of which is the number of shares of Series A Preferred Stock held by such Holder and the denominator of
which is the aggregate number of issued and outstanding shares of Series A Preferred Stock, in each case, at and calculated as of the record date for the determination of stockholders entitled to vote or consent on such matters

  
 31 

 
or, if no such record date is established, at and as of the date such vote or consent is taken or any written consent of stockholders is first executed; provided that, notwithstanding the
foregoing, no Holder shall be entitled to a number of votes with respect to a share of Series A Preferred Stock that exceeds the Voting Share Cap. The Holders shall be entitled to notice of any meeting of holders of Common Stock in accordance with
the Certificate of Incorporation and Bylaws of the Company. 
 (b) Adverse Changes. The affirmative vote or consent of the Holders of
at least a majority of the shares of Series A Preferred Stock outstanding at such time, voting together as a separate class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, will be
necessary for effecting or validating any of the following actions, whether or not such approval is required pursuant to the DGCL: 

(i) any amendment, alteration or repeal (whether by merger, consolidation or otherwise) of any provision of the Certificate of
Incorporation (including this Certificate of Designations) or Bylaws that would have an adverse effect on the rights, preferences, privileges or voting power of the Series A Preferred Stock or the Holder thereof; 

(ii) any amendment or alteration (whether by merger, consolidation or otherwise) of, or any supplement (whether by a
certificate of designations or otherwise) to, the Certificate of Incorporation or any provision thereof, or any other action to authorize or create, or increase the number of authorized or issued shares of, or any securities convertible into shares
of, or reclassify any security into, or issue, any Parity Stock or Senior Stock or any other class or series of Capital Stock of the Company ranking senior to, or on a parity basis with, the Series A Preferred Stock as to dividend rights or rights
on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company; 

(iii) any increase or decrease in the authorized number of shares of Series A Preferred Stock or issuance of shares of Series A
Preferred Stock after the Issuance Date; and 
 (iv) any dividend on the Common Stock that is a one-time special dividend of $100,000,000 or more (in cash or measured by the Fair Market Value of the property being distributed in the dividend). 

provided, however, (A) that, with respect to the occurrence of any of the events set forth in clause (i) above, so long as
(1) the Series A Preferred Stock remains outstanding with the terms thereof materially unchanged, or (2) the holders of the Series A Preferred Stock receive equity securities with rights, preferences, privileges and voting power
substantially the same as those of the Series A Preferred Stock, then the occurrence of such event shall not be deemed to adversely affect such rights, preferences, privileges or voting power of the Series A Preferred Stock, and in such case such
holders shall not have any voting rights with respect to the occurrence of any of the events set forth in clause (i) above and (B) that the authorization or creation of, or the increase in the number of authorized or issued shares of, or
any securities convertible into shares of, or the reclassification of any security (other than the Series A Preferred Stock) into, or the issuance of, Junior Stock will not require the vote the holders of the Series A Preferred Stock. 

  
 32 

 For purposes of this Section 13, the filing in accordance with
applicable law of a certificate of designations or any similar document setting forth or changing the designations, powers, preferences, rights, qualifications, limitations and restrictions of any class or series of stock of the Company shall be
deemed an amendment to the Certificate of Incorporation. 
 (c) Notwithstanding anything to the contrary in this Certificate of Designations,
any amendment, alteration or repeal (whether by merger, consolidation or otherwise) of any provision of the Certificate of Incorporation (including this Certificate of Designations) or Bylaws that adversely affects the Conversion Price, Conversion
Rate, Liquidation Preference, Dividend Rate, Make-Whole Amount, Change of Control Redemption, Change of Control Redemption Price, Company Redemption Right, Base Redemption Price, Redemption Price or the Holder Redemption Right shall not be effective
as to the shares of Series A Preferred Stock held by any Holder without the consent of such Holder. 
 (d) Each Holder of Series A Preferred
Stock will have one vote per share on any matter on which Holders of Series A Preferred Stock are entitled to vote separately as a class, whether at a meeting or by written consent. 

(e) The affirmative vote or consent of the Holders of a majority of the shares of Series A Preferred Stock outstanding at such time, voting
together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, will be sufficient to waive or amend the provisions of Section 9(h) of this
Certificate of Designations, and any amendment or waiver of any of the provisions of Section 9(h) approved by such percentage of the Holders shall be binding on all of the Holders. 

(f) For the avoidance of doubt and notwithstanding anything to the contrary in the Certificate of Incorporation or Bylaws of the Company, the
Holders of Series A Preferred Stock shall have the exclusive consent and voting rights set forth in Section 13(b) and may take action or consent to any action with respect to such rights without a meeting by delivering a
consent in writing or by electronic transmission of the Holders of the Series A Preferred Stock entitled to cast not less than the minimum number of votes that would be necessary to authorize, take or consent to such action at a meeting of
stockholders. 
 SECTION 14. RESERVED. 

SECTION 15. Preemptive Rights. Except for the right to participate in any issuance of new equity securities by the Company as set forth
in the Investment Agreement, the Holders shall not have any preemptive rights. 
 SECTION 16. Term. Except as expressly provided in
this Certificate of Designations, the shares of Series A Preferred Stock shall not be redeemable or otherwise mature and the term of the Series A Preferred Stock shall be perpetual. 

SECTION 17. Creation of Capital Stock. Subject to Section 13(b)(ii) or
Section 13(b)(iii), the Board, or any duly authorized committee thereof, without the vote of the Holders, may authorize and issue additional shares of Capital Stock of the Company. 

  
 33 

 SECTION 18. No Sinking Fund. Shares of Series A Preferred Stock shall not be subject
to or entitled to the operation of a retirement or sinking fund. 
 SECTION 19. Transfer Agent, Conversion Agent, Registrar and Paying
Agent. The duly appointed Transfer Agent, Conversion Agent, Registrar and paying agent for the Series A Preferred Stock shall be Computershare Trust Company, N.A.. The Company may, in its sole discretion, appoint any other Person to serve as
Transfer Agent, Conversion Agent, Registrar or paying agent for the Series A Preferred Stock and thereafter may remove or replace Computershare Trust Company, N.A. or such other Person at any time. Upon any such appointment or removal, the Company
shall send notice thereof to the Holders. 
 SECTION 20. Replacement Certificates. (a) Mutilated, Destroyed, Stolen and Lost
Certificates. If physical certificates evidencing the Series A Preferred Stock are issued, the Company shall replace any mutilated certificate at the Holder’s expense upon surrender of that certificate to the Transfer Agent. The Company
shall replace certificates that become destroyed, stolen or lost at the Holder’s expense upon delivery to the Company and the Transfer Agent of satisfactory evidence that the certificate has been destroyed, stolen or lost, together with any
indemnity that may be required by the Transfer Agent and the Company. 
 (b) Certificates Following Conversion. If physical
certificates representing the Series A Preferred Stock are issued, the Company shall not be required to issue replacement certificates representing shares of Series A Preferred Stock on or after the Conversion Date applicable to such shares (except
if any certificate for shares of Series A Preferred Stock shall be surrendered for partial conversion, the Company shall, at its expense, execute and deliver to or upon the written order of the Holder of the certificate so surrendered a new
certificate for the shares of Series A Preferred Stock not converted). In place of the delivery of a replacement certificate following the applicable Conversion Date, the Transfer Agent, upon receipt of the satisfactory evidence and indemnity
described in clause (a) above, shall deliver certificates representing the shares of Common Stock issuable upon conversion of such shares of Series A Preferred Stock formerly evidenced by the physical certificate. 

SECTION 21. Taxes. (a) Transfer Taxes. The Company shall pay any and all stock transfer, documentary, stamp and similar
taxes that may be payable in respect of any issuance or delivery of shares of Series A Preferred Stock or shares of Common Stock or other securities issued on account of Series A Preferred Stock pursuant hereto or certificates representing such
shares or securities. However, in the case of conversion of Series A Preferred Stock, the Company shall not be required to pay any such tax that may be payable in respect of any transfer involved in the issuance or delivery of shares of Series A
Preferred Stock, shares of Common Stock or other securities to a beneficial owner other than the beneficial owner of the Series A Preferred Stock immediately prior to such conversion, and shall not be required to make any such issuance, delivery or
payment unless and until the Person otherwise entitled to such issuance, delivery or payment has paid to the Company the amount of any such tax or has established, to the satisfaction of the Company, that such tax has been paid or is not payable.

  
 34 

 (b) Withholding; Tax Treatment. All payments and distributions (or deemed
distributions) on the shares of Series A Preferred Stock (and on the shares of Common Stock received upon their conversion) shall be subject to withholding and backup withholding of taxes to the extent required by law, subject to applicable
exemptions, and amounts withheld, if any, shall be treated as received by the Holders. Absent a change in law or a contrary determination (as defined in Section 1313(a) of the Code), the Holders and the Company agree not to treat (i) the
Series A Preferred Stock as “preferred stock” within the meaning of Section 305 of the Code and Treasury Regulation Section 1.305-5 for United States federal income tax and withholding tax
purposes, and shall not take a position inconsistent with such treatment and (ii) any Accrued Dividends, Compounded Dividends or any accrued amounts thereon as a dividend for U.S. federal income tax purposes and applicable state and local tax
purposes unless and until such dividends are declared and paid as Cash Dividends. 
 SECTION 22. Notices. All notices referred to
herein shall be in writing and, unless otherwise specified herein, all notices hereunder shall be deemed to have been given upon the earlier of receipt thereof or three (3) Business Days after the mailing thereof if sent by registered or
certified mail with postage prepaid, or by private courier service addressed: (i) if to the Company, to its office at Box, Inc., 900 Jefferson Avenue, Redwood City, CA 94063 (Attention: Chief Financial Officer), (ii) if to any Holder, to such
Holder at the address of such Holder as listed in the stock record books of the Company (which may include the records of the Transfer Agent) or (iii) to such other address as the Company or any such Holder, as the case may be, shall have
designated by notice similarly given. 
 SECTION 23. Facts Ascertainable. When the terms of this Certificate of Designations refers
to a specific agreement or other document to determine the meaning or operation of a provision hereof, the Secretary of the Company shall maintain a copy of such agreement or document at the principal executive offices of the Company and a copy
thereof shall be provided free of charge to any Holder who makes a request therefor. The Secretary of the Company shall also maintain a written record of the Issuance Date, the number of shares of Series A Preferred Stock issued to a Holder and the
date of each such issuance, and shall furnish such written record free of charge to any Holder who makes a request therefor. 
 SECTION 24.
Waiver. Notwithstanding any provision in this Certificate of Designations to the contrary, any provision contained herein and any right of the Holders of Series A Preferred Stock granted hereunder may be waived as to all shares of Series A
Preferred Stock (and the Holders thereof) upon the vote or written consent of the Holders of a majority of the shares of Series A Preferred Stock then outstanding; provided that any waiver that adversely affects the Conversion Price,
Conversion Rate, Liquidation Preference, Dividend Rate, Make-Whole Amount, Change of Control Redemption, Change of Control Redemption Price, Company Redemption Right, Base Redemption Price, Redemption Price or the Holder Redemption Right shall not
be effective as to the shares of Series A Preferred Stock held by any Holder without the consent of such Holder. 
 SECTION 25.
Severability. If any term of the Series A Preferred Stock set forth herein is invalid, unlawful or incapable of being enforced by reason of any rule of law or public policy, all other terms set forth herein which can be given effect without
the invalid, unlawful or unenforceable term will, nevertheless, remain in full force and effect, and no term herein set forth will be deemed dependent upon any other such term unless so expressed herein. 

  
 35 

 SECTION 26. Business Opportunities. To the fullest extent permitted by
Section 122(17) of the DGCL (or any successor provision) and except as may be otherwise expressly agreed in writing by the Company and the Investor Parties, the Company, on behalf of itself and its Subsidiaries, renounces any interest or
expectancy of the Company and its Subsidiaries in, or in being offered an opportunity to participate in, business opportunities, that are from time to time presented to the Investor Parties or any of their respective officers, representatives,
directors, agents, stockholders, members, partners, Affiliates, Subsidiaries (other than the Company and its Subsidiaries), or any of their respective designees on the Company’s Board and/or any of their respective representatives who, from
time to time, may act as officers of the Company, even if the opportunity is one that the Company or its Subsidiaries might reasonably be deemed to have pursued or had the ability or desire to pursue if granted the opportunity to do so, and no such
person shall be liable to the Company or any of its Subsidiaries for breach of any fiduciary or other duty, as a director or officer or otherwise, by reason of the fact that such person pursues or acquires such business opportunity, directs such
business opportunity to another person or fails to present such business opportunity, or information regarding such business opportunity, to the Company or its Subsidiaries unless, in the case of any such person who is a director or officer of the
Company, such business opportunity is expressly offered to such director or officer in writing solely in his or her capacity as a director or officer of the Company. Any Person purchasing or otherwise acquiring any interest in any shares of Capital
Stock of the Company shall be deemed to have notice of and consented to the provisions of this Section 26. Neither the alteration, amendment or repeal of this Section 26, nor the adoption of any
provision of the Certificate of Incorporation or this Certificate of Designations inconsistent with this Section 26, nor, to the fullest extent permitted by Delaware law, any modification of law, shall eliminate or reduce
the effect of this Section 26 in respect of any business opportunity first identified or any other matter occurring, or any cause of action, suit or claim that, but for this Section 26, would
accrue or arise, prior to such alteration, amendment, repeal, adoption or modification. If any provision or provisions of this Section 26 shall be held to be invalid, illegal or unenforceable as applied to any circumstance
for any reason whatsoever: (a) the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Section 26 (including, without limitation, each portion of
any paragraph of this Section 26 containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired
thereby and (b) to the fullest extent possible, the provisions of this Section 26 (including, without limitation, each such portion of any paragraph of this Section 26 containing any such
provision held to be invalid, illegal or unenforceable) shall be construed so as to permit the Company to protect its directors, officers, employees and agents from personal liability in respect of their good faith service to or for the benefit of
the Company to the fullest extent permitted by law. This Section 26 shall not limit any protections or defenses available to, or indemnification or advancement rights of, any director, officer, employee or agent of the
Company under the Certificate of Incorporation, the Bylaws, any other agreement between the Company and such director, officer, employee or agent or applicable law. 

[Signature Page Follows] 

  
 36 

 IN WITNESS WHEREOF, the Company has caused this Certificate of Designations to be executed
this [•] day of [•], 2021. 
  

			
	BOX, INC.
		
	By:	 	  

	Name:	 	
	Title:	 	

 [Signature Page to Certificate of Designations] 

 EXHIBIT B 

FORM OF REGISTRATION RIGHTS AGREEMENT 

REGISTRATION RIGHTS AGREEMENT, dated as of [•], 2021 (the “Agreement”), by and among Box, Inc., a Delaware corporation
(the “Company”), Powell Investors III L.P., a Cayman Islands exempted limited partnership, KKR-Milton Credit Holdings L.P., a Cayman Islands exempted limited partnership, KKR-NYC Credit C L.P., a Delaware limited partnership, Tailored Opportunistic Credit Fund, an Australian trust and CPS Holdings (US) L.P., a Delaware limited partnership, each of which are managed or advised by KKR
Credit Advisors (US) LLC or Affiliates thereof (collectively, the “Investor”). The Investor and any other party that may become a party hereto pursuant to Section 9(c) are referred to collectively as the
“Stockholders” and individually each as a “Stockholder”. 
 RECITALS 

WHEREAS, the Company and the Investor are parties to the Investment Agreement, dated as of April 7, 2021 (as amended from time to time,
the “Investment Agreement”), pursuant to which the Company is selling to the Investor, and the Investor is purchasing from the Company, an aggregate of 500,000 shares of Series A Preferred Stock (the “Series A Preferred
Stock”), which is convertible into shares of Common Stock; 
 WHEREAS, as a condition to the obligations of the Company and the
Investor under the Investment Agreement, the Company and the Investor are entering into this Agreement for the purpose of granting certain registration and other rights to the Stockholders. 

NOW, THEREFORE, in consideration of the foregoing recitals and of the mutual promises hereinafter set forth, the parties hereto agree as
follows: 
 AGREEMENT 

1. Definitions. As used in this Agreement, the following capitalized terms shall have the following respective meanings: 

“Adverse Disclosure” means public disclosure of material non-public information that,
in the good faith judgment of the Company (after consultation with external legal counsel): (i) would be required to be made in any Registration Statement or report filed with the SEC by the Company so that such registration statement would not
contain any untrue statement of material fact or omit to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they are made, not misleading; (ii) would not be required to be
made at such time but for the filing, effectiveness or continued use of such Registration Statement; and (iii) the Company has a bona fide business purpose for not disclosing publicly. 

“Affiliate” means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is
under common control with, such Person. For this purpose, “control” (including its correlative meanings, “controlling”, “controlled by” and “under common control with”), with
respect to the relationship between or among two or more Persons, means the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management of a Person, whether through the ownership of voting
securities, as trustee or executor, by contract or otherwise. 

 “as converted basis” means with respect to the outstanding shares of Common
Stock as of any date, all outstanding shares of Common Stock calculated on a basis in which all shares of Common Stock issuable upon conversion of the outstanding shares of Series A Preferred Stock (at the Conversion Rate in effect on such date as
set forth in the Certificate of Designations) are assumed to be outstanding as of such date. 
 “Business Day” or
“business day” means any day except a Saturday, a Sunday or other day on which the SEC or banks in the City of New York are authorized or required by law to be closed. 

“Certificate of Designations” means the Certificate of Designations setting forth voting powers, designations, preferences
and relative, participating, optional or other special rights, and the qualifications, limitations and restrictions of the Series A Preferred Stock, dated as of the date hereof. 

“Charitable Gifting Event” means any transfer by a Holder, or any subsequent transfer by such Holder’s members, partners
or other employees, in connection with a bona fide gift to any Charitable Organization made in connection with sales of Registrable Securities by a Holder pursuant to an effective registration statement. 

“Charitable Organization” means a charitable organization as described by Section 501(c)(3) of the Internal Revenue Code
of 1986, as in effect from time to time. 
 “Common Stock” means all shares currently or hereafter existing of the
Company’s class A common stock, par value $0.0001 per share. 
 “Conversion Rate” has the meaning set forth in the
Certificate of Designations. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and any successor
statute thereto and the rules and regulations of the SEC promulgated thereunder. 
 “FINRA” means the Financial Industry
Regulatory Authority. 
 “Holdback Period” means the period commencing on the date of an underwriters’ request (which
shall be no earlier than four (4) Business Days prior to the expected “pricing” of the related underwritten offering) and continuing for not more than ninety (90) calendar days after the date of the final prospectus (or final
prospectus supplement if the offering is made pursuant to a shelf registration), pursuant to which such underwritten offering shall be made, or such lesser period as is required by such underwriters (which shall also apply equally to all Holders).

 “Holder” means any Stockholder holding Registrable Securities. 

“Lock-Up Period” has the meaning set forth in the Investment Agreement. 

  
 2 

 “NYSE” means the New York Stock Exchange. 

“Person” means any individual, corporation, limited liability company, limited or general partnership, joint venture,
association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof, any other form of entity or any group comprised of two or more of the foregoing. 

“Prospectus” means the prospectus included in any Registration Statement (including, without limitation, a prospectus that
discloses information previously omitted from a prospectus filed as part of an effective Registration Statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with
respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated
by reference or deemed to be incorporated by reference in such prospectus. 
 “register”, “registered” and
“registration” refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such registration statement or the
automatic effectiveness of such registration statement, as applicable. 
 “Registrable Securities” means, as of any date of
determination, any shares of Series A Preferred Stock issued pursuant to the Investment Agreement and any shares of Common Stock issued pursuant to the conversion of any shares of Series A Preferred Stock, and any other securities issued or issuable
with respect to any such shares of Common Stock or Series A Preferred Stock by way of share split, share dividend, distribution, recapitalization, merger, exchange, replacement or similar event or otherwise. As to any particular Registrable
Securities, once issued, such securities shall cease to be Registrable Securities when (i) they are sold pursuant to an effective Registration Statement under the Securities Act, (ii) they are sold pursuant to Rule 144 (or other
exemption from registration under the Securities Act), (iii) in the case of any shares of Common Stock held by a Holder, all shares of Common Stock held by such Holder, on an as converted basis, constitute less than 1% of all outstanding shares of
Common Stock and may be sold in a single day pursuant to, and in accordance with, subsection (k) of Rule 144, (iv) they shall have ceased to be outstanding or (v) they have been sold in a private transaction in which the transferor’s
rights under this Agreement are not assigned to the transferee of the securities. 
 “Registration Statement” means any
registration statement of the Company filed with the SEC under the Securities Act which covers any of the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus, amendments and supplements to such registration
statement, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such registration statement. 

“Rule 144” means Rule 144 under the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the SEC. 

  
 3 

 “SEC” means the Securities and Exchange Commission or any other federal
agency at the time administering the Securities Act or the Exchange Act. 
 “Securities Act” means the Securities Act of
1933, as amended, and any successor statute thereto and the rules and regulations of the SEC promulgated thereunder. 
 2. Incidental
Registrations. 
 (a) Right to Include Registrable Securities. If, following the expiration of the
Lock-Up Period, the Company proposes to register its Common Stock under the Securities Act (other than pursuant to a Registration Statement filed by the Company on
Form S-4 or S-8, or any successor or other forms promulgated for similar purposes or filed solely in connection with an exchange offer or any employee benefit or
dividend reinvestment plan), whether or not for sale for its own account, in a manner which would permit registration of Registrable Securities for sale to the public under the Securities Act, it will, at each such time, give prompt written notice
to all Holders of its intention to do so and of such Holders’ rights under this Section 2. Upon the written request of any such Holder made within seven (7) calendar days after the receipt of any such notice
(which request shall specify the Registrable Securities intended to be disposed of by such Holder), the Company will use its reasonable best efforts to effect the registration under the Securities Act of all Registrable Securities which the Company
has been so requested to register by the Holders thereof, to the extent required to permit the disposition of the Registrable Securities so to be registered; provided that (i) if, at any time after giving written notice of its intention
to register any securities and prior to the effective date of the Registration Statement filed in connection with such registration, the Company shall determine for any reason not to proceed with the proposed registration of the securities to be
sold by it, the Company may, at its election, give written notice of such determination to each Holder and, thereupon, shall be relieved of its obligation to register any Registrable Securities in connection with such registration (but not from its
obligation to pay the registration expenses pursuant to Section 6 hereof in connection therewith), without prejudice to the rights of the Holders to request that such registration be effected as a registration under
Section 3, and (ii) if such registration involves an underwritten offering, all Holders requesting to be included in the Company’s registration and to participate in the underwritten offering must sell their
Registrable Securities to the underwriters selected by the Company on the same terms and conditions as apply to the Company, with such differences, including any with respect to indemnification and liability, as are customary in combined primary and
secondary offerings by the Company and the Investors. If a registration requested pursuant to this Section 2(a) involves an underwritten public offering, any Holder requesting to be included in such registration may elect,
in writing at least two business days prior to the effective date of the Registration Statement filed in connection with such registration or, in the case of a takedown from a Shelf Registration Statement, prior to the launch of such takedown, not
to register such securities in connection with such registration. The Company shall not be required to maintain the effectiveness of the Registration Statement for a registration requested pursuant to this Section 2(a)
beyond the earlier to occur of (i) 180 calendar days after the effective date thereof and (ii) consummation of the distribution by the Holders of the Registrable Securities included in such Registration Statement. Any Holder who has
elected to sell Registrable Securities in an offering pursuant to this Section 2 shall be permitted to withdraw from such registration by written notice to the Company if the price to the public at which the Registrable
Securities are proposed to be sold will be less than 90% of the average closing price of the class of stock being sold in the offering during the 10 trading days preceding the date on which the notice of such offering was given pursuant to this
Section 2(a). 

  
 4 

 (b) Priority in Incidental Registrations. The Company shall use reasonable efforts to
cause the managing underwriter or underwriters of a proposed underwritten offering to permit Holders who have requested to include Registrable Securities in such offering to include in such offering all Registrable Securities so requested to be
included on the same terms and conditions as any other shares of capital stock, if any, of the Company included in the offering. Notwithstanding the foregoing, if the managing underwriter or underwriters of such underwritten offering have informed
the Company in writing that it is their good faith opinion that the total amount of securities that are intended to be included in such offering is such as to adversely affect the success of such offering (including adversely affect the per-share offering price), then the amount of securities to be offered shall be reduced to the amount recommended by such managing underwriter or underwriters in its or their good faith opinion, which will be
allocated in the following order of priority: (i) first, the securities to be proposed to be sold by the Company for its own account, (ii) second, the Registrable Securities of each Investor, pro rata among such Investors on the
basis of the percentage of the Registrable Securities requested to be included in such underwritten offering by such Investors, (iii) third, the Registrable Securities of the Holders other than any Investor that have requested to participate in
such underwritten offering, allocated pro rata among such Holders on the basis of the percentage of the Registrable Securities requested to be included in such underwritten offering by such Holders and (iv) fourth, for the account of any
other holders of Common Stock that have requested to be included in such underwritten offering as a result of registration rights or otherwise. 

3. Registration on Request. 

(a) Request by the Demand Party. Subject to the following paragraphs of this Section 3(a), each Holder shall
have the right, by delivering a written notice to the Company, to require the Company to register, at any time following the expiration of the Lock-Up Period and pursuant to the terms of this Agreement, under
and in accordance with the provisions of the Securities Act, the number of Registrable Securities of such Holder requested to be so registered pursuant to the terms of this Agreement (any such written notice, a “Demand Notice”, any
such registration, a “Demand Registration” and any such Holder, a “Demand Party”); provided, however, that a Demand Notice may only be made if the sale of the Registrable Securities requested to be
registered by such Holder is reasonably expected to result in aggregate gross cash proceeds in excess of $50,000,000 (without regard to any underwriting discount or commission); provided, further, that the Company shall not be
obligated to file a registration statement relating to any registration request under this Section 3(a), (i) within the period as may be specified by the Company’s insider trading policy as applicable to Company
employees generally for any fiscal quarter or year or any special blackout period as specified by the Company’s insider trading policy (each, a “Blackout Period”) or (ii) within a period of sixty (60) calendar days
after the effective date of any other registration statement relating to any registration request under this Section 3(a); provided, further, that nothing in this Section 3(a) or
elsewhere herein shall be construed as limiting the frequency by which a Holder may effect a Shelf Underwritten Offering or Non-Underwritten Shelf Take-Down pursuant to Section 3(f).
Following receipt of a Demand Notice for a Demand Registration in accordance with this Section 3(a), the Company shall use its reasonable best efforts to file a Registration Statement as promptly as practicable within ten
(10) calendar days and shall use its reasonable best efforts to cause such Registration Statement to be declared effective under the Securities Act as promptly as practicable after the filing thereof. 

  
 5 

 No Demand Registration shall be deemed to have occurred for purposes of this
Section 3 if (i) the Registration Statement relating thereto (x) does not become effective, (y) is not maintained effective for the period required pursuant to this Section 3 or
(z) the offering of the Registrable Securities pursuant to such Registration Statement is subject to a stop order, injunction, or similar order or requirement of the SEC during such period, in which case, such requesting Holder shall be
entitled to an additional Demand Registration in lieu thereof, (ii) more than 90% of the Registrable Securities requested by the Demand Party to be included in the registration are not so included pursuant to
Section 3(b) or (iii) in the case of a Demand Registration for an underwritten offering, the conditions to closing specified in any underwriting agreement, purchase agreement or similar agreement entered into in
connection with the registration relating to such request are not satisfied (other than as a result of a material default or breach thereunder by such Demand Party) or otherwise waived by such Demand Party; provided that the Company’s
obligation to pay the registration expenses pursuant to Section 6 hereof in connection therewith shall still apply. 

As promptly as practicable within two (2) calendar days after receipt by the Company of a Demand Notice in accordance with this
Section 3(a), the Company shall give written notice (the “Demand Follow-up Notice”) of such Demand Notice to all other Holders and shall, subject to the provisions of
Section 3(b) hereof, include in such registration all Registrable Securities with respect to which the Company received written requests for inclusion therein within five (5) calendar days after such Demand Follow-up Notice is given by the Company to such Holders, provided that the Company shall not provide a Demand Follow-up Notice to any other Holder or holder of the
Company’s equity securities in the case of a sale of Registrable Securities by any Investor to one or several purchasers pursuant to a Shelf Underwritten Offering by means of a bought deal, a block trade or a similar transaction that is an
underwritten offering (a “Block Sale”). 
 All requests made pursuant to this Section 3 will
specify the number of Registrable Securities to be registered and the intended methods of disposition thereof. 
 The Company shall be
required to maintain the effectiveness of the Registration Statement with respect to any Demand Registration for a period of at least one hundred and eighty (180) calendar days after the effective date thereof or such shorter period during
which all Registrable Securities included in such Registration Statement have actually been sold; provided, however, that such period shall be extended for a period of time equal to the period the Holder refrains from selling any
securities included in such Registration Statement at the request of the Company or an underwriter of the Company pursuant to the provisions of this Agreement. 

(b) Priority on Demand Registration. If any of the Registrable Securities registered pursuant to a Demand Registration are to be sold in
a firm commitment underwritten offering, and the managing underwriter or underwriters advise the Holders of such securities in writing that in its or their good faith opinion the total number or dollar amount of Registrable Securities proposed to be
sold in such offering is such as to adversely affect the success of such offering (including, without limitation, securities proposed to be included by other holders of 

  
 6 

 
securities entitled to include securities in such Registration Statement pursuant to incidental or piggyback registration rights), then there shall be included in such firm commitment
underwritten offering the number or dollar amount of Registrable Securities that in the good faith opinion of such managing underwriter or underwriters can be sold without adversely affecting such offering, and such number of Registrable Securities
shall be allocated as follows, unless the underwriter or underwriters require a different allocation: 
 (i) first, to each
Investor pro rata among such Investors on the basis of the percentage of the Registrable Securities owned by each such Investor relative to the number of Registrable Securities owned by all such Investors, until all Registrable Securities
requested for registration by each such Investor have been included in such registration; 
 (ii) second, to any Holders
other than any Investor requesting such Demand Registration (whether pursuant to a Demand Notice or pursuant to incidental or piggyback registration rights) among such Holders pro rata on the basis of the percentage of Registrable Securities owned
by each such Holder relative to the number of Registrable Securities owned by all such Holders; 
 (iii) third, the
securities for which inclusion in such Demand Registration, as the case may be, was requested by any other holders of Common Stock as a result of registration rights or otherwise; and 

(iv) fourth, the securities for which inclusion in such Demand Registration was requested by the Company. 

(c) Cancellation of a Demand Registration. Each Demand Party and the Holders of a majority of the Registrable Securities which are to be
registered in a particular offering pursuant to this Section 3 shall have the right, prior to the effectiveness of the Registration Statement, to notify the Company that it or they, as the case may be, has or have
determined that such Registration Statement be abandoned or withdrawn, in which event the Company shall abandon or withdraw such registration statement. Any Holder who has elected to sell Registrable Securities in an underwritten offering pursuant
to this Section 3 (including the Demand Party of such Demand Registration) shall be permitted to withdraw from such registration by written notice to the Company if the price to the public at which the Registrable
Securities are proposed to be sold will be less than 90% of the average closing price of the class of stock being sold in the offering during the ten (10) trading days preceding the date on which the Demand Notice of such offering was given
pursuant to Section 3(a). 
 (d) Postponements in Requested Registrations. If the Company shall at any time
furnish to the Holders a certificate signed by its chairman of the board, chief executive officer or president stating that the filing of a Registration Statement or conducting a Shelf Underwritten Offering or
Non-Underwritten Shelf Take-Down would, in the good faith judgment of the board of directors of the Company (after consultation with external legal counsel), (i) require the Company to make an Adverse
Disclosure; (ii) materially interfere with any material proposed acquisition, disposition, financing, reorganization, recapitalization or similar transaction involving the Company or any of its subsidiaries then under consideration or
(iii) be 

  
 7 

 
materially detrimental to the Company and its stockholders, the Company may postpone the filing (but not the preparation) of a Registration Statement or the commencement of a Shelf Underwritten
Offering, as applicable, required by this Section 3 until such circumstance is no longer continuing but not to exceed sixty (60) days (such period, a “Postponement Period”); provided that the
Company shall at all times in good faith use its commercially reasonable best efforts to cause any Registration Statement required by this Section 3 to be filed as soon as possible or any Shelf Underwritten Offering to be
conducted as soon as possible, as applicable; provided, further, that the Company shall not be permitted to commence a Postponement Period pursuant to this Section 3(d) more than once in any 180-day period. The Company shall promptly give the Holders requesting registration thereof or that delivered a Take-Down Notice, as applicable, pursuant to this Section 3 written notice of
any postponement made in accordance with the preceding sentence. 
 (e) Shelf Registration Statement. 

(i) No later than the expiration of the Lock-Up Period, the Company shall file with the
SEC a shelf Registration Statement (on Form S-3 to the extent permissible) (a “Shelf Registration Statement”) covering the resale of all Registrable Securities, and shall use reasonable best
efforts to cause such registration statement to become effective no later than the expiration of the Lock-Up Period. Upon filing the Shelf Registration Statement, the Company shall use its reasonable best
efforts to keep such Shelf Registration Statement effective with the SEC at all times and to re-file such Shelf Registration Statement upon its expiration, and subject to Sections 3(f) and (g),
to cooperate in any shelf take-down, whether or not underwritten, by amending or supplementing the Prospectus related to such Shelf Registration Statement as may be reasonably requested by the Holders or as otherwise required, until such time as all
Registrable Securities that could be sold in such Shelf Registration Statement have been sold or are no longer outstanding. 

(ii) If the Company is a well-known seasoned issuer (as defined in Rule 405) (a “WKSI”) at a time when it is
obligated to file a Shelf Registration Statement pursuant to this Agreement, the Company shall file an automatic shelf registration statement (as defined in Rule 405 of the Securities Act) on Form S-3 (an
“Automatic Shelf Registration Statement”) in accordance with the requirements of the Securities Act and the rules and regulations of the SEC thereunder, that covers the Registrable Securities. The Company shall pay the registration
fee for all Registrable Securities to be registered pursuant to an Automatic Shelf Registration Statement at the time of filing of the Automatic Shelf Registration Statement and shall not elect to pay any portion of the registration fee on a
deferred basis. If at any time following the filing of an Automatic Shelf Registration Statement when the Company is required to re-evaluate its WKSI status the Company determines that it is not a WKSI, the
Company shall use its reasonable best efforts to post-effectively amend the Automatic Shelf Registration Statement to a Shelf Registration Statement that is not automatically effective or file a new Shelf Registration Statement. 

  
 8 

 (iii) To the extent that the Company becomes ineligible to use Form S-3, the Company shall file a “shelf” registration statement on Form S-1 registering the Registrable Securities for resale not later than thirty (30) calendar
days after the date of such ineligibility and use its reasonable best efforts to have such registration statement declared effective as promptly as practicable. 

(f) Shelf-Take Downs. At any time that a Shelf Registration Statement covering Registrable Securities pursuant to
Section 2 or Section 3 is effective, each Investor may, deliver a written notice to the Company (a “Take-Down Notice”) stating that it intends to effect an underwritten offering (a
“Shelf Underwritten Offering”) or other non-underwritten sale (a “Non-Underwritten Shelf Take-Down”) of all or part of its Registrable
Securities included by it on the Shelf Registration Statement, then, the Company shall amend or supplement the Shelf Registration Statement as may be necessary in order to enable such Registrable Securities to be distributed pursuant to the Shelf
Underwritten Offering (taking into account the inclusion of Registrable Securities by any other holders pursuant to Section 3(b)) or Non-Underwritten Shelf Take-Down; provided,
however that the Holders may not, without the Company’s prior written consent, (i) launch a Shelf Underwritten Offering the anticipated gross cash proceeds of which shall be less than $50,000,000 (unless the Holders are proposing to
sell all of their remaining Registrable Securities), (ii) launch more than four (4) Shelf Underwritten Offerings at the request of the Holders within any 365-day period or (iii) launch a Shelf
Underwritten Offering within any Blackout Period. Each Investor shall be entitled to deliver an unlimited number of Take-Down Notices to effect a Non-Underwritten Shelf Take-Down with respect to the
Registrable Securities held by each Investor in addition to the other registration rights provided in Section 2 and this Section 3. In connection with any Shelf Underwritten Offering: 

(i) the Company shall also as promptly as practicable within two (2) business days deliver the Take-Down Notice to all
other Holders with Registrable Securities included on such Shelf Registration Statement and permit each Holder to include its Registrable Securities included on the Shelf Registration Statement in the Shelf Underwritten Offering if such Holder
notifies the Company (who shall notify each Investor) within two (2) business days after delivery of the Take-Down Notice to such Holder, provided that the Company shall not provide a Take-Down Notice to any other Holder or holder of the
Company’s equity securities in the case of a Block Sale by any Investor; and 
 (ii) in the event that the underwriter
advises the Company (who shall notify each Investor) in its good faith opinion that the total number or dollar amount of Registrable Securities proposed to be sold in such offering is such as to adversely affect the success of such offering
(including an adverse effect on the per -share offering price), the underwriter may limit the number of shares which would otherwise be included in such Shelf Underwritten Offering in the same manner as described in
Section 3(b) with respect to a limitation of shares to be included in a registration. 
 (g) Selection of
Underwriters. If a requested registration pursuant to this Section 3 involves an underwritten offering, the investment banker(s) and manager(s) and lead investment banker(s) and manager(s) to administer the offering
shall be chosen by the KKR Investor (if the KKR Investor is participating in the offering) or otherwise by the Investor(s) selling the largest number of Registrable Securities in such offering, provided, that if a Holder other than the Demand
Party will sell at least 50% of the Registrable Securities proposed to be 

  
 9 

 
sold in such offering and neither the KKR Investor nor any other Investor is participating in such offering, the investment banker(s) and manager(s) and lead investment banker(s) and manager(s)
shall be chosen by such other Holder (such other Holder, if any, the “Lead Holder”), subject to the approval of the Company (not to be unreasonably delayed or withheld). If the offering is underwritten, the right of any Holder to
registration pursuant to this Section 3 will be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise
agreed by the Demand Party), and each such Holder will (together with the Company and the other Holders distributing their securities through such underwriting) enter into an underwriting agreement and lock-up
agreement in customary form with the underwriter or underwriters selected for such underwriting (including pursuant to the terms of any over-allotment or “green shoe” option requested by the managing underwriter(s)); provided that
(x) no Holder shall be required to sell more than the number of Registrable Securities that such Holder has requested the Company to include in any registration and (y) if any Holder disapproves of the terms of the underwriting, such
Holder may elect to withdraw prior to launching the applicable underwritten offering by written notice to the Company, the managing underwriter or underwriters and, in connection with an underwritten registration pursuant to this
Section 3, the Demand Party. 
 4. Registration Procedures. If and whenever the Company is required to use
its reasonable best efforts to effect the registration of any Registrable Securities under the Securities Act as provided in Section 2 and Section 3 hereof, the Company shall effect such
registration to permit the sale of such Registrable Securities in accordance with the intended method or methods of disposition thereof, and pursuant thereto the Company shall cooperate in the sale of the securities and shall, as expeditiously as
possible: 
 (a) prepare and file, in each case as promptly as practicable, with the SEC a Registration Statement or
Registration Statements on such form as shall be available for the sale of the Registrable Securities by the Holders thereof or by the Company in accordance with the intended method or methods of distribution thereof, make all required filings with
FINRA and use its reasonable best efforts to cause such Registration Statement to become effective as soon as practicable and to remain effective as provided herein; provided, however, that before filing a Registration Statement or
Prospectus or any amendments or supplements thereto (including any free writing prospectuses under Rule 433 under the Securities Act (each a “Free Writing Prospectus”) and including such documents that would be incorporated or
deemed to be incorporated therein by reference), the Company shall furnish or otherwise make available to the Holders of the Registrable Securities covered by such Registration Statement, their counsel and the managing underwriters, if any, copies
of all such documents proposed to be filed, which documents will be subject to the reasonable review and comment of such counsel, and such other documents reasonably requested by such counsel, including any comment letter from the SEC, and, if
requested by such counsel, provide such counsel reasonable opportunity to participate in the preparation of such Registration Statement and each Prospectus included therein and such other opportunities to conduct a reasonable investigation within
the meaning of the Securities Act, including reasonable access to the Company’s books and records, officers, accountants and other advisors. The Company shall not file any such Registration Statement or Prospectus or any amendments or
supplements thereto (including any Free Writing Prospectuses and including such 

  
 10 

 
documents that, upon filing, would be incorporated or deemed to be incorporated by reference therein) with respect to a Demand Registration to which the Demand Party, the Holders of a majority of
the Registrable Securities covered by such Registration Statement, or their counsel, or the managing underwriters, if any, shall reasonably object, in writing, on a timely basis, unless, in the opinion of the Company, such filing is necessary to
comply with applicable law; 
 (b) subject to Section 3(e), prepare and file with the SEC such
amendments, post-effective amendments and supplements to each Registration Statement and the Prospectus used in connection therewith and such Free Writing Prospectuses and Exchange Act reports as may be necessary to keep such Registration Statement
continuously effective during the period provided herein and comply in all material respects with the provisions of the Securities Act with respect to the disposition of all Registrable Securities covered by such Registration Statement; and cause
the related Prospectus to be supplemented by any Prospectus supplement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of the Registrable Securities covered by such Registration Statement, and
as so supplemented to be filed pursuant to Rule 424 (or any similar provisions then in force) under the Securities Act, in each case, until such time as all of such securities have been disposed of in accordance with the intended method or methods
of disposition by the seller or sellers thereof set forth in such Registration Statement; 
 (c) notify each selling Holder,
its counsel and the managing underwriters, if any, promptly, and (if requested by any such Person) confirm such notice in writing, (i) when a Prospectus or any Prospectus supplement or post-effective amendment or any Free Writing Prospectus has
been filed, and, with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the SEC or any other federal or state governmental authority for amendments or supplements to
a Registration Statement or related Prospectus or for additional information, (iii) of the issuance by the SEC of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose,
(iv) if at any time the Company has reason to believe that the representations and warranties of the Company contained in any agreement (including any underwriting agreement) contemplated by Section 4(n) below cease to
be true and correct, (v) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation
or threatening of any proceeding for such purpose, and (vi) of the happening of any event that makes any statement made in such Registration Statement, related Prospectus, Free Writing Prospectus, amendment or supplement thereto or any document
incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in such Registration Statement, Prospectus or documents so that, in the case of the Registration Statement, it
will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, not misleading, and that in the case of the Prospectus, it will not contain any
untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading (which notice shall notify the selling Holders only of
the occurrence of such an event and shall provide no additional information regarding such event to the extent such information would constitute material non-public information); 

  
 11 

 (d) use its reasonable best efforts to obtain the withdrawal of any order
suspending the effectiveness of a Registration Statement, or the lifting of any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction at the earliest date reasonably
practical; 
 (e) if requested by the managing underwriters, if any, the Demand Party with respect to the offering or the
Holders of a majority of the then issued and outstanding Registrable Securities being sold in connection with an underwritten offering, promptly include in a Prospectus supplement or post-effective amendment such information as the managing
underwriters, if any, or such Demand Party or Holders, as the case may be, may reasonably request in order to permit the intended method of distribution of such Registrable Securities and make all required filings of such Prospectus supplement or
such post-effective amendment as soon as practicable after the Company has received such request; provided, however, that the Company shall not be required to take any actions under this Section 4(e) that are
not, in the opinion of counsel for the Company, in compliance with applicable law; 
 (f) deliver to each selling Holder, its
counsel, and the underwriters, if any, without charge, as many copies of the Prospectus or Prospectuses (including each form of Prospectus) and each amendment, supplement or post-effective amendment thereto as such Persons may reasonably request
from time to time in connection with the distribution of the Registrable Securities; and the Company, subject to the last paragraph of this Section 4, hereby consents to the use of such Prospectus and each amendment or
supplement thereto by each of the selling Holders and the underwriters, if any, in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any such amendment or supplement thereto; 

(g) prior to any public offering of Registrable Securities, use its reasonable best efforts to register or qualify or cooperate
with the selling Holders, the underwriters, if any, and their respective counsel in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for offer and sale under the
securities or “Blue Sky” laws of such jurisdictions within the United States as any seller or underwriter reasonably requests in writing and to keep each such registration or qualification (or exemption therefrom) effective during the
period such Registration Statement is required to be kept effective and to take any other action that may be necessary or advisable to enable such Holders to consummate the disposition of such Registrable Securities in such jurisdiction in
accordance with the intended method or methods of disposition thereof; provided, however, that the Company will not be required to (i) qualify generally to do business in any jurisdiction where it is not then so required to
qualify but for this paragraph (g) or (ii) take any action that would subject it to general service of process in any such jurisdiction where it is not then so subject (other than service of process in connection with such registration or
qualification or any sale of Registrable Securities in connection therewith); 

  
 12 

 (h) cooperate with the selling Holders and the managing underwriters, if
any, to facilitate the timely preparation and delivery of certificates (not bearing any legends) representing Registrable Securities to be sold after receiving written representations from each Holder of such Registrable Securities that the
Registrable Securities represented by the certificates so delivered by such Holder will be transferred in accordance with the Registration Statement, and enable such Registrable Securities to be in such denominations and registered in such names as
the managing underwriters, if any, or Holders may request; 
 (i) use its reasonable best efforts to cause the Registrable
Securities covered by the Registration Statement to be registered with or approved by such other governmental agencies or authorities within the United States as may be necessary in light of the business or operations of the Company to enable the
seller or sellers thereof or the managing underwriters, if any, to consummate the disposition of such Registrable Securities, in accordance with the intended method or methods thereof, except as may be required solely as a consequence of the nature
of such selling Holder’s business, in which case the Company will cooperate in all reasonable respects with the filing of such Registration Statement and the granting of such approvals, as may be necessary to enable the seller or sellers
thereof or the underwriters, if any, to consummate the disposition of such Registrable Securities in accordance with the intended method or methods thereof; 

(j) upon the occurrence of any event contemplated by Section 4(c)(vi) above, promptly prepare a
supplement or post-effective amendment to the Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, or file any other required document so that, as thereafter
delivered to the purchasers of the Registrable Securities being sold thereunder, such Prospectus will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading; 
 (k) prior to the effective
date of the Registration Statement relating to the Registrable Securities, provide a CUSIP number for the Registrable Securities; 

(l) provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by such
Registration Statement from and after a date not later than the effective date of such Registration Statement (and in connection therewith, if reasonably required by the Company’s transfer agent, the Company will cause an opinion of counsel as
to the effectiveness of the Registration Statement to be delivered to such transfer agent, together with any other authorizations, certificates and directions reasonably required by the transfer agent which authorize and direct the transfer agent to
issue such Registrable Securities without any legend upon sale by the Holder or the underwriter or managing underwriter of an underwritten offering of Registrable Securities, if any, of such Registrable Securities under the Registration Statement);

  
 13 

 (m) use its reasonable best efforts to cause all shares of Registrable
Securities covered by such Registration Statement to be listed on the NYSE or other national securities exchange on which the Common Stock is then listed, prior to the effectiveness of such Registration Statement (or, if no Common Stock issued by
the Company is then listed on any securities exchange, use its reasonable best efforts to cause such Registrable Securities to be so listed on the NYSE or NASDAQ, as determined by the Company); 

(n) enter into such agreements (including an underwriting agreement in form, scope and substance as is customary in
underwritten offerings) and take all such other actions reasonably requested by the Demand Party or the Holders of a majority of the Registrable Securities being sold in connection therewith (including those reasonably requested by the managing
underwriters, if any) to expedite or facilitate the disposition of such Registrable Securities, and in such connection, whether or not an underwriting agreement is entered into and whether or not the registration is an underwritten registration,
(i) make such representations and warranties to the Holders of such Registrable Securities and the underwriters, if any, with respect to the business of the Company and its subsidiaries, and the Registration Statement, Prospectus and documents,
if any, incorporated or deemed to be incorporated by reference therein, in each case, in form, substance and scope as are customarily made by issuers to underwriters in underwritten offerings, and, if true, confirm the same if and when requested,
(ii) use its reasonable best efforts to furnish to the selling Holders and the underwriters, if any, opinions of outside counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably
satisfactory to the managing underwriters, if any), addressed to each of the underwriters, if any, covering the matters customarily covered in opinions requested in underwritten offerings and such other matters as may be reasonably requested by such
counsel and underwriters, (iii) use its reasonable best efforts to obtain “cold comfort” letters and updates thereof from the independent certified public accountants of the Company (and, if necessary, any other independent certified
public accountants of any subsidiary of the Company or of any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement) who have certified the financial
statements included in such Registration Statement, addressed to each selling Holder (unless such accountants shall be prohibited from so addressing such letters by applicable standards of the accounting profession) and each of the underwriters, if
any, such letters to be in customary form and covering matters of the type customarily covered in “cold comfort” letters in connection with underwritten offerings, (iv) if an underwriting agreement is entered into, the same shall
contain indemnification provisions and procedures substantially to the effect set forth in Section 5 hereof with respect to all parties to be indemnified pursuant to Section 5 except as otherwise
agreed by the Holders and (v) deliver such documents and certificates as may be reasonably requested by the Demand Party, the Holders of a majority of the Registrable Securities being sold pursuant to such Registration Statement, its or their
counsel or the managing underwriters, if any, to evidence the continued validity of the representations and warranties made pursuant to Section 4(n)(i) above and to evidence compliance with any customary conditions
contained in the underwriting agreement or other agreement entered into by the Company. The above shall be done at each closing under such underwriting or similar agreement, or as and to the extent required thereunder; 

  
 14 

 (o) make available for inspection by a representative of the selling
Holders, any underwriter participating in any such disposition of Registrable Securities, if any, and any attorneys or accountants retained by such selling Holders or underwriter, at the offices where normally kept, during reasonable business hours,
all financial and other records, pertinent corporate documents and properties of the Company and its subsidiaries, and cause the officers, directors and employees of the Company and its subsidiaries to supply all information in each case reasonably
requested by any such representative, underwriter, attorney or accountant in connection with such Registration Statement; provided, however, that any information that is not generally publicly available at the time of delivery of such
information shall be kept confidential by such Persons unless (i) disclosure of such information is required by court or administrative order, (ii) disclosure of such information, in the opinion of counsel to such Person, is required by
law or applicable legal process, or (iii) such information becomes generally available to the public other than as a result of a disclosure or failure to safeguard by such Person. In the case of a proposed disclosure pursuant to (i) or
(ii) above, such Person shall be required to give the Company written notice of the proposed disclosure prior to such disclosure and, if requested by the Company, assist the Company in seeking to prevent or limit the proposed disclosure. Without
limiting the foregoing, no such information shall be used by such Person as the basis for any market transactions in securities of the Company or its subsidiaries in violation of law; 

(p) cause its officers, including its executive officers, to use their reasonable best efforts to support the marketing of the
Registrable Securities covered by the Registration Statement (including, without limitation, participation in “road shows” and other customary marketing activities) taking into account the Company’s business needs; 

(q) cooperate with each seller of Registrable Securities and each underwriter or agent participating in the disposition of such
Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; 
 (r)
otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the SEC, and make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve
(12) months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement, which earnings statement will satisfy the provisions of Section 11(a) of the Securities
Act and Rule 158 thereunder; and 
 (s) cooperate with the Holders subject to the Registration Statement and with the
underwriter(s) or agent participating in the distribution, if any, to facilitate any Charitable Gifting Event and to prepare and file with the SEC such amendments and supplements to such Registration Statement and the Prospectus used in connection
therewith as may be necessary to permit any such recipient Charitable Organization to sell in the underwritten offering if it so elects. 

The Company may require each Holder as to which any registration is being effected to furnish to the Company in writing such information
required in connection with such registration regarding such seller and the distribution of such Registrable Securities as the Company may, from time to time, reasonably request in writing and the Company may exclude from such registration the
Registrable Securities of any Holder who unreasonably fails to furnish such information within a reasonable time after receiving such request. 

  
 15 

 The Company agrees not to file or make any amendment to any Registration Statement with
respect to any Registrable Securities, or any amendment of or supplement to the Prospectus or any Free Writing Prospectus used in connection therewith, that refers to any Holder covered thereby by name, or otherwise identifies such Holder as the
holder of any securities of the Company, without the consent of such Holder, such consent not to be unreasonably withheld or delayed, unless and to the extent such disclosure is required by law. 

If the Company files any Shelf Registration Statement for the benefit of the holders of any of its securities other than the Holders, the
Company agrees that it shall use its reasonable best efforts to include in such registration statement such disclosures as may be required by Rule 430B under the Securities Act (referring to the unnamed selling security holders in a generic manner
by identifying the initial offering of the securities to the Holders) in order to ensure that such Holders may be added to such Shelf Registration Statement at a later time through the filing of a Prospectus supplement rather than a post-effective
amendment. 
 Notwithstanding any provision hereof to the contrary, to the extent that any pro rata or other allocation or reduction of
Registrable Securities is required pursuant to Sections 2(b), 3(b), 3(g)(ii) or any other section herein, (i) all Registrable Securities transferred by a Holder to a Charitable Organization in connection with an
underwritten offering for which such pro rata or other allocation is required shall be included in the number of Registrable Securities deemed to be held by each Holder (or deemed to be included in such Holder’s request for inclusion of
Registrable Securities) for purposes of calculating such Holder’s pro rata allocation or reduction in such underwritten offering and (ii) the number of Registrable Securities that a Holder is otherwise entitled to include in such
underwritten offering shall be reduced by the number of Registrable Securities transferred by such Holder to a Charitable Organization in connection with such underwritten offering. 

Each Holder agrees if such Holder has Registrable Securities covered by such Registration Statement that, upon receipt of any notice from the
Company of the happening of any event of the kind described in Section 4(c)(ii), 4(c)(iii), 4(c)(iv), 4(c)(v) or 4(c)(vi) hereof, such Holder will forthwith discontinue disposition of such
Registrable Securities covered by such Registration Statement or Prospectus until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 4(j) hereof, or until it is
advised in writing by the Company that the use of the applicable Prospectus may be resumed, and has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus;
provided, however, that the time periods under Section 3 with respect to the length of time that the effectiveness of a Registration Statement must be maintained shall automatically be extended by the amount
of time the Holder is required to discontinue disposition of such securities. 

  
 16 

 5. Indemnification. 

(a) Indemnification by the Company. The Company shall, without limitation as to time, indemnify and hold harmless, to the fullest extent
permitted by law, each Holder whose Registrable Securities are covered by a Registration Statement or Prospectus, the officers, directors, partners, members, managers, shareholders, accountants, attorneys, agents and employees of each of them, each
Person who controls each such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, partners, members, managers, shareholders, accountants, attorneys, agents and
employees of each such controlling person, each underwriter, if any, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) such underwriter (each such person being referred
to herein as a “Covered Person”), from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, costs of preparation and reasonable attorneys’ fees and any legal or other fees or
expenses incurred by such party in connection with any investigation or proceeding), expenses, judgments, fines, penalties, charges and amounts paid in settlement (collectively, “Losses”), as incurred, arising out of or based upon
any untrue statement (or alleged untrue statement) of a material fact contained in any Prospectus, offering circular, or other document (including any related Registration Statement, notification, or the like or Free Writing Prospectus or any
amendment thereof or supplement thereto or any document incorporated by reference therein) incident to any such registration, qualification, or compliance, or based on any omission (or alleged omission) to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading, or any violation by the Company of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation thereunder applicable to the Company and
(without limitation of the preceding portions of this Section 5(a)) will reimburse each such Covered Person for any legal and any other expenses reasonably incurred in connection with investigating and defending or settling
any such Loss, provided that the Company will not be liable in any such case to the extent that any such Loss arises out of or is based on any untrue statement or omission by such Covered Person related to such Covered Person or its
Affiliates (other than the Company or any of its subsidiaries, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement, Prospectus, offering circular,
Free Writing Prospectus or any amendment thereof or supplement thereto, or any document incorporated by reference therein, or other document in reliance upon and in conformity with written information furnished to the Company by such Covered Person
with respect to such Covered Person for use therein. It is agreed that the indemnity agreement contained in this Section 5(a) shall not apply to amounts paid in settlement of any such Loss or action if such settlement is
effected without the consent of the Company (which consent shall not be unreasonably delayed or withheld), provided that notwithstanding the foregoing, the indemnity agreement contained in this Section 5(a) shall
apply to amounts paid in settlement of any Loss or action even if such settlement is effected without the consent of the Company if the Company does not timely reply to a request for its consent. 

(b) Indemnification by Holder. The Company may require, as a condition to including any Registrable Securities in any Registration
Statement filed in accordance with Section 4 hereof, that the Company shall have received an undertaking reasonably satisfactory to it from the participating Holder of such Registrable Securities to indemnify, to the
fullest extent permitted by law, severally and not jointly with any other Holders, the Company, its directors 

  
 17 

 
and officers and each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), from and against all Losses arising
out of or based on any untrue statement of a material fact contained in any such Registration Statement, Prospectus, Free Writing Prospectus, offering circular, or other document, or any omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, and will (without limitation of the portions of this Section 5(b)) reimburse the Company, such directors, officers and controlling persons for any
legal or any other expenses reasonably incurred in connection with investigating or defending any such Loss, in each case to the extent, but only to the extent, that such untrue statement or omission is made in such Registration Statement,
Prospectus, Free Writing Prospectus, offering circular, or other document in reliance upon and in conformity with written information furnished to the Company by such Holder with respect to such Holder for inclusion in such Registration Statement,
Prospectus, offering circular or other document; provided, however, that the obligations of such Holder hereunder shall not apply to amounts paid in settlement of any such Losses (or actions in respect thereof) if such settlement is
effected without the consent of such Holder (which consent shall not be unreasonably withheld); and provided, further, that the liability of such Holder shall be individual, not joint and several, for each Holder and shall be limited
to the aggregate gross proceeds (net of any underwriting commissions and discounts, but before deducting other expenses) received by such selling Holder from the sale of Registrable Securities covered by such Registration Statement, Prospectus,
offering circular or other document containing such untrue statement (or alleged untrue statement) or omission (or alleged omission) (less the aggregate amount of any damages which such Holder has otherwise been required to pay in respect of such
Loss or any substantially similar Loss arising from the sale of such Registrable Securities). 
 (c) Conduct of Indemnification
Proceedings. If any Person shall be entitled to indemnification hereunder (an “Indemnified Party”), such Indemnified Party shall give prompt notice to the party from which such indemnity is sought (the “Indemnifying
Party”) of any claim or of the commencement of any proceeding with respect to which such Indemnified Party seeks indemnification or contribution pursuant hereto; provided, however, that the delay or failure to so notify the
Indemnifying Party shall not relieve the Indemnifying Party from any obligation or liability except to the extent that the Indemnifying Party has been materially prejudiced by such delay or failure. The Indemnifying Party shall have the right,
exercisable by giving written notice to an Indemnified Party promptly after the receipt of written notice from such Indemnified Party of such claim or proceeding, to, unless in the Indemnified Party’s reasonable judgment a conflict of interest
between such indemnified and indemnifying parties may exist in respect of such claim, assume, at the Indemnifying Party’s expense, the defense of any such claim or proceeding, with counsel reasonably satisfactory to such Indemnified Party;
provided, however, that an Indemnified Party shall have the right to employ separate counsel in any such claim or proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Party unless: (i) the Indemnifying Party agrees to pay such fees and expenses; or (ii) the Indemnifying Party fails promptly to assume, or in the event of a conflict of interest cannot assume, the defense of such claim
or proceeding or fails to employ counsel reasonably satisfactory to such Indemnified Party; in which case the Indemnified Party shall have the right to employ counsel and to assume the defense of such claim or proceeding at the Indemnifying
Party’s expense; provided, further, however, that the Indemnifying Party shall not, in connection with any one such claim or proceeding or separate 

  
 18 

 
but substantially similar or related claims or proceedings in the same jurisdiction, arising out of the same general allegations or circumstances, be liable for the fees and expenses of more than
one firm of attorneys (together with appropriate local counsel) at any time for all of the Indemnified Parties, or for fees and expenses that are not reasonable. Whether or not such defense is assumed by the Indemnifying Party, such Indemnifying
Party will not be subject to any liability for any settlement made without its consent (but such consent will not be unreasonably delayed or withheld). Without the prior written consent of the Indemnified Party, the Indemnifying Party shall not
consent to entry of any judgment or enter into any settlement that (x) does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release, in form and substance reasonably
satisfactory to the Indemnified Party, from all liability in respect of such claim or litigation for which such Indemnified Party would be entitled to indemnification hereunder or (y) involves the imposition of equitable remedies or the
imposition of any obligations on the Indemnified Party or adversely affects such Indemnified Party other than as a result of financial obligations for which such Indemnified Party would be entitled to indemnification hereunder. 

(d) Contribution. If the indemnification provided for in this Section 5 is unavailable to an Indemnified Party
in respect of any Losses (other than in accordance with its terms), then each applicable Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such
Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party, on the one hand, and such Indemnified Party, on the other hand, in connection with the actions, statements or omissions that resulted in such
Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party, on the one hand, and Indemnified Party, on the other hand, shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, has been made (or omitted) by, or relates to information supplied by, such Indemnifying Party or Indemnified
Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent any such action, statement or omission. 

The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were
determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this
Section 5(d), an Indemnifying Party that is a selling Holder shall not be required to contribute any amount in excess of the net proceeds to such Holder from the Registrable Securities sold pursuant to the Registration
Statement which gives rise to such obligation to contribute (less the aggregate amount of any damages which the Holder has otherwise been required to pay in respect of such Loss or any substantially similar Loss arising from the sale of such
Registrable Securities). No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. No
selling Holder shall be liable for contribution under this Section 5(d), except under such circumstances as such selling Holder would have been liable for indemnification under this Section 5 if
such indemnification were enforceable under applicable law. 

  
 19 

 Notwithstanding the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection with the underwritten offering are more favorable to the Holders than the foregoing provisions, the provisions in the underwriting agreement shall control. 

(e) Deemed Underwriter. To the extent that any of the Holders is, or would be expected to be, deemed to be an underwriter of Registrable
Securities pursuant to any SEC comments or policies or any court of law or otherwise, the Company agrees that (i) the indemnification and contribution provisions contained in this Section 5 shall be applicable to the
benefit of such Holder in its role as deemed underwriter in addition to its capacity as a Holder (so long as the amount for which any other Holder is or becomes responsible does not exceed the amount for which such Holder would be responsible if the
Holder were not deemed to be an underwriter of Registrable Securities) and (ii) such Holder and its representatives shall be entitled to conduct the due diligence which would normally be conducted in connection with an offering of securities
registered under the Securities Act, including receipt of customary opinions and comfort letters. 
 (f) Other Indemnification.
Indemnification similar to that specified in the preceding provisions of this Section 5 (with appropriate modifications) shall be given by the Company and each seller of Registrable Securities with respect to any required
registration or other qualification of securities under any federal or state law or regulation or governmental authority other than the Securities Act. 

(g) Non-Exclusivity. The obligations of the parties under this
Section 5 shall be in addition to any liability which any party may otherwise have to any other party. 
 6.
Registration Expenses. All reasonable fees and expenses incident to the performance of or compliance with this Agreement by the Company (including, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses (A) with respect to filings required to be made with the SEC, NYSE, FINRA or the National Association of Securities Dealers, Inc. and (B) of compliance with securities or Blue Sky laws, including, without limitation, any
fees and disbursements of counsel for the underwriters in connection with Blue Sky qualifications of the Registrable Securities pursuant to Section 4(h)), (ii) printing expenses (including, without limitation, expenses of
printing certificates for Registrable Securities in a form eligible for deposit with The Depository Trust Company and of printing Prospectuses if the printing of Prospectuses is requested by the managing underwriters, if any, the Demand Party or by
the Holders of a majority of the Registrable Securities included in any Registration Statement), (iii) messenger, telephone and delivery expenses of the Company, (iv) fees and disbursements of counsel for the Company, (v) expenses of the
Company incurred in connection with any road show, (vi) fees and disbursements of all independent certified public accountants referred to in Section 4(o) hereof (including, without limitation, the expenses of any
“cold comfort” letters required by this Agreement) and any other persons, including special experts retained by the Company and (vii) reasonable and documented fees and disbursements of one counsel for the Holders whose shares are
included in a Registration Statement (which counsel shall be selected as set forth in Section 8)) shall be borne by the Company whether or not any Registration Statement is filed or becomes effective. In addition, the
Company shall pay its internal expenses (including, without limitation, all salaries and expenses of its officers and 

  
 20 

 
employees performing legal or accounting duties), the expense of any annual audit, the fees and expenses incurred in connection with the listing of the securities to be registered on the NYSE or
such other national securities exchange on which the Common Stock is listed and rating agency fees and the fees and expenses of any Person, including special experts, retained by the Company. 

The Company shall not be required to pay (i) fees and disbursements of any counsel retained by any Holder or by any underwriter (except
as set forth in this Section 6 and in Section 8 or pursuant to the underwriting agreement entered into in connection with such offering), (ii) any underwriter’s fees (including discounts,
commissions or fees of underwriters, selling brokers, dealer managers or similar securities industry professionals) relating to the distribution of the Registrable Securities (other than with respect to Registrable Securities sold by the Company),
or (iii) any other expenses of the Holders not specifically required to be paid by the Company pursuant to the first paragraph of this Section 6. 

7. Rule 144. The Company covenants that it will use reasonable best efforts to file the reports required to be filed
by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the request of any Demand Party, make publicly available such
information so long as necessary to permit sales of Registrable Securities pursuant to Rule 144), and it will take such further action as any Holder (or, if the Company is not required to file reports as provided above, any Demand Party) may
reasonably request, all to the extent required from time to time to enable such Holder to sell shares of Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (i) Rule 144 under
the Securities Act, as such Rule may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder, the Company will deliver to such Holder a written statement as to whether it
has complied with such requirements and, if not, the specific requirements with which it did not so comply. Notwithstanding anything contained in this Section 7, the Company may deregister under Section 12 of the
Exchange Act if it then is permitted to do so pursuant to the Exchange Act and the rules and regulations thereunder. 
 8. Selection of
Counsel. In connection with any registration of Registrable Securities pursuant to Section 2 or 3 hereof, if any Investor is participating in such registration pursuant to Section 2 or
3 hereof, the participating Investors holding a majority of the Registrable Securities covered by such registration may select one counsel to represent them and all other Holders participating in such registration, and if none of the
Investors is participating in such registration pursuant to Section 2 or 3 hereof, the Holders of a majority of the Registrable Securities covered by any such registration may select one counsel to represent such
Holders covered by such registration; provided, however, that in the event that the counsel selected as provided above is also acting as counsel to the Company in connection with such registration, the Holders shall be entitled to
select one additional counsel at the Company’s expense to represent all Holders. 

  
 21 

 9. Miscellaneous. 

(a) Holdback Agreement. In consideration for the Company agreeing to its obligations under this Agreement, each Holder agrees in
connection with any underwritten offering of the Company’s securities with respect to which the Company has complied with its obligations under Section 2 or Section 3 hereof, as applicable
(whether or not such Holder is participating in such offering) upon the request of the underwriters managing any such underwritten offering, not to effect (other than pursuant to such offering) any public sale or distribution of Registrable
Securities, including, but not limited to, any sale pursuant to Rule 144, or make any short sale of, grant any option for the purchase of, or otherwise dispose of any Registrable Securities, any other equity securities of the Company or any
securities convertible into or exchangeable or exercisable for any equity securities of the Company, in each case without the prior written consent of such underwriters and subject to customary exceptions, during the Holdback Period; provided
that nothing herein will prevent (i) any Holder that is a partnership or corporation from making a transfer to an Affiliate that is otherwise in compliance with applicable securities laws, (ii) any pledge of Registrable Securities by a
Holder in connection with a Permitted Loan (as defined in the Investment Agreement) or (iii) any foreclosure in connection with a Permitted Loan (as defined in the Investment Agreement) or transfer in lieu of a foreclosure thereunder, in each
case that is otherwise in compliance with applicable securities laws. Notwithstanding the foregoing, any discretionary waiver or termination of this holdback provision by such underwriters with respect to any of the Holders shall apply to the other
Holders as well, pro rata based upon the number of shares subject to such obligations. 
 If any registration pursuant to
Section 3 of this Agreement shall be in connection with any underwritten public offering, if requested by the managing underwriter or underwriters, the Company will not effect any public sale or distribution of any common
equity (or securities convertible into or exchangeable or exercisable for common equity) (other than a registration statement (i) on Form S-4, Form S-8 or
any successor forms thereto or (ii) filed solely in connection with an exchange offer or any employee benefit or dividend reinvestment plan) for its own account, during the Holdback Period. 

(b) Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or
supplemented, and waivers or consents to departures from the provisions hereof may not be given without the written consent of each of the Company and the Holders of a majority of the Registrable Securities; provided, however, that
(x) any amendment, modification, supplement, waiver or consent to departures from the provisions of this Agreement that would subject a Stockholder to adverse differential treatment relative to the other Stockholders shall require the agreement
of the differentially treated Stockholder and (y) any amendment, modification, supplement, waiver or consent to departures from the provisions of this Agreement that would be adverse to a right specifically granted to a specific Stockholder
herein (but not to other Stockholders) shall require the agreement of that Stockholder. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of
Holders whose securities are being sold pursuant to a Registration Statement and that does not directly or indirectly affect the rights of other Holders may be given by Holders of at least a majority of the Registrable Securities being sold by such
Holders pursuant to such Registration Statement. 

  
 22 

 (c) Successors, Assigns and Transferees. This Agreement shall be binding upon and
shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. The provisions of this Agreement which are for the benefit of the parties hereto other than the Company may be transferred or assigned to any
Person in connection with a Transfer (as defined in the Investment Agreement) of Series A Preferred Stock or Common Stock issued upon conversion of the Series A Preferred Stock to such Person in a Transfer permitted by
Section 5.08(b)(i) of the Investment Agreement or to any lender under a Permitted Loan (as defined in the Investment Agreement) in connection with a Transfer permitted by Section 5.08(b)(vi) of the
Investment Agreement; provided, however, that (i) prior written notice of such assignment of rights is given to the Company and (ii) such transferee agrees in writing to be bound by, and subject to, this Agreement as a
“Holder” pursuant to a written instrument in form and substance reasonably acceptable to the Company; provided further that if such transferee is a Permitted Investor Transferee under the Investment Agreement, such transferee shall also
agree in such writing to be bound by, and subject to, this Agreement as a “Investor”. Except as provided in Section 5 with respect to an Indemnified Party, nothing expressed or mentioned in this Agreement is
intended or shall be construed to give any Person other than the parties hereto and their respective successors and permitted assigns any legal or equitable right, remedy or claim under, or in respect of this Agreement or any provision herein
contained. 
 (d) Notices. All notices, requests and other communications to any party hereunder shall be in writing and shall be
deemed given if delivered personally, emailed (which is confirmed) or sent by overnight courier (providing proof of delivery) to the parties at the following addresses: 

if to the Company, to: 
 Box,
Inc. 
 900 Jefferson Ave. 

Redwood City, California 94063 

Attention:      David Leeb 

Email:            dleeb@box.com 

  
 23 

 with a copy (which shall not constitute notice) to: 

Wilson Sonsini Goodrich & Rosati, P.C. 

650 Page Mill Road 
 Palo Alto,
CA 94304 
 Attn:     Jose Macias 

    Martin Korman 

    Erik Franks 

Email:   jmacias@wsgr.comm 

    korman@wsgr.com 

    efranks@wsgr.com 

with a copy (which shall not constitute notice) to: 

Wilson Sonsini Goodrich & Rosati, P.C. 

One Market Plaza, Spear Tower, Suite 3300 

San Francisco, CA 94105 

Attention:   Rich Mullen 

Email:         rich.mullen@wsgr.com 

if to the Stockholders or to any Investor, to: 

KKR Credit Advisors (US) LLC 

555 California Street, 50th Floor 

San Francisco, CA 94104 
 Email:
  creditmiddleoffice@kkr.com 
     kkrcreditlegal@kkr.com 

with a copy (which shall not constitute notice) to: 

Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 
 New York,
NY 10017 
 Attention:   Marni J. Lerner 

          Ravi Purushotham 

Email:         mlerner@stblaw.com 

          rpurushotham@stblaw.com 

or such other address or email address as such party may hereafter specify by like notice to the other parties hereto, or as set forth in any written joinder
agreement contemplated by Section 9(c). All such notices, requests and other communications shall be deemed received on the date of actual receipt by the recipient thereof if received prior to 5:00 p.m. local time in the place of receipt
and such day is a business day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding business day in the place of receipt. 

  
 24 

 (e) Descriptive Headings. The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning of terms contained herein. 
 (f) Severability. If any term,
condition or other provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of law or public policy, all other terms, provisions and conditions of this Agreement
shall nevertheless remain in full force and effect. Upon such determination that any term, condition or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so
as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable law. 
 (g)
Counterparts. This Agreement may be executed in one or more counterparts (including by facsimile or electronic mail), each of which shall be deemed to be an original but all of which taken together shall constitute one and the same agreement,
and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties hereto. 

(h) Governing Law; Submission to Jurisdiction. (i) This Agreement and all matters, claims or Actions (whether at law, in equity, in
Contract, in tort or otherwise) based upon, arising out of or relating to this Agreement or the negotiation, execution or performance of this Agreement (collectively, the “Relevant Matters”), shall be governed by, and construed in
accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under any applicable conflict of Laws principles. 

All Actions arising out of or relating to any Relevant Matter shall be heard and determined in the Chancery Court of the State of Delaware
(or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over any Action, any state or federal court within the State of Delaware) and the parties hereto hereby irrevocably submit to the exclusive jurisdiction and venue of
such courts in any such Action and irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such Action. The consents to jurisdiction and venue set forth in this Section 9(h)
shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this Section 9(h) and shall not be deemed to confer rights on any Person
other than the parties hereto. Each party hereto agrees that service of process upon such party in any Action arising out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in
Section 9(d) of this Agreement. The parties hereto and the Parties hereby waive any right to stay or dismiss any action or proceeding in connection with any Relevant Matter brought before the foregoing courts on the basis
of (i) any claim that it is not personally subject to the jurisdiction of the above-named courts for any reason or that it or any of its property is immune from the above-described legal process, (ii) that such action or proceeding is
brought in an inconvenient forum, that venue for the action or proceeding is improper or that this Agreement may not be enforced in or by such courts, or (iii) any other defense that would hinder or delay the levy, execution or collection of
any amount to which any Party hereto is entitled pursuant to any final judgment of any court having jurisdiction. The parties hereto agree that a final judgment in any such Action shall be conclusive and may be enforced in other jurisdictions by
suit on the judgment or in any other manner provided by applicable Law; provided that nothing in the foregoing shall restrict any party’s rights to seek any post-judgment relief regarding, or any appeal from, a final trial court
judgment. 

  
 25 

 (i) Specific Performance. Each party hereto acknowledges that money damages would not
be an adequate remedy in the event that any of the covenants or agreements in this Agreement are not performed in accordance with its terms, and it is therefore agreed that in addition to and without limiting any other remedy or right it may have,
the non-breaching party will have the right to an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach and enforcing specifically
the terms and provisions hereof. 
 (j) Further Assurances. At any time or from time to time after the date hereof, the parties agree
to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably request in order to evidence or effectuate the
consummation of the transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder. 
 (k)
Termination. The provisions of this Agreement (other than Section 5 and Section 6) shall terminate upon the earliest to occur of (i) its termination by the written agreement of all
parties hereto or their respective successors in interest, (ii) the date on which all shares of Common Stock and Series A Preferred Stock have ceased to be Registrable Securities, (iii) the dissolution, liquidation or winding up of the
Company, and (iv) concurrently with the consummation of a Change of Control (as defined in the Certificate of Designations). Nothing herein shall relieve any party from any liability for the breach of any of the agreements set forth in this
Agreement. 
 (l) No Inconsistent Agreements; Most Favored Nations. The Company shall not hereafter enter into any agreement with
respect to its securities that is inconsistent with or violates the rights granted to the Holders in this Agreement. In the event that the Company desires to enter into any agreement with any Person, including any holder or prospective holder of any
securities of the Company, giving or granting any registration (or related) rights the terms of which are more favorable than or senior to the registration or other rights granted to the Holders hereunder, then (i) the Company shall provide
prior written notice thereof to the Holders and (ii) upon execution by the Company of such other agreement, the terms and conditions of this Agreement shall be, without any further action by the Holders or the Company, automatically amended and
modified in an economically and legally equivalent manner such that the Holders shall receive the benefit of the more favorable terms and/or conditions (as the case may be) set forth in such other agreement, provided that upon written notice
to the Company at any time, any Holder may elect not to accept the benefit of any such amended or modified term or condition, in which event the term or condition contained in this Agreement shall apply to such Holder as it was in effect immediately
prior to such amendment or modification as if such amendment or modification never occurred with respect to such Holder. 
  

  
 26 

 IN WITNESS WHEREOF, each of the undersigned has executed this Agreement or caused this
Agreement to be duly executed on its behalf as of the date first written above. 
  

					
	BOX, INC.
		
	By:	 	  

		 	Name:	 	[●]
		 	Title:	 	[●]

 [Signature Page to Registration Rights Agreement] 

 
					
	POWELL INVESTORS III L.P.
		
	By:	 	  

		 	Name:	 	[●]
		 	Title:	 	[●]
	
	KKR-MILTON CREDIT HOLDINGS L.P.
		
	By:	 	  

		 	Name:	 	[●]
		 	Title:	 	[●]
	
	KKR-NYC CREDIT C L.P.
		
	By:	 	  

		 	Name:	 	[●]
		 	Title:	 	[●]
	
	TAILORED OPPORTUNISTIC CREDIT FUND
		
	By:	 	  

		 	Name:	 	[●]
		 	Title:	 	[●]
	
	CPS HOLDINGS (US) L.P.
		
	By:	 	  

		 	Name:	 	[●]
		 	Title:	 	[●]

 [Signature Page to Registration Rights Agreement] 

 EXHIBIT C 

FORM OF JOINDER AGREEMENT 

This JOINDER AGREEMENT (this “Joinder”) is entered into as of [•], 2021 by and among [•] (the “Joining
Party”), Box, Inc. (the “Company”) and Powell Investors III L.P., KKR-Milton Credit Holdings L.P., KKR-NYC Credit C L.P., Tailored
Opportunistic Credit Fund and CPS Holdings (US) L.P., which are managed or advised by KKR Credit Advisors (US) LLC or Affiliates thereto (collectively, the “Investor”). 

Reference is hereby made to (a) the Investment Agreement, dated April 7, 2021 (as it may be amended, restated, supplemented or
otherwise modified from time to time, the “Investment Agreement”), by and among the Company and the Investor, (b) the Registration Rights Agreement, dated [•], 2021 (as it may be amended, restated, supplemented or
otherwise modified from time to time, the “Registration Rights Agreement”), by and among the Company and the Investor, and (c) the Back-to-Back
Fund Commitment letter agreement, dated April 7, 2021 (as it may be amended, restated, supplemented or otherwise modified from time to time, the “Assignment Agreement”), by and among the Investor, the Joining Party and the
other parties thereto. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Investment Agreement. 

Each party to this Joinder hereby agrees that: 
  

	1.	 Pursuant to Sections 5.08 and 8.03 of the Investment Agreement, upon the execution of this Joinder, the Joinder
will be fully enforceable and the Joining Party shall become a party to the Investment Agreement as a “party”, “Permitted Investor Transferee”, and “Investor Party” thereunder and be fully bound by, and subject to, all
covenants, terms, conditions, obligations and provisions of the Investment Agreement applicable to a “party”, “Permitted Investor Transferee”, or an “Investor Party”, and shall be fully entitled to all rights and
interests under the Investment Agreement applicable to a “party”, “Permitted Investor Transferee” or an “Investor Party”, in each case except as otherwise set forth herein. 

 

	2.	 Pursuant to Section 9(c) of the Registration Rights Agreement and upon the execution of this Joinder, the
Joinder will be fully enforceable and the Joining Party shall be a party to the Registration Rights Agreement as a “party” and an “Investor” thereunder and be fully bound by, and subject to, all covenants, terms, conditions,
obligations and provisions of the Registration Rights Agreement applicable to a “party” or an “Investor”, and be fully entitled to all rights and interests under the Registration Rights Agreement applicable to a “party”
or an “Investor”. 

  

	3.	 Pursuant to the Investment Agreement and the Assignment Agreement and subject to the conditions and terms set
forth herein and therein, the Joining Party hereby has the right to purchase and acquire from the Company, at the Closing, the number of shares of Series A Preferred Stock set forth in Exhibit A hereto under the heading “Acquired
Shares” and has the obligation to pay, at the Closing, the portion of the Purchase Price set forth in Exhibit A hereto under the heading “Purchase Price”. 

	4.	 The Company hereby acknowledges and accepts the foregoing, and represents and warrants that the Investment
Agreement set forth in Exhibit B hereto is a true and correct copy of the Investment Agreement, the form of the Registration Rights Agreement set forth in Exhibit C hereto is a true and correct copy of the form of the Registration
Rights Agreement and the form of the Series A Certificate of Designations set forth in Exhibit D hereto is a true and correct copy of the form of the Certificate of Designations. 

 

	5.	 The Company hereby makes to the Joining Party the representatives and warranties expressly set forth in
Article III of the Investment Agreement in each case as if such representations and warranties were made as of the date of the signing of the Investment Agreement and as of the Closing Date (except to the extent any such representation and
warranty is expressly made as of an earlier date, in which case as of such earlier date). 

  

	6.	 Further, the Joining Party hereby makes to the Company, as if such Joining Party were an Investor under the
Investment Agreement, the representations and warranties expressly set forth in Article IV of the Investment Agreement, in each case as if such representations and warranties were made as of the date of this Joinder and as of the Closing Date
(except to the extent any such representation and warranty is expressly made as of the date of the signing of the Investment Agreement, in which case as of the date of this Joinder). 

 

	7.	 The Joining Party represents and warrants to the Company that on or prior to the date that is ten
(10) Business Days after the date of the Investment Agreement, the Joining Party and its ultimate parent entities made an appropriate filing of a HSR Form pursuant to the HSR Act if a filing under the HSR Act was required for such Joining Party
or its ultimate parent entities with respect to the Transactions. 

  

	8.	 Notwithstanding anything to the contrary in this Joinder or the Investment Agreement: 

 

	 	a.	 The obligations of the Joining Party and its Affiliates and the other Investor Parties and their Affiliates
under the Investment Agreement and the Registration Rights Agreement shall be several and not joint. 

  

	 	b.	 The only confidentiality obligations of the Joining Party and its Affiliates with respect to Confidential
Information shall be set forth in the last sentence of Section 5.05 of the Investment Agreement, which provides that any Confidential Information that any Permitted Investor Transferee (or its Affiliates) received prior to Closing shall be
subject to the confidentiality restrictions (and exceptions) set forth in Section 5.05 of the Investment Agreement, mutatis mutandis, for a period of 12 months from the Closing Date, and that otherwise the provisions of Section 5.05
of the Investment Agreement shall not apply to any Permitted Investor Transferee (or its Permitted Transferees and Affiliates). Notwithstanding the foregoing, from and after the Closing, the Joining Party (and its Affiliates) are entitled to
disclose the information permitted to be disclosed pursuant to the last sentence of Section 5.04 of the Investment Agreement; 

  

	 	c.	 The Joining Party shall not be bound by, or subject to, any covenants, terms, conditions, obligations or
provisions of, or be entitled to any rights or interests under, Section 5.10 of the Investment Agreement, which shall solely be applicable to the Investor; 

	 	d.	 For purposes of Section 5.18 (Preemptive Rights) of the Investment Agreement, as it applies to the Joining
Party as an “Investor Party” under such sections, the “50% Beneficial Ownership Requirement” shall be deemed satisfied so long as the Joining Party, together with its Permitted Transferees, beneficially own shares of Series A
Preferred Stock and/or shares of Common Stock that represent, in the aggregate and on an as converted basis, at least 50% of the number of shares of Common Stock beneficially owned by the Joining Party and any such Permitted Transferees, on an as
converted basis, as of immediately following the Closing; 

  

	 	e.	 The Joining Party and its Permitted Transferees shall be solely responsible for their compliance with the
obligations under the Investment Agreement and Registration Rights Agreement as set forth in this Joinder. 

  

	 	f.	 The Joining Party, its Permitted Transferees and their respective Affiliates and Representatives shall not have
any liability or obligation of any sort whatsoever for any actions or omissions of the Investor, any other Permitted Investor Transferees and their respective Affiliates and Representatives taken (or not taken) in connection with the Investment
Agreement or the Registration Rights Agreement and any of the transactions contemplated thereby. 

  

	 	g.	 The Company acknowledge and agree that none of the Investor or its Affiliates, or any other Permitted Investor
Transferees or their Affiliates, shall have any liability or obligation of any sort whatsoever for any actions or omissions of the Joining Party, its Permitted Transferees and their respective Affiliates and Representatives taken (or not taken) in
connection with the Investment Agreement or the Registration Rights Agreement and any of the transactions contemplated thereby. 

  

	 	h.	 The “Pro Rata Share” shall mean, with respect to each of the Investor and the Joining Party, the
percentage set forth opposite such Person’s name on Annex I hereto under the heading “Pro Rata Share”. 

  

	9.	 For the avoidance of doubt, Section 5.07(a) of the Investment Agreement shall apply to the Joining Party
and the other Investor Parties severally and not jointly, and the Joining Party and its Affiliates are permitted to collectively acquire up to 1% of the then outstanding Common Stock (excluding any shares of Series A Preferred Stock or Common Stock
issued in connection with the Conversion of the Series A Preferred Stock) and up to 10% of any tranche of any debt securities of the Company. 

  

	10.	 All notices, requests and other communications to the Joining Party under the Investment Agreement or the
Registration Rights Agreement shall be deemed given if delivered personally, emailed (which is confirmed) or sent by overnight courier (providing proof of delivery), in each case, in accordance with and subject to Sections 8.09 of the Investment
Agreement or Section 9(d) of the Registration Rights Agreement, as applicable, to the Joining Party at the address set forth in Exhibit A hereto under the heading “Notice Address” or such other address or email address as the
Joining Party may hereafter specify by like notice to the other parties to the Investment Agreement and the Registration Rights Agreement. 

  

	11.	 This Joinder and all matters, claims or Actions (whether at law, in equity, in Contract, in tort or otherwise)
based upon, arising out of or relating to this Joinder or the negotiation, execution or performance of this Joinder (collectively, the “Relevant Matters”), shall be governed by, and construed in accordance with, the laws of the
State of Delaware, regardless of the laws that might otherwise govern under any applicable conflict of Laws principles. 

	12.	 All Actions arising out of or relating to any Relevant Matter shall be heard and determined in the Chancery
Court of the State of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over any Action, any state or federal court within the State of Delaware) and the parties hereto hereby irrevocably submit to the
exclusive jurisdiction and venue of such courts in any such Action and irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such Action. The consents to jurisdiction and venue set forth in this
Section 8.06 shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this Section 12 and shall not be
deemed to confer rights on any Person other than the parties hereto. Each party hereto agrees that service of process upon such party in any Action arising out of or relating to this Joinder shall be effective if notice is given by overnight courier
at the address set forth in Exhibit A hereto under the heading “Notice Address”. The parties hereto hereby waive any right to stay or dismiss any action or proceeding in connection with any Relevant Matter brought before the
foregoing courts on the basis of (i) any claim that it is not personally subject to the jurisdiction of the above-named courts for any reason or that it or any of its property is immune from the above-described legal process, (ii) that
such action or proceeding is brought in an inconvenient forum, that venue for the action or proceeding is improper or that this Joinder may not be enforced in or by such courts, or (iii) any other defense that would hinder or delay the levy,
execution or collection of any amount to which any Party hereto is entitled pursuant to any final judgment of any court having jurisdiction. The parties hereto agree that a final judgment in any such Action shall be conclusive and may be enforced in
other jurisdictions by suit on the judgment or in any other manner provided by applicable Law; provided that nothing in the foregoing shall restrict any party’s rights to seek any post-judgment relief regarding, or any appeal from, a
final trial court judgment. 

 [Signature page follows] 

 IN WITNESS WHEREOF, each of the undersigned has executed this Joinder or caused this Joinder
to be duly executed on its behalf as of the date first written above. 
  

			
	[PERMITTED INVESTOR TRANSFEREE]
		
	By:	 	  

		 	Name:
		 	Title:

			
	BOX, INC.
		
	By:	 	  

		 	Name:
		 	Title:
	
	POWELL INVESTORS III L.P.
		
	By:	 	  

		 	Name:
		 	Title:
	
	KKR-MILTON CREDIT HOLDINGS L.P.
		
	By:	 	  

		 	Name:
		 	Title:
	
	KKR-NYC CREDIT C L.P.
		
	By:	 	  

		 	Name:
		 	Title:
	
	TAILORED OPPORTUNISTIC CREDIT FUND
		
	By:	 	  

		 	Name:
		 	Title:

			
	CPS HOLDINGS (US) L.P.
		
	By:	 	  

		 	Name:
		 	Title:

 ANNEX I 

 

							
	 Investor Party
	  	 Purchase Price
	  	 Acquired Shares
	  	 Pro Rata
Share

	 [•]
	  	[•]	  	[•]	  	[•]
	 [•]
	  	[•]	  	[•]	  	[•]
	 [•]
	  	[•]	  	[•]	  	[•]
	 [•]
	  	[•]	  	[•]	  	[•]
	 [•]
	  	[•]	  	[•]	  	[•]
	 [•]
	  	[•]	  	[•]	  	[•]
	 [•]
	  	[•]	  	[•]	  	[•]
	 [•]
	  	[•]	  	[•]	  	[•]
	 [•]
	  	[•]	  	[•]	  	[•]
		  	  
	  	  
	  	  

	 Total
	  	[•]	  	[•]	  	[•]
		  	  
	  	  
	  	  

 EXHIBIT A 

 

					
	 Notice Address
	  	 Acquired Shares
	  	 Purchase Price

	 [•]
	  	 [•]
	  	 $[•]

 EXHIBIT B 

[Investment Agreement to be provided separately] 

 EXHIBIT C 

[Registration Rights Agreement to be provided separately] 

 EXHIBIT D 

Box, Inc. 
 [•] 

Attention: [•] 
 This Joinder (this
“Joinder”) is entered into as of [•], 2021 by [•] (the “Joining Party”). 
 Reference is hereby
made to (a) the Investment Agreement, dated April 7, 2021 (as it may be amended, restated, supplemented or otherwise modified from time to time, the “Investment Agreement”), by and among Box, Inc. (the
“Company”) and Powell Investors III L.P., KKR-Milton Credit Holdings L.P., KKR-NYC Credit C L.P., Tailored Opportunistic Credit Fund and CPS Holdings
(US) L.P., each of which are managed or advised by KKR Credit Advisors (US) LLC or Affiliates thereof (collectively, the “Investor”), and (b) the Registration Rights Agreement, dated [•], 2021 (as it may be amended,
restated, supplemented or otherwise modified from time to time, the “Registration Rights Agreement”), by and among the Company and the Investor. Capitalized terms used but not defined herein shall have the meanings ascribed to such
terms in the Investment Agreement. 
 Pursuant to Sections 5.08 and 8.03 of the Investment Agreement, upon the execution of this Joinder,
the Joinder will be fully enforceable and the Joining Party shall become a party to the Investment Agreement as a “party” and an “Investor Party” of the Investor of which the Joining Party is a Permitted Transferee thereunder and
be fully bound by, and subject to, all covenants, terms, conditions, obligations and provisions of the Investment Agreement applicable to such “party” and Investor Party, and shall be fully entitled to all rights and interests under the
Investment Agreement applicable to such a “party” and “Investor Party”. 
 Pursuant to Section 9(c) of the
Registration Rights Agreement and upon the execution of this Joinder, the Joinder will be fully enforceable and the Joining Party shall be a party to the Registration Rights Agreement as a “party” and an “Investor” thereunder and
be fully bound by, and subject to, all covenants, terms, conditions, obligations and provisions of the Registration Rights Agreement applicable to a “party” and an “Investor”, and be fully entitled to all rights and interests
under the Registration Rights Agreement applicable to a “party” and an “Investor”. 
 All notices, requests and other
communications to the Joining Party under the Investment Agreement or the Registration Rights Agreement shall be deemed given if delivered personally, emailed (which is confirmed) or sent by overnight courier (providing proof of delivery), in each
case, in accordance with and subject to Sections 8.09 of the Investment Agreement or Section 9(d) of the Registration Rights Agreement, as applicable, to the Joining Party at the address set forth in in the signature page hereto or such other
address or email address as the Joining Party may hereafter specify by like notice to the other parties to the Investment Agreement and the Registration Rights Agreement 

[Signature page follows] 

 
					
	Joining Party

 
					
			
	[•]	 		 	

 
					
		
	By:	 	  

					
		 	  Name:	 	
		 	  Title:	 	
	
	Address:
			
	[•]	 		 	

 
					
	Attention:	 		 	[•]
	Email:	 		 	[•]Exhibit 10.1

 

Confidential

 

FORM OF SUBSCRIPTION AGREEMENT

 

Rice Acquisition Corp.

102 East Main Street, Second Story

Carnegie, Pennsylvania 15106

 

Ladies and Gentlemen:

 

This Subscription Agreement
(this “Subscription Agreement”) is being entered into as of the date set forth on the signature page hereto, by and
between Rice Acquisition Corp., a Delaware corporation (“RAC”), and the undersigned subscriber (the “Investor”),
in connection with (i) the Business Combination Agreement, dated as of the date hereof (as may be amended, supplemented or otherwise modified
from time to time, the “Aria Merger Agreement”), by and among RAC, Rice Acquisition Holdings LLC, a Delaware limited
liability company and direct subsidiary of RAC (“RAC OpCo”), LFG Intermediate Co, LLC, a Delaware limited liability
company and direct subsidiary of RAC OpCo (“RAC Intermediate”), LFG Buyer Co, LLC, a Delaware limited liability company
and a direct subsidiary of RAC Intermediate (“RAC Buyer”), Inigo Merger Sub, LLC, a Delaware limited liability company
and a direct subsidiary of RAC Buyer (“Aria Merger Sub”), Aria Energy LLC, a Delaware limited liability company (“Aria”),
and the Equityholder Representative (as defined therein), pursuant to which, among other things, Aria Merger Sub will merge with and into
Aria, with Aria surviving the merger and becoming a direct subsidiary of RAC Buyer, and (ii) the Business Combination Agreement, dated
as of the date hereof (as may be amended, supplemented or otherwise modified from time to time, the “Archaea Merger Agreement”
and, together with the Aria Merger Agreement, the “Transaction Agreements”), by and among RAC, RAC OpCo, RAC Intermediate,
RAC Buyer, Fezzik Merger Sub, LLC, a Delaware limited liability company and direct subsidiary of RAC Buyer (“Archaea Merger Sub”),
Archaea Energy LLC, a Delaware limited liability company (“Archaea”), and Archaea Energy II LLC, a Delaware limited
liability company (“Archaea II”), pursuant to which, among other things, Archaea Merger Sub will merge with and into
Archaea II, with Archaea II surviving the merger and becoming a direct subsidiary of RAC Buyer, in each case, on the terms and subject
to the conditions therein (the transactions contemplated by the Transaction Agreements, the “Transactions”).

 

In connection with the Transactions,
RAC is seeking commitments from interested investors to purchase, contingent upon and substantially concurrently with the closing of the
Transactions, shares of Class A Common Stock, par value $0.0001 per share (the “Shares”),
of RAC, in a private placement for a purchase price of $10.00 per share (the “Per Share
Purchase Price”). On or about the date of this Subscription Agreement, RAC is entering
into subscription agreements substantially in the same form as this Subscription Agreement (the “Other Subscription Agreements”
and, together with this Subscription Agreement, the “Subscription Agreements”) with certain other investors (the “Other
Investors” and, together with the Investor, the “Investors”), pursuant to which the Investors have agreed
to purchase severally and not jointly on the closing date of the Transactions, inclusive of the Shares subscribed for by the Investor,
an aggregate amount of up to 30 million Shares, at the Per Share Purchase Price. The aggregate purchase price to be paid by the
Investor for the subscribed Shares is set forth on the signature page hereto and is referred to herein as the “Subscription Amount.”
The transactions contemplated by this Subscription Agreement and the Other Subscription Agreement are referred to collectively as the
“Investment Transactions.”

 

In connection therewith, and
in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth herein,
and intending to be legally bound hereby, the Investor and RAC acknowledge and agree as follows:

 

1. Subscription. The
Investor hereby irrevocably subscribes for and agrees to purchase from RAC the number of Shares set forth on the signature page of this
Subscription Agreement on the terms and subject to the conditions provided for herein. The Investor acknowledges and agrees that RAC
reserves the right to accept or reject the Investor’s subscription for the Shares for any reason or for no reason, in whole or
in part, at any time prior to its acceptance, and the same shall be deemed to be accepted by RAC only when this Subscription Agreement
is signed by a duly authorized person by or on behalf of RAC.

 

     

     

    

 

2. Closing. The closing
of the sale of the Shares contemplated hereby (the “Closing”) is contingent
upon the substantially concurrent consummation of the Transactions. The Closing shall occur on the date of, substantially concurrently
with and conditioned upon the effectiveness of, the consummation of the Transactions. Upon (a) satisfaction or waiver of the conditions
set forth in Section 4 and (b) delivery of written notice from (or on behalf of) RAC to the Investor (the “Closing
Notice”) that RAC reasonably expects the closing of the Transactions to occur on a specified date that is not less than
five business days after the date on which the Closing Notice is delivered to the Investor, the Investor shall deliver to RAC (i) at
least one full business day prior to the closing date specified in the Closing Notice (the “Closing
Date”), the Subscription Amount by wire transfer of United States dollars in immediately available funds to the account
specified by RAC in the Closing Notice, to be held in escrow until the Closing and (ii) at least three business days prior to the Closing
Date, any other information that is reasonably requested in the Closing Notice in order for RAC to issue the Investor the Shares to be
acquired hereunder, including, without limitation, the legal name of the person in whose name such Shares are to be issued and a duly
executed Internal Revenue Service Form W-9 or W-8, as applicable. On the Closing Date, RAC shall issue the number of Shares set forth
on the signature page of this Subscription Agreement to the Investor and subsequently cause such Shares to be registered in book entry
form in the name of the Investor on RAC’s share register (provided, however, that RAC’s obligation to issue
such Shares to the Investor is contingent upon RAC having received the Subscription Amount in full accordance with this Section 2),
and the Subscription Amount shall be released from escrow automatically and without further action by RAC or the Investor. In the event
that the consummation of the Transactions does not occur on or prior to the third business day after the anticipated Closing Date specified
in the Closing Notice, unless otherwise agreed to in writing by RAC and the Investor, RAC shall return on the next business day (or such
later date as shall be agreed in writing by the Investor) the funds so delivered by the Investor to RAC by wire transfer in immediately
available funds to the account specified by the Investor. Notwithstanding such return or cancellation, (x) a failure to close on the
anticipated Closing Date shall not, by itself, be deemed to be a failure of any of the conditions to Closing set forth in Section
4 to be satisfied or waived on or prior to the Closing Date, and (y) unless and until this Subscription Agreement is terminated in
accordance with Section 9, each of the Investor and RAC will continue to be bound by this Subscription Agreement, including that
the Investor shall remain obligated (A) to redeliver funds to RAC in escrow following RAC’s delivery to the Investor of a new Closing
Notice in accordance with this Section 2 and (B) to consummate the Closing upon satisfaction of the conditions set forth in Section
4. For purposes of this Subscription Agreement, “business day” shall mean any day other than (1) any Saturday or Sunday
or (2) any other day on which commercial banks located in New York, New York are required or authorized by applicable law to be closed
for business other than Lincoln’s Birthday (February 12) and Election Day.

 

 

3. Separate
Agreements. It is expressly understood and agreed that each provision contained in this Subscription Agreement is between RAC and
Investor, solely, and not between RAC and the Other Investors, collectively, and not between and among the Investors. Nothing contained
herein, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association,
a joint venture or any other kind of group or entity, or create a presumption that the Investors are in any way acting in concert or as
a group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
with respect to such obligations or the transactions contemplated by this Agreement. Each Investor shall be entitled to independently
protect and enforce its rights, including without limitation, the rights arising out of this Subscription Agreement, and it shall not
be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose.

 

4. Closing Conditions.

 

a. The
obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is subject
to the following conditions:

 

(i) no
applicable governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or regulation
(whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the Investment Transactions
illegal or otherwise restraining or prohibiting consummation of the Investment Transactions; and

 

(ii) all
conditions precedent to the closing of the Transactions under the Transaction Agreements shall have been satisfied (as determined by the
parties to the Transaction Agreements) or waived (other than those conditions which, by their nature, are to be satisfied at the closing
of the Transactions, including to the extent that any such condition is dependent upon the consummation of the purchase and sale of the
Shares pursuant to this Subscription Agreement), and the closing of the Transactions shall be scheduled to occur substantially concurrently
with or immediately following the Closing.

 

    2

     

    

 

b. The
obligation of RAC to consummate the issuance and sale of the Shares pursuant to this Subscription Agreement shall be subject to the satisfaction
or waiver by RAC of the additional conditions that:

 

(i) all
representations and warranties of the Investor contained in this Subscription Agreement are true and correct in all material respects
at and as of the Closing Date, and consummation of the Closing shall constitute a reaffirmation by the Investor of each of the representations,
warranties, covenants and agreements of the Investor contained in this Subscription Agreement as of the Closing Date; and

 

(ii) the
Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing.

 

c. The
obligation of the Investor to consummate the purchase of the Shares pursuant to this Subscription Agreement shall be subject to the satisfaction
or waiver by the Investor of the additional conditions that:

 

(i) all
representations and warranties of RAC contained in this Subscription Agreement shall be true and correct in all material respects (other
than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined below), which representations
and warranties shall be true and correct in all respects) at and as of the Closing Date, and consummation of the Closing shall constitute
a reaffirmation by RAC of each of the representations, warranties, covenants and agreements of RAC contained in this Subscription Agreement
as of the Closing Date;

 

(ii) RAC
shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription
Agreement to be performed, satisfied or complied with by it at or prior to the Closing; and

 

(iii) no
suspension of the qualification of the Shares for offering or sale or trading in any applicable jurisdiction, or initiation or threatening
of any proceedings for any such purposes, shall have occurred.

 

5. Further Assurances.
At or prior to the Closing, RAC and the Investor shall execute and deliver, or cause to be executed and delivered, such additional documents
and take such additional actions as the parties, acting reasonably, may deem to be practical and necessary in order to consummate the
subscription as contemplated by this Subscription Agreement.

 

6. RAC Representations
and Warranties. RAC represents and warrants to the Investor that:

 

a. RAC
has been duly incorporated as a Delaware corporation and is validly existing and in good
standing under the laws of the State of Delaware, with corporate power and authority to own, lease and operate its properties and conduct
its business as presently conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.

 

b. As
of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor in
accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable and will not
have been issued in violation of or subject to any preemptive or similar rights created under RAC’s certificate of incorporation
and bylaws (as amended on the Closing Date) or under the Delaware General Corporation Law.

 

    3

     

    

 

c. Immediately
after giving effect to the Closing, the Investor shall have received all right and title to, and interests in, the Shares to be purchased
pursuant to this Subscription Agreement, free and clear of all liens (other than those arising under this Subscription Agreement or state
or federal securities laws).

 

d. This
Subscription Agreement has been duly authorized, executed and delivered by RAC and, assuming that this Subscription Agreement constitutes
the valid and binding agreement of the Investor, this Subscription Agreement is enforceable against RAC in accordance with its terms,
except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other
laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether considered at law or equity.

 

e. The
execution, delivery and performance by RAC of this Subscription Agreement, including the issuance and sale of the Shares, and the compliance
by RAC with all of the provisions of this Subscription Agreement and the consummation of the Investment Transactions will be done in accordance
with the rules of the New York Stock Exchange (the “NYSE”) or such other applicable stock exchange on which the Shares
are then listed (the “Stock Exchange”) and do and will not conflict with or result in a breach or violation of any
of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance
upon any of the property or assets of RAC or any of its subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust,
loan agreement, lease, license or other agreement or instrument to which RAC or any of its subsidiaries is a party or by which RAC or
any of its subsidiaries is bound or to which any of the property or assets of RAC is subject that would reasonably be expected to have
a material adverse effect on the business, financial condition or results of operations of RAC and its subsidiaries, taken as a whole,
(a “Material Adverse Effect”) or materially affect the validity of the Shares
or the legal authority of RAC to comply in all material respects with this Subscription Agreement; (ii) result in any violation of the
provisions of the organizational documents of RAC; or (iii) result in any violation of any statute or any judgment, order, rule or regulation
of any court or governmental agency or body, taxing authority or regulatory body, domestic or foreign, having jurisdiction over RAC or
any of its properties that would reasonably be expected to have a Material Adverse Effect or materially affect the validity of the Shares
or the legal authority of RAC to comply in all material respects with this Subscription Agreement.

 

f. As
of their respective dates, all reports (the “SEC Reports”) required to be filed by RAC with the U.S. Securities and
Exchange Commission (the “SEC”) complied in all material respects with the applicable requirements of the Securities
Act of 1933, as amended (the “Securities Act”), and the Exchange Act and the rules and regulations of the SEC promulgated
thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The financial statements of RAC included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing and fairly present
in all material respects the financial position of RAC as of and for the dates thereof and the results of operations and cash flows for
the periods then ended, subject, in the case of unaudited financial statements, to normal, year-end audit adjustments. A copy of each
SEC Report is available to the Investor via the SEC’s EDGAR system. There are no outstanding or unresolved comments in comment letters
received by RAC from the staff of the Division of Corporation Finance of the SEC with respect to any of the SEC Reports as of the date
hereof.

 

g. Other
than the Other Subscription Agreements, the Transaction Agreements and any other agreement expressly contemplated by the Transaction Agreements
or as described in the SEC Reports, RAC has not entered into any side letter or similar agreement with any investor in connection with
such investor’s direct or indirect investment in RAC (other than any side letter or similar agreement relating to the transfer to
any investor of (i) securities of RAC by existing securityholders of RAC, which may be effectuated as a forfeiture to RAC and reissuance
or (ii) securities to be issued to the direct or indirect securityholders of Aria or Archaea pursuant to the Transaction Documents). No
Other Investor may purchase Shares pursuant to an Other Subscription Agreement at a price per Share less than the Per Share Purchase Price,
and no Other Subscription Agreement includes terms and conditions that are materially more advantageous to any such Other Investor than
the Investor hereunder other than terms particular to the regulatory requirements of such subscriber or its affiliates or related funds
that are mutual funds or are otherwise subject to regulations related to the timing of funding and the issuance of the related Shares.

 

    4

     

    

 

h. RAC
is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with,
any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with
the execution, delivery and performance by RAC of this Subscription Agreement (including, without limitation, the issuance of the Shares),
other than (i) filings with the SEC, (ii) filings required by applicable state securities laws, (iii) filings required by the Stock Exchange,
and (iv) the failure of which to obtain would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect.

 

i. As
of the date of this Subscription Agreement, the authorized capital stock of RAC consists of (i) 1,000,000 shares of preferred stock, par
value $0.0001 per share (“Preferred Stock”), and (ii) 270,000,000 shares of common stock, par value $0.0001 per share
(the “Common Stock”), including (A) 250,000,000 shares of Class A Common Stock, par value $0.0001 per share (“Class
A Common Stock”), and (B) 20,000,000 shares of Class B Common Stock, par value $0.0001 (“Class B Common Stock”).
As of the date of this Subscription Agreement, (i) no shares of Preferred Stock are issued and outstanding, (ii) 23,727,500 shares
of Class A Common Stock are issued and outstanding, (iii) 5,931,350 shares of Class B Common Stock are issued and outstanding
and (iv) 18,633,500 redeemable warrants (each of which entitles the holder thereof to purchase one share of Class A Common Stock) and 6,771,000
private placement warrants (each of which entitles the holder thereof to one share of Class A Common Stock or, in certain circumstances,
one Class A unit of RAC OpCo, together with a corresponding share of Class B Common Stock) are outstanding. All issued and outstanding
shares of Class A Common Stock and Class B Common Stock have been duly authorized and validly issued, are fully paid and are non-assessable,
and all outstanding warrants have been duly authorized and validly issued. Except as set forth above and pursuant to the Other Subscription
Agreements, the Transaction Agreements and the other agreements and arrangements referred to therein or in the SEC Reports (as defined
below), as of the date hereof, there are no outstanding options, warrants or other rights to subscribe for, purchase or acquire from RAC
any shares of Common Stock or other equity interests in RAC, or securities convertible into or exchangeable or exercisable for such equity
interests. As of the date hereof, RAC has no subsidiaries, other than RAC OpCo, Aria Merger Sub and Archaea Merger Sub, and does not own,
directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There
are no stockholder agreements, voting trusts or other agreements or understandings to which RAC is a party or by which it is bound relating
to the voting of any securities of RAC, other than (i) as set forth in the SEC Reports and (ii) as contemplated by the Transaction Agreements.
There are no securities or instruments issued by or to which RAC is a party containing anti-dilution or similar provisions that will be
triggered by the issuance of the Shares hereunder or under any Other Subscription Agreement, in each case, that have not been or will
not be waived on or prior to the Closing Date.

 

j. As
of the date hereof, the issued and outstanding Shares are registered pursuant to Section 12(b) of the Exchange Act and are listed for
trading on the NYSE under the symbol “RICE” (it being understood that the trading symbol may be changed in connection with
the Transactions). As of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of RAC, threatened
against RAC by the NYSE or the SEC to prohibit or terminate the listing of the Shares on the Stock Exchange or to deregister the Shares
under the Exchange Act, respectively. RAC has taken no action that is designed to terminate the registration of the Shares under the Exchange
Act. Prior to the Closing, a supplemental listing application shall have been filed with the Stock Exchange to list the Shares, and at
the Closing, (i) either the Shares to be acquired hereunder shall have been approved for listing on the Stock Exchange, subject to official
notice of issuance, or (ii) RAC will use best efforts to obtain such approval as expeditiously as possible.

 

k. Assuming
the accuracy of the Investor’s representations and warranties set forth in Section 7, no registration under the Securities
Act is required for the offer and sale of the Shares by RAC to the Investor hereunder. The Shares (i) were not offered by any form of
general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or in a distribution
in violation of, the Securities Act, or any state securities laws.

 

l. Except
for Citigroup Global Markets Inc., Jefferies LLC and Roth Capital Partners, LLC (the “Placement Agents”), no broker,
finder, commission agent or arranger is entitled to any brokerage or finder’s fees or other commission solely in connection with
the Investment Transactions.

 

    5

     

    

 

m. Neither
the execution of this Subscription Agreement nor the issuance or sale of the Shares as contemplated by this Subscription Agreement gives
rise to any rights of first refusal, rights of first offer or similar rights under any agreement to which RAC is a party that would entitle
any person, whether incorporated or not, to purchase or otherwise acquire any of the Shares to be acquired by the Investor pursuant to
this Subscription Agreement or require that an offer to purchase or acquire any of such Shares be made to any person.

 

n. RAC
is not and, as of the Closing Date after the application of the proceeds from this Subscription Agreement will not be, an “investment
company” or a company “controlled” by an “investment company” within the meaning of the Investment Company
Act of 1940, as amended.

 

o. Except
for such matters as have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect,
as of the date hereof, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending,
or, to the knowledge of RAC, threatened against RAC or (ii) judgment, decree, injunction, ruling or order of any governmental entity or
arbitrator outstanding against RAC. The aggregate of all pending legal or governmental proceedings to which RAC or its subsidiaries is
a party to or of which any of their respective property or assets is the subject of that are not described in the SEC Reports, including
ordinary routine litigation incidental to the business, would not reasonably be expected to result in a Material Adverse Effect.

 

p. There
is no civil, criminal or administrative suit, action, proceeding, arbitration, investigation, review or inquiry pending or, to the knowledge
of RAC, threatened against or affecting RAC or any of RAC’s properties or rights that affects or would reasonably be expected to
affect RAC’s ability to consummate the transactions contemplated by this Subscription Agreement, nor is there any decree, injunction,
rule or order of any governmental authority or arbitrator outstanding against RAC or any of RAC’s properties or rights that affects
or would reasonably be expected to affect RAC’s ability to consummate the transactions contemplated by this Subscription Agreement.

 

q. Neither
RAC nor any of its subsidiaries nor any director or officer of any of the foregoing, nor, to the knowledge of RAC, any agent, employee
or affiliate of any of the foregoing, is aware of or has knowingly taken or will take any action, directly or indirectly, that would result
in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively,
the “FCPA”), or any other applicable anti-corruption or anti-bribery laws, including, without limitation, making use
of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay, or
authorization or approval of the payment or giving of money, property, gifts or anything else of value, directly or indirectly, to any
“foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate
for foreign political office, in contravention of the FCPA or any other applicable anti-corruption or anti-bribery laws.

 

r. No
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving RAC or any of
its subsidiaries with respect to the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes
of all applicable jurisdictions, the rules and regulations thereunder or any related or similar rules, regulations or guidelines issued,
administered or enforced by any governmental authority with jurisdiction over RAC or its subsidiaries is pending or, to the knowledge
of RAC, threatened.

 

s. Neither
RAC, nor any director or officer thereof, nor, to the knowledge of RAC, any employee, agent, controlled affiliate or representative of
RAC, is a person that is, or is owned or controlled by a person that is currently subject to, any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department (“OFAC”) or any other applicable sanction laws; and RAC will
not knowingly directly or indirectly use the proceeds from the Investment Transactions, or knowingly lend, contribute or otherwise make
available such proceeds to any subsidiary, joint venture partner or other person, to (i) fund or facilitate any activities or business
of or with any person that, at the time of such funding or facilitation, is subject to any U.S. sanctions administered by OFAC or any
other applicable sanctions laws or (ii) in any other manner that will result in a violation of any U.S. sanctions administered by
OFAC or any other applicable sanctions laws by any person.

 

    6

     

    

 

t. RAC
acknowledges and agrees that, notwithstanding anything herein to the contrary, the Shares may be pledged by the Investor in connection
with a bona fide margin agreement, provided such pledge shall be (i) pursuant to an available exemption from the registration requirements
of the Securities Act or (ii) pursuant to, and in accordance with, a registration statement that is effective under the Securities Act
at the time of such pledge, and the Investor effecting a pledge of Shares shall not be required to provide RAC with any notice thereof;
provided, however, that neither RAC, Aria, Archaea or any of their respective subsidiaries or their respective counsels
shall be required to take any action (or refrain from taking any action) in connection with any such pledge, other than providing any
such lender of such margin agreement with an acknowledgment that the Shares are not subject to any contractual prohibition on pledging
or lock up, the form of such acknowledgment to be subject to review and comment by RAC in all respects.

 

7. Investor Representations
and Warranties. The Investor represents and warrants to RAC that:

 

a. The
Investor, or each of the funds managed by or affiliated with the Investor for which the Investor is acting as nominee, as applicable,
(i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act), or an institutional “accredited
investor” (described in Rule 501(a)(1), (2), (3) or (7) under the Securities Act), in each case, satisfying the applicable requirements
set forth on Schedule A, (ii) is acquiring the Shares in reliance on a private placement exemption from registration under the
Securities Act and is acquiring the Shares only for its own account and not for the account of others, or if the Investor is subscribing
for the Shares as a fiduciary or agent for one or more investor accounts, the Investor has full investment discretion with respect to
each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each
owner of each such account and (iii) is not acquiring the Shares with a view to, or for offer or sale in connection with, any distribution
thereof in violation of the Securities Act (and shall provide the requested information set forth on Schedule A). The Investor
is not an entity formed for the specific purpose of acquiring the Shares and is an “institutional account” as defined in FINRA
Rule 4512(c).

 

b. The
Investor acknowledges that the Shares are being offered in a transaction not involving any public offering within the meaning of the Securities
Act and that neither the offer nor the sale of the Shares has been registered under the Securities Act. The Investor acknowledges and
agrees that the Shares may not be offered, resold, transferred, pledged or otherwise disposed of by the Investor absent an effective registration
statement under the Securities Act except (i) to RAC or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that
occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption
from the registration requirements of the Securities Act, and in each of clauses (i) and (iii) in accordance with any applicable securities
laws of the states and other jurisdictions of the United States, and that book entry positions representing the Shares shall contain a
restrictive legend to such effect (provided that such legend shall be subject to removal in accordance with Section 8(d)).
The Investor acknowledges and agrees that the Shares will be subject to these securities laws transfer restrictions, and as a result,
the Investor may not be able to readily offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required to bear
the financial risk of an investment in the Shares for an indefinite period of time. The Investor acknowledges and agrees that the Shares
will not be eligible for offer, resale, transfer or disposition pursuant to Rule 144 promulgated under the Securities Act (“Rule
144”) until at least one year from the Closing Date. The Investor acknowledges and agrees that it has been advised to consult
legal counsel and tax and accounting advisors prior to making any offer, resale, pledge, transfer or other disposition of any of the Shares.
Nothing contained herein shall be deemed a representation or warranty by such Investor to hold the Shares for any period of time.

 

c. The
Investor acknowledges and agrees that the Investor is purchasing the Shares directly from RAC. The Investor further acknowledges and agrees
that there have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of RAC, Aria or Archaea
or any of their respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any
of the foregoing or any other person or entity, expressly or by implication, other than those representations, warranties, covenants and
agreements of RAC expressly set forth in Section 6.

 

d. The
Investor’s acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited transaction under Section
406 of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended,
or any applicable similar law.

 

    7

     

    

 

e. The
Investor acknowledges and agrees that the Investor has received such information as the Investor deems necessary in order to make an investment
decision with respect to the Shares, including, with respect to RAC, the Transactions and the businesses of Aria and Archaea and their
respective subsidiaries. Without limiting the generality of the foregoing, the Investor acknowledges and agrees that it has reviewed,
or has had an adequate opportunity to review, the SEC Reports. The Investor acknowledges and agrees that the Investor and the Investor’s
professional advisor(s), if any, have had the opportunity to ask such questions, receive such answers and obtain such information as the
Investor and such Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect
to the Shares. The Investor acknowledges and agrees that certain information provided to it by RAC was based on good-faith projections,
and such good-faith projections were prepared based on assumptions and estimates that are inherently uncertain and are subject to a wide
variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially
from those contained in the good-faith projections.

 

f. The
Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and RAC, Aria, Archaea or
a representative thereof, or by means of contact from the Placement Agents, and the Shares were offered to the Investor by RAC solely
by direct contact between the Investor and RAC, Aria, Archaea or a representative thereof, or the Placement Agents. The Investor did not
become aware of this offering of the Shares, nor were the Shares offered to the Investor, by any other means. The Investor acknowledges
and agrees that the Shares (i) were not offered to the Investor by any form of general solicitation or general advertising and (ii) to
the Investor’s knowledge are not being offered in a manner involving a public offering under, or in a distribution in violation
of, the Securities Act, or any state securities laws. The Investor acknowledges and agrees that it is not relying upon, and has not relied
upon, any statement, representation or warranty made by any person, firm or corporation (including, without limitation, RAC, Aria, Archaea
or the Placement Agents or any of their respective affiliates or any of its or their control persons, officers, directors, employees,
partners, agents or representatives), other than the representations and warranties of RAC contained in Section 6, in making its
investment or decision to invest in RAC. The Investor further acknowledges and agrees that the Placement Agents have not made, do not
make and shall not be deemed to make any express or implied representation or warranty with respect to RAC, Aria, Archaea, this offering
or the Transactions.

 

g. The
Investor acknowledges and agrees that it is aware that there are substantial risks incident to the purchase and ownership of the Shares,
including those set forth in RAC’s filings with the SEC. The Investor is a sophisticated investor and has such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares. The Investor has
sought such accounting, legal and tax advice as the Investor has considered necessary to make an informed investment decision, and the
Investor has made its own assessment and has satisfied itself concerning relevant tax and other economic considerations relative to its
purchase of the Shares. The Investor is able to sustain a complete loss on its investment in the Shares. The Investor acknowledges and
agrees that none of the Placement Agents, nor any of their respective affiliates, control persons, officers, directors or employees, shall
be liable to the Investor pursuant to this Subscription Agreement for any action heretofore or hereafter taken or omitted to be taken
by any of them in connection with the purchase by the Investor of the Shares. On behalf of itself and its affiliates, the Investor acknowledges
and agrees it will not look to any of the Placement Agents for all or any part of loss the Investor may suffer by reason of acquiring
the Shares.

 

h. Alone,
or together with any professional advisor(s), the Investor has analyzed and considered the risks of an investment in the Shares and determined
that the Shares are a suitable investment for the Investor and that the Investor is able at this time and in the foreseeable future to
bear the economic risk of a total loss of the Investor’s investment in RAC. The Investor acknowledges and agrees specifically that
a possibility of total loss exists.

 

i. In
making its decision to purchase the Shares, the Investor has relied solely upon independent investigation made by the Investor. The Investor
acknowledges and agrees that the Investor has not relied on any statements or other information provided by or on behalf of the Placement
Agents or any of their respective affiliates, control persons, officers, directors, employees, partners, agents or representatives concerning
RAC, Aria, Archaea, the Transaction Agreements, the Transactions, this Subscription Agreement, the Investment Transactions, the Shares
or the offer and sale of the Shares. The Placement Agents shall not have any liability or obligation (including without limitation, for
or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements
incurred by the Investor), whether in contract, tort or otherwise, to the Investor, and the Investor releases the Placement Agents, in
respect of this Subscription Agreement, the Investment Transactions or the Transactions.

 

    8

     

    

 

j. The
Investor further acknowledges and agrees that the Placement Agents and their respective affiliates, control persons, officers, directors,
employees or representatives (i) have not provided the Investor with any information or advice with respect to the Shares, (ii) have not
made or make any representation, express or implied as to RAC, Aria, Archaea, the credit quality of RAC, Aria or Archaea, the Shares or
the Investor’s purchase of the Shares, (iii) have not acted as the Investor’s financial advisor or fiduciary in connection
with the Investment Transactions or the Transactions, (iv) may have acquired or may acquire non-public information with respect to RAC,
Aria or Archaea, which, subject to the requirements of applicable law, the Investor agrees need not be provided to it or (v) may have
existing or future business relationships with RAC, Aria or Archaea (including, but not limited to, lending, depository, risk management,
advisory and banking relationships) and will pursue actions and take steps that it deems or they deem necessary or appropriate to protect
its or their interests arising therefrom without regard to the consequences for a holder of Shares, and that certain of these actions
may have material and adverse consequences for a holder of Shares.

 

k. The
Investor acknowledges and agrees that it has not relied on the Placement Agents in connection with its determination as to the legality
of its acquisition of the Shares or as to the other matters referred to herein and the Investor has not relied on any investigation that
the Placement Agents or any person acting on their behalf have conducted with respect to the Shares, RAC, Aria or Archaea. The Investor
further acknowledges and agrees that it has not relied on any information contained in any research reports prepared by the Placement
Agents.

 

l. The
Investor acknowledges and agrees that no federal or state agency, securities commission or similar authority has passed upon or endorsed
the merits of the offering of the Shares or made any findings or determination as to the fairness of this investment.

 

m. The
Investor has been duly formed or incorporated and is validly existing and in good standing under the laws of its jurisdiction of incorporation
or formation, with power and authority to enter into, deliver and perform its obligations under this Subscription Agreement.

 

n. The
execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the Investor, have been duly
authorized and do not and will not (i) constitute or result in a breach or default under or conflict with any order, ruling or regulation
of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the Investor
is a party or by which the Investor is bound, except for such breaches, defaults or conflicts that would not reasonably be expected to
have a material adverse effect on the ability of the Investor to enter into and timely perform its obligations under this Subscription
Agreement, and (ii) violate any provisions of the Investor’s organizational documents, including, without limitation, its incorporation
or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature on this Subscription
Agreement is genuine, and the signatory, if the Investor is an individual, has legal competence and capacity to execute the same or, if
the Investor is not an individual, the signatory has been duly authorized to execute the same, and assuming that this Subscription Agreement
constitutes the valid and binding obligation of RAC, this Subscription Agreement constitutes a legal, valid and binding obligation of
the Investor, enforceable against the Investor in accordance with its terms except as may be limited or otherwise affected by (i) bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally,
or (ii) principles of equity, whether considered at law or equity.

 

o. The
Investor is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by OFAC
or in any Executive Order issued by the President of the United States and administered by OFAC (“OFAC
List”), or a person or entity prohibited by any OFAC sanctions program, (ii) owned, directly or indirectly, or controlled
by, or acting on behalf of, one or more persons that are named on the OFAC List, (iii) organized, incorporated, established, located,
resident or born in, or a citizen, national or the government, including any political subdivision, agency or instrumentality thereof,
of Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine or any other country or territory embargoed or subject to substantial
trade restrictions by the United States, (iv) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part
515 or (v) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (each, a “Prohibited Investor”).
The Investor agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable law, provided
that the Investor is permitted to do so under applicable law. If the Investor is a financial institution subject to the Bank Secrecy Act
(31 U.S.C. Section 5311 et seq.) (the “BSA”), as amended by the USA PATRIOT
Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively,
the “BSA/PATRIOT Act”), the Investor maintains policies and procedures reasonably
designed to comply with applicable obligations under the BSA/PATRIOT Act. To the extent required, it maintains policies and procedures
reasonably designed to ensure compliance with OFAC-administered sanctions programs, including for the screening of its investors against
the OFAC sanctions programs, including the OFAC List. To the extent required by applicable law, the Investor maintains policies and procedures
reasonably designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived and were not obtained,
directly or indirectly, from a Prohibited Investor.

 

    9

     

    

 

p. The
Investor acknowledges and agrees that it has been informed that no disclosure or offering document has been prepared by the Placement
Agents in connection with the offer and sale of the Shares.

 

q. No
foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign state have
a substantial interest (as defined in 31 C.F.R. Part 800.244) will acquire a substantial interest in RAC as a result of the purchase and
sale of the Shares hereunder such that a declaration to the Committee on Foreign Investment in the United States would be mandatory under
31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208) over RAC from and after the Closing
as a result of the purchase and sale of the Shares hereunder.

 

r. No
broker or finder is entitled to any brokerage or finder’s fee or commission solely in connection with the sale of the Shares to
the Investor based on any arrangement entered into by or on behalf of the Investor.

 

s. The
Investor hereby acknowledges and agrees that it will not, nor will any person acting at the Investor’s direction or pursuant to
any understanding with the Investor, directly or indirectly engage in hedging activities or execute any “short sales” as defined
in Rule 200 of Regulation SHO under the Exchange Act of the Shares subscribed for hereunder (collectively, the “Short Sales”)
until the consummation of the Investment Transactions or the Transactions (or such earlier termination of this Subscription Agreement
in accordance with its terms). Notwithstanding the foregoing or anything else in this Subscription Agreement, this Section 7(s)
shall not apply to (i) any sale (including the exercise of any redemption right) of securities of RAC (x) held by the Investor, its affiliates
or any person or entity acting on behalf of the Investor or any of its affiliates prior to the execution of this Subscription Agreement
or (y) purchased by the Investor, its affiliates or any person or entity acting on behalf of the Investor or any of its affiliates after
the execution of this Subscription Agreement or (ii) ordinary course hedging transactions so long as the sales or borrowings relating
to such hedging transactions are not settled with the Shares subscribed for hereunder and the number of securities sold in such transactions
does not exceed the number of securities owned or subscribed for at the time of such transactions. Notwithstanding the foregoing or anything
else in this Subscription Agreement, (I) nothing herein shall prohibit (A) other entities under common management with the Investor or
(B) in the case of an Investor that is externally managed, advised or sub-advised by another person, any other person that is not directly
controlled or managed by such manager, adviser or sub-adviser, from entering into any Short Sales and (II) in the case of an Investor
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Investor’s assets
and the portfolio managers have no knowledge of the investment decisions made by the portfolio managers managing other portions of such
Investor’s assets, the representations set forth in this Section 7(s) shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase the Shares covered by this Subscription Agreement.

 

t. The
Investor acknowledges that the Placement Agents and their respective directors, officers, employees, partners, agents, representatives
and controlling persons have made no independent investigation with respect to RAC, Aria, Archaea or their respective affiliates, subsidiaries
or businesses or the Shares or the accuracy, completeness or adequacy of any information supplied to the Investor by RAC.

 

    10

     

    

 

u. The
Investor has or has commitments to have and, when required to deliver payment to RAC pursuant
to Section 2, will have, sufficient funds to pay the Subscription Amount and
consummate the purchase and sale of the Shares pursuant to this Subscription Agreement.

 

8. Registration Rights.

 

a. RAC
agrees that, within 30 calendar days after the Closing Date, it will file with the SEC (at its sole cost and expense) a registration statement
(the “Registration Statement”) registering, among other things, the resale
of the Shares acquired by the Investor pursuant to this Subscription Agreement (which for purposes of this Section shall include any other
equity security issued or issuable with respect to the Shares by way of share split, dividend, distribution, recapitalization, merger,
exchange, replacement or similar event), provided that the Investor has timely provided RAC with information regarding the Investor
that is, in the opinion of RAC’s counsel, required to be included in the Registration Statement, which information shall be requested
by RAC from the Investor at least five business days prior to the anticipated filing date of the Registration Statement. RAC further agrees
that it shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after
the filing thereof, but no later than the earlier of (i) 60 calendar days after the filing
thereof (or, in the event the SEC reviews and has written comments to the Registration Statement, the 90th calendar day following
the filing thereof) and (ii) the seventh business day after the date RAC is notified (orally
or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed” or will not be subject
to further review (the earlier of (i) and (ii), the “Effectiveness Deadline”); provided, that if such
deadline falls on a Saturday, Sunday or other day that the SEC is closed for business, the Effectiveness Deadline shall be extended to
the next business day on which the SEC is open for business. RAC agrees to cause such Registration Statement, or another shelf registration
statement that includes the Shares to be sold pursuant to this Subscription Agreement, to remain effective until the earliest of (A) the
third anniversary of the date the initial Registration Statement hereunder is declared effective, (B) the date on which the Investor ceases
to hold any Shares issued pursuant to this Subscription Agreement or (C) on the first date on which the Investor can sell all of its Shares
issued pursuant to this Subscription Agreement (or shares received in exchange therefor) under Rule 144 within 90 days without being subject
to the public information, volume or manner of sale limitations of such rule (such date, the “End Date”). The Investor
agrees to disclose its ownership to RAC upon request to assist it in making the determination described above. RAC may amend the Registration
Statement so as to convert the Registration Statement to a Registration Statement on Form S-3 at such time after RAC becomes eligible
to use such Form S-3. RAC’s obligations to include the Shares issued pursuant to this Subscription Agreement (or shares issued in
exchange therefor) for resale in the Registration Statement are contingent upon the Investor furnishing in writing to RAC such information
regarding the Investor, the securities of RAC held by the Investor and the intended method of disposition of such Shares, which shall
be limited to non-underwritten public offerings, as shall be reasonably requested by RAC to effect the registration of such Shares, and
shall execute such documents in connection with such registration as RAC may reasonably request that are customary of a selling stockholder
in similar situations; provided that the Investor shall not in connection with the foregoing be required to execute any lock-up
or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Shares. The Investor acknowledges
and agrees that unless it has timely provided such information and consented to the inclusion of such information in the Registration
Statement, it will not be entitled to have its Shares included in the Registration Statement.

 

b. The
Investor acknowledges and agrees that RAC may suspend the use of the Registration Statement if it determines that, in order for such Registration
Statement not to contain a material misstatement or omission, an amendment thereto would be needed to include information that would at
that time not otherwise be required in a current, quarterly or annual report under the Exchange Act, provided, that, (i) RAC shall
not so delay filing or so suspend the use of the Registration Statement on more than three occasions for a period of more than 60 consecutive
days or more than a total of 120 calendar days, in each case in any 360-day period and (ii) RAC shall use commercially reasonable efforts
to make such Registration Statement available for the sale by the Investor of such securities as soon as practicable thereafter.

 

c. RAC
will provide a draft of the Registration Statement to the Investor for review at least two business days in advance of filing the Registration
Statement. In no event shall the Investor be identified as a statutory underwriter in the Registration Statement unless in response to
a comment or request from the staff of the SEC or another regulatory agency; provided, however, that if the SEC requests
that the Investor be identified as a statutory underwriter in the Registration Statement, the Investor will have an opportunity to withdraw
from the Registration Statement. RAC shall upon reasonable request inform the Investor as to the status of a registration pursuant to
Section 8.

 

    11

     

    

 

d. If
the SEC prevents RAC from including any or all of the Shares proposed to be registered for resale under the Registration Statement due
to limitations on the use of Rule 415 of the Securities Act for the resale of the Shares by the applicable shareholders or otherwise,
(i) such Registration Statement shall register for resale such number of Shares that is equal to the maximum number of Shares as is permitted
by the SEC, (ii) the number of Shares to be registered for each Investor named in the Registration Statement shall be reduced pro rata
among all such Investors, and (iii) as promptly as practicable after being permitted to register additional Shares under Rule 415 of the
Securities Act, RAC shall file a new Registration Statement to register such Shares not included in the initial Registration Statement
and cause such Registration Statement to become effective as promptly as practicable.

 

e. Prior
to the End Date, RAC shall advise the Investor within five business days (at RAC’s expense): (i) when a Registration Statement or
any post-effective amendment thereto has been filed and when it becomes effective; (ii) of any request by the SEC for amendments or supplements
to any Registration Statement or the prospectus included therein or for additional information; (iii) of the issuance by the SEC of any
stop order suspending the effectiveness of any Registration Statement or the initiation of any proceedings for such purpose; (iv) of the
receipt by RAC of any notification with respect to the suspension of the qualification of the Shares included therein for sale in any
jurisdiction or the initiation or threatening of any proceeding for such purpose; and (v) subject to the provisions in this Subscription
Agreement, of the occurrence of any event that requires the making of any changes in any Registration Statement or prospectus so that,
as of such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary
to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading
(provided that any such notice pursuant to this Section 8(e) shall solely provide that the use of the Registration Statement
or prospectus has been suspended without setting forth the reason for such suspension). Notwithstanding anything to the contrary set forth
herein, RAC shall not, when so advising the Investor of such events, provide the Investor with any material, nonpublic information regarding
RAC other than to the extent that providing notice to the Investor of the occurrence of the events listed in (i) through (v) above may
constitute material, nonpublic information regarding RAC. RAC shall use its commercially reasonable efforts to obtain the withdrawal of
any order suspending the effectiveness of any Registration Statement as soon as reasonably practicable. Upon the occurrence of any event
contemplated in clauses (i) through (v) above, except for such times as RAC is permitted hereunder to suspend, and has suspended, the
use of a prospectus forming part of a registration statement, RAC shall use its commercially reasonable efforts to as soon as reasonably
practicable prepare a post-effective amendment to such Registration Statement or a supplement to the related prospectus, or file any other
required document so that, as thereafter delivered to purchasers of the Shares included therein, such prospectus will not include any
untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The Investor agrees that it will immediately discontinue offers and sales of the Shares using
the Registration Statement until the Investor receives copies of a supplemental or amended prospectus that corrects the misstatement(s)
or omission(s) referred to above in clause (v) and receives notice that any post-effective amendment has become effective or unless otherwise
notified by RAC that it may resume such offers and sales. If so directed by RAC, the Investor will deliver to RAC or, in the Investor’s
sole discretion destroy, all copies of the prospectus covering the Shares in the Investor’s possession; provided, however,
that this obligation to deliver or destroy all copies of the prospectus covering the Shares shall not apply (x) to the extent the Investor
is required to retain a copy of such prospectus in order to comply with applicable legal, regulatory, self-regulatory or professional
requirements or in accordance with a bona fide pre-existing document retention policy or (y) to copies stored electronically on archival
servers as a result of automatic data back-up.

 

f. Prior
to the End Date, RAC shall use its commercially reasonable efforts to cause all Shares issued to the Investor pursuant to this Subscription
Agreement to be listed on each securities exchange or market, if any, on which the shares of Class A Common Stock of RAC have been listed.
With a view to making available to the Investor the benefits of Rule 144 that may, at such times as Rule 144 is available to shareholders
of RAC, permit the Investors to sell securities of RAC to the public without registration, RAC agrees to, for so long as such Investor
owns the Shares acquired hereunder: (i) make and keep public information available, as those terms are understood and defined in Rule
144; (ii) file with the SEC in a timely manner all reports and other documents required of RAC under the Securities Act and the Exchange
Act so long as RAC remains subject to such requirements and the filing of such reports and other documents is required for the applicable
provisions of Rule 144; and (iii) furnish to the Investor, within two business days following its receipt of a written request, (A) a
written statement by RAC, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange
Act, (B) a copy of the most recent annual or quarterly report of RAC and such other reports and documents so filed by RAC (it being understood
that the availability of such report on the SEC’s EDGAR system shall satisfy this requirement) and (C) such other information as
may be reasonably requested in writing to permit the Investor to sell such securities pursuant to Rule 144 without registration.

 

    12

     

    

 

g. In
addition, in connection with any sale, assignment, transfer or other disposition of the Shares by the Investor pursuant to Rule 144 or
pursuant to any other exemption under the Securities Act such that the Shares held by the Investor become freely tradable and upon compliance
by the Investor with the requirements of this Subscription Agreement, if requested by the Investor, RAC shall cause the transfer agent
for the Shares (the “Transfer Agent”) to remove any restrictive legends related to the book entry account holding such
Shares and make a new, unlegended entry for such book entry Shares sold or disposed of without restrictive legends within two trading
days of any such request therefor from the Investor, provided that RAC and the Transfer Agent have timely received from the Investor
customary representations and other documentation reasonably acceptable to RAC and the Transfer Agent in connection therewith. Subject
to receipt from the Investor by RAC and the Transfer Agent of customary representations and other documentation reasonably acceptable
to RAC and the Transfer Agent in connection therewith, including, if required by the Transfer Agent, an opinion of RAC’s counsel,
in a form reasonably acceptable to the Transfer Agent, to the effect that the removal of such restrictive legends in such circumstances
may be effected under the Securities Act, the Investor may request that RAC remove any legend from the book entry position evidencing
its Shares following the earliest of such time as such Shares (i) have been or are about to be sold or transferred pursuant to an effective
registration statement or pursuant to Rule 144 or (ii) are eligible for resale under Rule 144(b)(1) or any successor provision without
the requirement for RAC to be in compliance with the current public information requirement under Rule 144 and without volume or manner-of-sale
restrictions applicable to the sale or transfer of such Shares. If restrictive legends are no longer required for such Shares pursuant
to the foregoing, RAC shall, in accordance with the provisions of this section and within three trading days of any request therefor from
the Investor accompanied by such customary and reasonably acceptable representations and other documentation referred to above establishing
that restrictive legends are no longer required, deliver to the Transfer Agent irrevocable instructions that the Transfer Agent shall
make a new, unlegended entry for such book entry Shares. RAC shall be responsible for the fees of its Transfer Agent and all DTC fees
associated with such issuance.

 

h. Indemnification.

 

(i) RAC
agrees to indemnify and hold harmless, to the extent permitted by law, the Investor, its directors, officers, employees, advisors and
agents, and each person who controls the Investor (within the meaning of the Securities Act or the Exchange Act) and each affiliate of
the Investor (within the meaning of Rule 405 under the Securities Act) from and against any and all out-of-pocket losses, claims, damages,
liabilities and expenses (including, without limitation, any reasonable and documented attorneys’ fees and expenses incurred in
connection with defending or investigating any such action or claim) caused by any untrue or alleged untrue statement of material fact
contained in any Registration Statement, prospectus included in any Registration Statement or preliminary prospectus or any amendment
thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make
the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to
RAC by or on behalf of the Investor expressly for use therein.

 

(ii) The
Investor agrees, severally and not jointly with any person that is a party to the Other Subscription Agreements, to indemnify and hold
harmless RAC, its directors and officers and agents and each person who controls RAC (within the meaning of the Securities Act) against
any losses, claims, damages, liabilities and expenses (including, without limitation, reasonable and documented attorneys’ fees)
resulting from any untrue statement of material fact contained in the Registration Statement, prospectus or preliminary prospectus or
any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the
statements therein not misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit
so furnished in writing by or on behalf of the Investor expressly for use therein. In no event shall the aggregate liability of the Investor
under this clause (ii) and under clause (iv) below be greater in amount than the dollar amount of the net proceeds received by the Investor
upon the sale of the Shares purchased pursuant to this Subscription Agreement giving rise to such indemnification obligation.

 

    13

     

    

 

(iii) Any
person entitled to indemnification herein shall (A) give prompt written notice to the indemnifying party of any claim with respect to
which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification
hereunder to the extent such failure has not prejudiced the indemnifying party) and (B) permit such indemnifying party to assume the defense
of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall
not be subject to any liability for any settlement made by the indemnified party without its consent. An indemnifying party who elects
not to assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified
by such indemnifying party with respect to such claim, unless in the reasonable judgment of legal counsel to any indemnified party a conflict
of interest exists between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying
party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot
be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such
settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect to such claim or litigation.

 

(iv) The
indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation made
by or on behalf of the indemnified party or any officer, director, employee, agent, affiliate or controlling person of such indemnified
party and shall survive the transfer of the Shares purchased pursuant to this Subscription Agreement.

 

(v) If
the indemnification provided under this Section 8(h) from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party,
in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of
such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying
party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or
alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information
supplied by or on behalf of, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s
relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party
as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth above,
any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No
person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
pursuant to this Section 8(h)(v) from any person who was not guilty of such fraudulent misrepresentation. Any contribution pursuant
to this Section 8(h)(v) by any seller of Shares shall be limited in amount to the amount of net proceeds received by such seller
from the sale of such Shares pursuant to the Registration Statement. Notwithstanding anything to the contrary herein, in no event will
any party be liable for consequential, special, exemplary or punitive damages in connection with this Subscription Agreement.

 

    14

     

    

 

9. Termination. This
Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of (a)
such date and time as either of the Transaction Agreements is terminated in accordance with its terms without being consummated, (b)
upon the mutual written agreement of each of the parties hereto and Aria and Archaea to terminate this Subscription Agreement, (c) if
the Closing has not occurred by such date other than as a result of a breach of the Investor’s obligations hereunder, upon 30 days
after the Outside Date (as defined in the Aria Merger Agreement as in effect on the date hereof), which date is (x) October 4, 2021,
if the “Expiration Date” under the Debt Commitment Letter (as defined in the Aria Merger Agreement as in effect on the date
hereof) has not been extended in accordance with its terms or (y) between October 5, 2021 and November 3, 2021, if the “Expiration
Date” under the Debt Commitment Letter has been extended in accordance with its terms, or (d) if any of the conditions to Closing
set forth in Section 4 are not satisfied or waived, or are not capable of being satisfied, on or prior to the Closing and, as
a result thereof, the Investment Transactions will not be and are not consummated at the Closing (the termination events described in
clauses (a) through (d) above, collectively, the “Termination Events”); provided that nothing herein will relieve
any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies
at law or in equity to recover losses, liabilities or damages arising from any such breach. In the event that either of the Transaction
Agreements is terminated in accordance with its terms, RAC shall notify the Investor in writing of the termination of such Transaction
Agreement promptly after the termination thereof. Upon the occurrence of any Termination Event, this Subscription Agreement shall be
void ab initio and of no further effect and any monies paid by the Investor to RAC in connection herewith shall promptly (and in any
event within one business day) following the Termination Event be returned to the Investor.
 

10. Trust Account Waiver.
The Investor acknowledges that RAC is a blank check company with the powers and privileges to effect a merger, asset acquisition, reorganization
or similar business combination involving RAC and one or more businesses or assets. The Investor further acknowledges that, as described
in RAC’s prospectus relating to its initial public offering dated October 21, 2020 (the “IPO Prospectus”)
available at www.sec.gov, substantially all of RAC’s assets consist of the cash proceeds of RAC’s initial public offering
and private placement of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust
Account”) for the benefit of RAC, its public shareholders and the underwriters of RAC’s initial public offering.
Except with respect to interest earned on the funds held in the Trust Account that may be released to RAC to pay its tax obligations,
if any, the cash in the Trust Account may be disbursed only for the purposes set forth in the IPO Prospectus. For and in consideration
of RAC entering into this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged, the Investor hereby irrevocably
(a) waives any and all right, title and interest, or any claim of any kind, it has or may have in the future in or to any monies held
in the Trust Account, and (b) agrees not to seek recourse against the Trust Account, in each case, as a result of, or arising out of,
this Subscription Agreement; provided, however, that nothing in this Section 10 shall (i) serve to limit or prohibit
the Investor’s right to pursue a claim against assets held outside the Trust Account for specific performance or other equitable
relief, (ii) serve to limit or prohibit any claims that the Investor may have in the future against RAC’s assets or funds that
are not held in the Trust Account (including any funds that have been released from the Trust Account and any assets that have been purchased
or acquired with any such funds) or (iii) be deemed to limit the Investor’s right, title, interest or claim to any monies held
in the Trust Account by virtue of its record or beneficial ownership of Shares acquired other than pursuant to this Subscription Agreement,
pursuant to a validly exercised redemption right with respect to any such Shares, except to the extent that the Investor has otherwise
agreed with RAC to not exercise such redemption right.

 

    15

     

    

 

11. Miscellaneous.

 

a. Neither
this Subscription Agreement nor any rights that may accrue to the parties hereunder (other than the Shares acquired hereunder, if any)
may be transferred or assigned without the prior written consent of each of the other parties hereto; provided that (i) this Subscription
Agreement and any of the Investor’s rights and obligations hereunder may be assigned to any fund or account managed by the same
investment manager as the Investor or by an affiliate (as defined in Rule 12b-2 of the Exchange Act) of such investment manager without
the prior consent of RAC and (ii) the Investor’s rights under Section 8 may be assigned to an assignee or transferee of the
Shares; provided further that prior to such assignment any such assignee shall agree in writing to be bound by the terms hereof;
provided, that no assignment pursuant to clause (i) of this Section 11(a) shall relieve the Investor of its obligations
hereunder.

 

b. RAC
may request from the Investor such additional information as RAC, acting reasonably, may deem necessary to evaluate the eligibility of
the Investor to acquire the Shares, and the Investor shall promptly provide such information as may reasonably be requested. The Investor
acknowledges and agrees that RAC may file a form of this Subscription Agreement with the SEC as an exhibit to a current or periodic report,
proxy statement or a registration statement of RAC. Notwithstanding anything in this Subscription Agreement to the contrary, RAC shall
not publicly disclose the name of the Investor or any of its affiliates or advisers, or include the name of the Investor or any of its
affiliates or advisers in any press release or in any filing with the SEC or any regulatory agency or trading market, without the prior
written consent of the Investor, except (i) as required by the federal securities law or pursuant to other routine proceedings of regulatory
authorities, after giving advance notice to the Investor, to the extent allowed by law or such regulatory authorities, or (ii) to the
extent such disclosure is required by law, at the request of the staff of the SEC or regulatory agency or under the regulations of the
Stock Exchange, after giving advance notice to the Investor, to the extent allowed by law, the SEC, the Stock Exchange or such other regulatory
agency.

 

c. The
Investor acknowledges and agrees that RAC will rely on the acknowledgments, understandings, agreements, representations and warranties
of the Investor contained in this Subscription Agreement, including Schedule A hereto. Prior to the Closing, the Investor agrees to promptly
notify RAC and the Placement Agents if any of the acknowledgments, understandings, agreements, representations and warranties set forth
in Section 7 above are no longer accurate in any material respect (other than those acknowledgments, understandings, agreements,
representations and warranties qualified by materiality, in which case the Investor shall notify RAC and the Placement Agents if they
are no longer accurate in all respects). The Investor acknowledges and agrees that the purchase by the Investor of Shares from RAC under
this Subscription Agreement will constitute a reaffirmation of the acknowledgments, understandings, agreements, representations and warranties
herein (as modified by any such notice) by the Investor as of the time of such purchase. The Investor further acknowledges and agrees
that the Placement Agents, Aria and Archaea will rely on the representations and warranties of the Investor contained in Section 7
(including the acknowledgements, understandings and agreements of the Investor contained therein) and are third-party beneficiaries of
Section 11 and of the representations and warranties (including the acknowledgements, understandings and agreements of the Investor
contained therein) of the Investors contained in Section 7.

 

d. RAC
and, to the extent set forth in Section 11(c), Aria, Archaea and the Placement Agents, are each entitled to rely upon this Subscription
Agreement, and the Placement Agents are entitled to rely on the representations and warranties of RAC contained in Section 6 hereof,
and each is irrevocably authorized to produce this Subscription Agreement or a copy hereof to any interested party in any administrative
or legal proceeding or official inquiry with respect to the matters covered hereby; provided, however, that the foregoing clause
of this Section 11(d) shall not give RAC or the Placement Agents any rights other than those expressly set forth herein.

 

e. All
of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

f. This
Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 9 above) except by
an instrument in writing, signed by each of the parties hereto; provided, however, that no modification or waiver by RAC
of the provisions of this Subscription Agreement shall be effective without the prior written consent of Aria and Archaea (other than
modifications or waivers that are solely ministerial in nature or otherwise immaterial and do not affect any economic or any other material
term of this Subscription Agreement). No failure or delay of either party in exercising any right or remedy hereunder shall operate as
a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to
enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right
or power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies that they would
otherwise have hereunder. Notwithstanding anything to the contrary herein, Section 7, Section 11(c), Section 11(d),
this Section 11(f) and Section 12 may not be modified, waived or terminated in a manner that is adverse to the Placement
Agents without the written consent of the Placement Agents.

 

    16

     

    

 

g. This
Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings,
representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as set forth
in Section 8(h), Section 9, Section 11(c), Section 11(d), Section 11(f), this Section 11(g), the
last sentence of Section 11(k) and Section 12 with respect to the persons referenced therein, and Section 6 and Section
7 with respect to the Placement Agents, this Subscription Agreement shall not confer any rights or remedies upon any person other
than the parties hereto and their respective successors and assigns, and the parties hereto acknowledge and agree that such persons so
referenced are third party beneficiaries of this Subscription Agreement with right of enforcement for the purposes of, and to the extent
of, the rights granted to them, if any, pursuant to the applicable provisions.

 

h. Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their
heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties,
covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators,
successors, legal representatives and permitted assigns.

 

i. If
any provision (or part thereof) of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid,
illegal or unenforceable, the validity, legality or enforceability of the remaining provisions (or parts thereof) of this Subscription
Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.

 

j. This
Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf) and by different
parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed
and delivered shall be construed together and shall constitute one and the same agreement.

 

k. The
parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Subscription
Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties
shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting a bond or undertaking
and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition
to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise. The parties hereto acknowledge
and agree that each of Aria and Archaea shall be entitled to specifically enforce the provisions of the Subscription Agreement of which
Aria and Archaea are express third party beneficiaries, in each case, on the terms and subject to the conditions set forth herein.

 

l. If
any change in the number, type or classes of authorized shares of RAC (including the Shares), other than as contemplated by the Transaction
Agreements or any agreement contemplated by the Transaction Agreements, shall occur between the date hereof and immediately prior to the
Closing by reason of reclassification, recapitalization, stock split (including reverse stock split) or combination, exchange or readjustment
of shares, or any stock dividend, the number of Shares issued to the Investor and Per Share Purchase Price shall be appropriately adjusted
to reflect such change. In no event will this Section 11(l) be construed to require the Investor to complete the purchase of the
Shares contemplated hereby without satisfaction of all of the conditions to Closing contained in this Subscription Agreement.

 

m. This
Subscription Agreement and all claims and causes of action hereunder shall be governed by and construed in accordance with the laws of
Delaware (regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters
(including any action, suit, litigation, arbitration, mediation, claim, charge, complaint, inquiry, proceeding, hearing, audit, investigation
or reviews by or before any governmental entity related hereto), including matters of validity, construction, effect, performance and
remedies.

 

    17

     

    

 

n. Each
party hereto hereby, and any person asserting rights as a third party beneficiary may do so only if he, she or it, irrevocably agrees
that any action, suit or proceeding between or among the parties hereto, whether arising in contract, tort or otherwise, arising in connection
with any disagreement, dispute, controversy or claim arising out of or relating to this Subscription Agreement or any related document
or any of the Investment Transactions or the Transactions (“Legal Dispute”) shall be brought only to the exclusive
jurisdiction of the Chancery Court of the State of Delaware or, in the event, but only in the event, that the Court of Chancery of the
State of Delaware does not have subject matter jurisdiction, the Superior Court of the State of Delaware (Complex Commercial Division)
or, if subject matter jurisdiction over the action or proceeding is vested exclusively in the federal courts of the United States of America,
the United States District Court for the District of Delaware, and each party hereto hereby consents to the jurisdiction of such courts
(and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent
permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in
any such court or that any such suit, action or proceeding that is brought in any such court has been brought in an inconvenient forum.
During the period a Legal Dispute that is filed in accordance with this Section 11(n) is pending before a court, all actions, suits
or proceedings with respect to such Legal Dispute or any other Legal Dispute, including any counterclaim, cross-claim or interpleader,
shall be subject to the exclusive jurisdiction of such court. Each party hereto and any person asserting rights as a third party beneficiary
may do so only if he, she or it hereby waives, and shall not assert as a defense in any Legal Dispute, that (a) such party is not
personally subject to the jurisdiction of the above named courts for any reason, (b) such action, suit or proceeding may not be brought
or is not maintainable in such court, (c) such party’s property is exempt or immune from execution, (d) such action, suit
or proceeding is brought in an inconvenient forum or (e) the venue of such action, suit or proceeding is improper. A final judgment
in any action, suit or proceeding described in this Section 11(n) following the expiration of any period permitted for appeal and
subject to any stay during appeal shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other
manner provided by applicable laws. EACH OF THE PARTIES HERETO AND ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY MAY DO SO
ONLY IF HE, SHE OR IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY
LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT, THE INVESTMENT TRANSACTIONS OR THE TRANSACTIONS AND FOR ANY COUNTERCLAIM RELATING
THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY HERETO NOR ANY
PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR
RELATING TO THIS SUBSCRIPTION AGREEMENT, THE INVESTMENT TRANSACTIONS OR THE TRANSACTIONS. FURTHERMORE, NO PARTY HERETO NOR ANY PERSON
ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING
IN WHICH A JURY TRIAL CANNOT BE WAIVED.

 

o. Any
notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or sent by overnight
mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed to be given and
received (i) when so delivered personally, (ii) when sent, with no mail undeliverable or other rejection notice, if sent by email,
or (iii) three business days after the date of mailing to the address below or to such other address or addresses as such person may hereafter
designate by notice given hereunder:

 

	 	(i) 	if to the Investor, to such address(es) or email address(es) set forth on the signature page hereto;
	 	 	 
	 	(ii) 	if to RAC, to:
	 	 	 
	 	 	Rice Acquisition Corp.
	 	 	102 East Main Street, Second Story
	 	 	Carnegie, Pennsylvania 15106
	 	 	Attention: 	Kyle Derham
	 	 	E-mail:	kyle@riceinvestmentgroup.com
	 	 	 	 
	 	 	with a required copy to (which copy shall not constitute notice):
	 	 	 
	 	 	Kirkland & Ellis LLP
	 	 	609 Main Street
	 	 	Houston, Texas 77002
	 	 	Attention:	Matthew R. Pacey, P.C.
	 	 	 	Cyril V. Jones, P.C.
	 	 	Email:	matt.pacey@kirkland.com 
	 	 	 	cyril.jones@kirkland.com

 

    18

     

    

 

	 	(iii)	if to Aria, to:
	 	 
	 	 	Aria
    Energy LLC
	 	 	46280
    Dylan Drive, Ste 200
	 	 	Novi,
    MI 48377
	 	 	Attention:
    	Richard
    DiGia
	 	 	E-mail:	richard.digia@ariaenergy.com
	 	 	 	 
	 	 	with
    a required copy to (which copy shall not constitute notice):
	 	 	 
	 	 	Orrick,
    Herrington & Sutcliffe LLP
	 	 	The
    Orrick Building
	 	 	405
    Howard Street
	 	 	San
    Francisco, CA 94105
	 	 	Attention:	John
    Cook
	 	 	 	Kristin
    Seeger
	 	 	Email:	jcook@orrick.com
    
	 	 	 	kseeger@orrick.com
	 	 	 	 
	 	(iii)	if
    to Archaea, to:
	 	 	 
	 	 	Archaea
    Energy LLC
	 	 	500
    Technology Drive
	 	 	Second
    Floor
	 	 	Canonsburg,
    PA 15317
	 	 	Attention:	Nicholas
    Stork
	 	 	 	Andrew
    Eastman
	 	 	Email:	nstork@archaea.energy
	 	 	 	aeastman@archaea.energy
	 	 	 	 
	 	 	with
    a required copy to (which copy shall not constitute notice):
	 	 	 	 
	 	 	Pillsbury
    Winthrop Shaw Pittman LLP
	 	 	31
    West 52nd Street
	 	 	New
    York, NY 10019-6131
	 	 	Attention:	Mona
    Dajani
	 	 	Email:	mona.dajani@pillsburylaw.com

 

p. The
Investor shall pay all of its own expenses in connection with this Subscription Agreement and the Investment Transactions.

 

12. Non-Reliance and Exculpation.
The Investor acknowledges and agrees that it is not relying upon, and has not relied upon, any statement, representation or warranty
made by any person, firm or corporation (including, without limitation, RAC, Archaea, Aria, the
Placement Agents or any of their respective control persons, officers, directors, employees, partners, agents or representatives),
other than the statements, representations and warranties of RAC expressly contained in Section 6, in making its investment or
decision to invest in RAC. The Investor acknowledges and agrees that none of (a) any other investor pursuant to an Other Subscription
Agreement (including such investor’s affiliates or any control persons, officers, directors, partners, agents, employees or representatives
of any of the foregoing), (b) the Placement Agents or any of their respective control persons,
officers, directors, partners, agents, employees or representatives or (c) any party to the Transaction Agreements, including
any such party’s representatives, affiliates or any of its or their control persons, officers,
directors, partners, agents, employees or representatives, that is not a party hereto, shall be liable to the Investor, or to
any other investor, pursuant to, or arising out of or relating to, this Subscription Agreement or any Other Subscription Agreement arising
out of the private placement of the Shares, the negotiation hereof or thereof or its subject matter, or the Investment Transactions or
the Transactions, including, without limitation, with respect to any action heretofore or hereafter taken or omitted to be taken by any
of them in connection with the purchase of the Shares or with respect to any claim (whether in tort, contract or otherwise) for breach
of this Subscription Agreement or in respect of any written or oral representations made or alleged to be made in connection herewith,
as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions with respect to any information or
materials of any kind furnished by RAC, Aria, Archaea, the Placement Agents or any Non-Party Affiliate concerning RAC, Aria, Archaea,
the Placement Agents, any of their respective controlled affiliates, this Subscription Agreement, the Investment Transactions or the
Transactions. For purposes of this Subscription Agreement, “Non-Party Affiliates” means each former, current or future
officer, director, employee, partner, member, manager, direct or indirect equityholder or affiliate of RAC, Aria, Archaea, the Placement
Agents or any of RAC’s, Aria’s, Archaea’s or either of the Placement Agents’ controlled affiliates or any family
member of the foregoing.

 

13. Disclosure. RAC
shall, by 9:00 a.m., New York City time, on the first business day immediately following the date of this Subscription Agreement, issue
one or more press releases or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”)
disclosing all material terms of the Investment Transactions, the Transactions and any other material, nonpublic information that RAC,
or any of its officers, employees or agents on behalf of RAC, has provided to the Investor at any time prior to the filing of the Disclosure
Document. Upon the issuance of the Disclosure Document, to the knowledge of RAC, the Investor shall not be in possession of any material,
non-public information received from RAC or any of its officers, directors, employees or agents, and the Investor shall no longer be
subject to any confidentiality or similar obligations under any current agreement, whether written or oral, with RAC or any of its affiliates,
relating to the transactions contemplated by this Subscription Agreement. Notwithstanding anything in this Subscription Agreement to
the contrary, RAC shall not publicly disclose the name of the Investor or any of its affiliates or advisers, or include the name of the
Investor or any of its affiliates or advisers in any press release or in any filing with the SEC or any regulatory agency or trading
market, without the prior written consent of the Investor, except (a) as required by the federal securities law or pursuant to other
routine proceedings of regulatory authorities, after giving advance notice to the Investor, to the extent allowed by law or such regulatory
authorities or (b) to the extent such disclosure is required by law, at the request of the staff of the SEC or regulatory agency or under
the regulations of the Stock Exchange, after giving advance notice to the Investor, to the extent allowed by law, the SEC, the Stock
Exchange or such other regulatory agency.

 

[SIGNATURE PAGES FOLLOW]

 

    19

     

    

 

IN WITNESS WHEREOF,
the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the date set
forth below.

 

	Name of Investor:	 	State/Country of Formation or Domicile:
	 	 	 
	By:	 	 	 
	Name:	                	 	 
	Title:	 	 	 
	 	 	 	 
	Name in which Shares are to be registered (if different):	 	Date: ________, 2021
	 	 	 
	Investor’s EIN:	 	 
	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	City, State, Zip:	 	City, State, Zip:
	 	 	 
	Attn:	 	 	Attn:	           
	 	 	 	 	 
	Telephone No.:	 	Telephone No.:
	Facsimile No.:	 	Facsimile No.:
	 	 	 
	Number of Shares subscribed for:	 	 
	 	 	 
	Aggregate Subscription Amount: $ 	Price Per Share: $10.00

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by RAC in the Closing Notice.

 

     

     

    

 

IN WITNESS WHEREOF, Rice Acquisition
Corp. has accepted this Subscription Agreement as of the date set forth below.

 

	 	Rice Acquisition Corp.
	 	 
	 	By:	           
	 	Name:  
	 	Title:  
	Date:                , 2021	 

 

     

     

    

 

SCHEDULE A

ELIGIBILITY REPRESENTATIONS
OF THE INVESTOR

 

	A.	QUALIFIED INSTITUTIONAL BUYER STATUS

 

	 	(Please check the applicable subparagraphs):

 

☐  We
are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act).

 

	B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS

 

	 	(Please check the applicable subparagraphs):

 

	 	1.	☐  We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

	 	2.	☐  We are not a natural person.

 

Rule 501(a), in relevant part, states that
an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably
believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated,
by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under which the Investor accordingly
qualifies as an “accredited investor.”

 

☐  Any
bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business investment
company;

 

☐  Any
plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions
for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

☐  Any
employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered
investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

☐  Any
organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership, not
formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

☐  Any
trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated
person; or

 

☐  Any
entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

	C.	AFFILIATE STATUS

 

	 	(Please check the applicable box)
	 	 
	 	SUBSCRIBER:

 

		☐	is:

		☐	is not:

an “affiliate” (as defined in Rule 144 under the Securities Act) of RAC or acting on behalf of an affiliate of RAC.

 

	D.	
    FINRA INSTITUTIONAL ACCOUNT STATUS

    (Please check the applicable subparagraphs):

 

	 	1.	☐  We are an “institutional account” under FINRA Rule 4512(c).

 

	 	2.	☐  We are not an “institutional account” under FINRA Rule 4512(c).

 

This Schedule A
should be completed by the Investor

and constitutes
a part of the Subscription Agreement.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]